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Chapter 1. A not-so-ancient grease history: click chemistry and protein lipid 
modifications 
 
Reproduced with permission from Kiall F. Suazo, Keun-Young Park, and Mark Distefano. A Not-So-
Ancient Grease History: Click Chemistry and Protein Lipid Modifications 
 
This chapter comprises of sections from a manuscript published in the journal Chemical Reviews. 
The review article embodied a complete story on the details of various lipid modifying enzymes and 
how click chemistry was exploited in research with those enzymes, both in studying the biological 
significance of protein lipid modification and for performing biotechnological applications in a site-
specific fashion. This chapter focuses on the latter part of the review paper. Starting with an 
introduction to different types of click chemistry reactions that have been utilized in biological 
environments, a description of the use of protein-lipid modifying enzymes for specific applications 




Protein lipid modification involves the attachment of hydrophobic groups to proteins via 
ester, thioester, amide or thioether linkages; this process occurs in eukaryotes but not 
prokaryotes.1,2 The most common purpose of such modifications is to cause the association of the 
resulting proteins to various membranes where they can interact with other proteins involved in 
signal transduction pathways. Proteins containing such modifications are involved in a diverse 
range of cellular functions including cell division, subcellular organization, secretion and 
differentiation.3–7 Due to their critical role in such processes, these lipid-modified proteins are often 
mutated in various diseases or targets for therapeutic intervention.8–11 In addition, the consensus 
sequences that mark proteins for lipidation are often simple and can be incorporated into other 
proteins to render them membrane-bound or provide a new site for selective modification. That 
feature has been exploited for a myriad of applications ranging from protein immobilization to the 
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creation of protein-drug conjugates for therapeutic applications.12,13 Click chemistry has played a 
key role in both illuminating features of protein lipid modification as well as exploiting it for the 
aforementioned alternative applications.14–18 
In this review, the specific click chemical reactions that have been employed to study 
protein lipid modification and their use for specific labeling applications are first described. That is 
followed by a description of the use of protein-lipid modifying enzymes for specific labeling 
applications including protein immobilization, fluorescent labeling, assembly of nanostructures and 
the construction of protein drug conjugates. Concluding remarks and future directions are 
presented in the final section.  
 
1.2. Click chemistry 
 
A term coined by Sharpless and coworkers, click chemistry is defined as reactions that 
are modular, wide in scope, give very high yields, generate only inoffensive byproducts, require 
simple reaction conditions, and use benign solvents such as water.19 Click chemistry closely 
overlaps with bio-orthogonal chemistry, which is defined as reactions that do not interfere with 
biological processes that proceed rapidly and selectively under physiological conditions.20 Tools 
developed for click chemistry enable bio-orthogonal reactions and developments in chemical 
biology stimulate the conception of novel click chemistry. Before the birth of these two concepts, 
chemistry and biology were somewhat disconnected as many advances in chemistry were 
inapplicable to living systems. The development of click chemistry revolutionized chemical biology, 
especially when performed in tandem with enzymatic labeling due to the synergetic effects 
generated by the unique advantages that the two components each provide. To be used in cellular 
environments, the participating click chemistry functionalities require a few additional 
characteristics. The molecular reaction components must possess cell penetrating capabilities and 
click-induced modifications must introduce minimal perturbation, which often necessitates the 
reaction components to be hydrophobic, neutrally charged, and small in size. Fortunately, many 
types of click reactions meet these criteria. Therefore, the bio-orthogonality of click chemistry has 
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allowed selective labeling and therefore real-time investigation of enzymatic processes of interest 
both in vitro and in vivo, providing insights into many biological questions and biomedical 
challenges including cancer, Alzheimer’s disease, and coronavirus, among others. The site-
specificity and rapid rates of both click chemistry and enzymatic labeling have also been purposed 
to tackle those biomedical challenges by efficiently functionalizing therapeutic molecules of interest. 
The combination of the two principles has created a powerful and multifunctional “Swiss Army knife-
like” tool. In this section, click reactions that are most commonly used specifically in tandem with 
lipid modifying enzymes are described (Fig. 1.1). For a broader scope of click chemistry or 
applications to other specific fields, readers are directed to other reviews including those included 
in the current thematic issue.21–25  
One type of click reactions involve azides which are a versatile functionality due to their 
small size, stability and inertness. Azides are known to be truly bio-orthogonal as they are 
essentially absent in biological systems.22 The first bio-orthogonal click reaction reported was a 
Staudinger ligation between an azide and a functionalized triphenylphosphine (Fig. 1.1A). Bertozzi 
and coworkers exploited a modified version of the classic Staudinger reaction where they appended 
an ester to the phosphine component to prevent the hydrolysis of the aza-ylide intermediate, and 
instead via intramolecular trapping pushed the reaction towards a stable amide-linked product.26 
This classic reaction has been and is still widely used for many applications both in cellular 
environments and in live animals due to its selectivity and biocompatibility.27 However, slow reaction 
kinetics (k ~ 10-3 M-1s-1) and the oxidation-prone phosphine reagents have driven investigations 
into alternative click chemistries,28 which has led to the emergence of the copper-catalyzed azide-
alkyne cycloaddition (CuAAC, Fig. 1.1B), the most widely used click chemistry to date. CuAAC 
takes advantage of a Cu(I) catalyst which lowers the activation barrier for the formation of the 
triazole ring, resulting in significantly enhanced kinetics (k ~ 10-100 M-1s-1).29–32 Cu(I) is typically 
prepared in situ from Cu(II) salts by reducing agents, and is stabilized by various ligands that allows 
the reaction to proceed in aqueous conditions.33–35 The use of copper however is a double-edged 
sword, as its cytotoxicity is a significant liability. Cu(I) is involved in protein oxidation via reactive 
oxygen species (ROS) that also causes DNA strand breaks,32 which restricts the application of 
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CuAAC with proteins or living cells. Efforts have been made to overcome the toxicity issue by 
utilizing novel ligands36,37 or improved azide structures38–40 which allow reduced copper 
concentrations while maintaining reaction efficiency, or reducing the generation of reactive oxygen 
species (ROS).34,41 Strain-promoted azide-alkyne cycloaddition (SPAAC, Fig. 1.1C) is an 
alternative to CuAAC which exploits activated alkynes incorporating ring strain to eliminate the 
requirement for metal catalysts.42 The non-toxic nature of copper-free click chemistry has allowed 
SPAAC to be employed in various in vivo applications.25 The use of SPAAC has significantly grown 
in the field of protein conjugation, often used in tandem with enzymatic labeling to maximize its 
selectivity and site-specificity. The growth is expected to continue as many pharmaceutical 
companies have established platforms for synthesizing site-specific antibody drug conjugates 
(ADC) based on site-specific installation of an azide and use of strained-alkyne payloads.43 In terms 
of accelerating the rate of SPAAC, progress has been made through various strategies including 
adding electron-withdrawing fluorines adjacent to the alkyne,44 adding a ketone to distort the alkyne 
into a more reactive geometry,45 adding a nitrogen in the ring for increased hydrophilicity,46 or 
forming a fused ring system for additional ring strain.47 However, the rate of SPAAC (k ~ 0.1-1 M-
1s-1) still falls far behind CuAAC, and there are concerns that the large size and hydrophobicity of 
the ring-fused strained alkynes are prone to modulate the properties of target molecules or 
introduce off-target binding.48,49  
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Figure 1.1 Reaction scheme of biorthogonal click reactions for modifying proteins of interest. (A) 
Modified Staudinger ligation between an azide and phosphine reagent. An aza-ylide intermediate 
is formed followed by a transfer to the ester forming an amide bond. The O-alkyl imidate product 
can occur especially with aryl azides. (B) The copper-catalyzed azide-alkyne cycloaddition reaction 
(CuAAC) is a 1,3-dipolar cycloaddition between alkynes and azides that results in a 1,2,3-triazole 
product. (C) Strain-promoted azide-alkyne cycloaddition (SPAAC) reaction that employs strained 
octynes. (D) Inverse-electron demand Diels-Alder (iEDDA) reaction between strained alkenes 
(trans-cyclooctene or norbornene) with tetrazine. (E) Reaction between aldehyde and hydrazines 
or aminooxy compounds to form hydrazone or oxime bonds, respectively. These reactions can be 
catalyzed by aniline and related reagents (mPDA). (F) Radical reactions between thiols and 
alkenes or alkynes initiated by UV light. 
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Strained alkenes such as trans-cyclooctenes (TCO) or norbornenes undergo inverse 
electron demand Diels-Alder (iEDDA, Fig. 1.1D) reactions with tetrazines, which is the fastest click 
reaction identified to date (k > 103 M-1s-1). Although tetrazine ligation exploits ring strain to achieve 
accelerated rates under copper free conditions, it has been shown to be orthogonal to SPAAC 
which therefore allows the use of both reactions simultaneously for selective labeling of multiple 
targets.50,51 The fast rate even at low concentrations makes it especially useful in radiolabeling 
studies where the short half-life of isotopes requires rapid labeling,52 or tracking and imaging of fast 
dynamic biological processes in living cells.23 In imaging studies, tetrazine-conjugated fluorophores 
have been used as turn-on probes due to the dual functionality of the tetrazine as both a bio-
orthogonal moiety and a fluorescence quencher.25 Similar to SPAAC, the biggest drawback in 
tetrazine ligation is the hydrophobicity and large size of the ring-containing alkenes. However, 
smaller dienophiles such as cyclopropenes or azetines have been shown to retain reactivity and 
aqueous stability which introduces minimal perturbation at the target site comparable to products 
of the CuAAC reaction.53–55 
Aldehydes and ketones undergo transamination reactions with amine nucleophiles that 
exhibit the α-effect, namely, increased nucleophilicity from the presence of lone pair electrons on 
the atom adjacent to the amine.24 to form oximes or hydrazones. Although endogenous intracellular 
aldehydes and ketones do exist, oxime and hydrazone ligation (Fig. 1.1E) are considered bio-
orthogonal as the α-effect nucleophile counterpart is rare and the reaction can be useful in other 
biological environments where aldehydes and ketones are absent. Oxime and hydrazone ligation 
products are among the smallest possible products in size among other click reaction products 
which therefore results in minimal structural perturbation. Rapid rate (k ~ 1-103 M-1s-1) at 
physiological conditions has been achieved by careful structural design of the substrates56 and use 
of various catalysts.57–60 While an oxime linkage is more stable than a hydrazone,61 both ligation 
products are susceptible to hydrolysis, and especially for hydrazones  that have a low equilibrium 
constant (Keq) which at low concentration reactions causes incomplete product conversion and 
dissociation of the products.59 However, the instability of oximes and hydrazones has actually 
provided them with a unique reversible capability which has been exploited for various 
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applications.62–64 For studies that require stable products, modified ligation reactions have been 
developed that utilize the reaction of aldehydes with alternative nucleophiles that yield stable C-C 
bonds instead of the labile C=N bonds.65–67  Due to their unique advantages, the use of oxime and 
hydrazone ligation has been well established for site-specific protein labeling and in vitro cell 
surface labelling especially in combination with enzymatic labelling methods which allows 
controlled installment of an aldehyde.68,69 However, in vivo applications employing aldehyde and 
ketones are considerably more limited. 
Thiol-ene (and thiol-yne) reactions (Fig. 1.1F) are click reactions that occur between thiols 
and alkenes or alkynes. Thiol-ene click chemistry has been heavily utilized for the functionalization 
of polymeric materials or nanoparticles.70,71 While the use of thiol-ene chemistry in biochemical 
applications has held challenges in retaining its bio-orthogonality and site-specificity due to cellular 
thiols and other nucleophilic and electrophilic groups prone to side reactions,72–74 it has been shown 
that exploiting photochemistry, in which the reaction proceeds via a single electron radical chemistry, 
provides enhanced selectivity.75 Additionally, using light as the external stimulus allows applications 
in studies that require spatiotemporal control. These properties of thiol-ene click chemistry have 
prompted its use for protein modification such as surface immobilization, extracellular matrix (ECM) 
generation, and protein patterning in hydrogels.76,77  
 
1.3 Proteins of interest site-specifically functionalized via lipid modifying 
enzymes and click chemistry for biotechnological applications 
 
Previous sections described the use of click chemistry for biological studies of proteins 
modified via lipidating enzymes. In the following sections, we focus on prior art that has exploited 
those enzymes for the modification of proteins of interests (POI) with various functionalities together 
with click chemistry. Protein modification via enzymatic methods provide unique advantages. The 
site-specificity allows homogenous product formation with controlled stoichiometry, as opposed to 
conventional chemical methods such as cysteine-maleimide or lysine-N-hydroxylsuccinimide ester 
chemistry in which conjugation of a specific site or number of amino acid residues is difficult to 
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achieve. Precise control over the site of modification tends to cause minimal perturbation of native 
protein activity. For instance, modification via S-prenylation occurs at the C-terminus and N-
myristoylation at the N-terminus, which are often distanced from the active sites of target proteins. 
Enzymatic labeling is bio-orthogonal as it occurs only on proteins that contain the specific 
consensus sequence, Ca1a2X for S-prenylation and MGXXXS/T/C for N-myristoylation. This allows 
selective labeling of the POI in mixtures such as crude lysates, which eliminates purification steps 
which is important in biotechnology where downstream processing of protein products is 
responsible for over half of the total production cost.78 Finally, enzymatic reactions enable fast 
modifications with high yields under mild conditions, in contrast to other site-specific methods such 
as unnatural amino acid incorporation which is often limited by low protein yields and technical 
difficulties.79  
While a number of different lipid modifying enzymes exist, as noted above, the products 
of palmitoylation yield a hydrolysis-prone thioester linkage that is potentially susceptible to loss of 
the conjugated payload in various biological environments. Similarly, the ester linkages from 
cholesterylation and GPI-modification have related instability features, that has prompted the 
development of biotechnological applications that utilize lipid modifying enzymes to be focused on 
S-prenylation and N-myristoylation. In future research, it will be interesting to see advances that 
allow the expansion of the range of exploitable lipid modifying enzymes. For instance, it may be 
become possible to utilize palmitoylation in situations that require reversible attachment and 
detachment of a payload, or by enhancing the linker stability through formation of an amide bond 
instead of the thioester through an intramolecular S-to-N shift.80  
 
1.3.1 C-terminal protein functionalization through S-prenylation  
 
Protein S-prenylation allows site-specific protein modification of almost any protein by 
simple appending of a short Ca1a2X recognition motif onto the C-terminus of the POI. The use of 
S-prenylation for biotechnological applications has mostly evolved around FTase for a number of 
reasons. The synthesis of analogues of farnesyl diphosphate is much easier than that of 
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geranylgeranyl diphosphate due to their simpler structure. FTase is known for its promiscuity that 
enables it to accept a wide variety of substrates including ones that incorporate a bulky aryl group 
or even a biotin functionality.81,82 The plasticity of FTase can be even further improved by 
engineering the active site via mutagenesis.82,83 While GGTase-1 accepts various analogues as 
well, it still exhibits more limited lipid substrate specificity compared to FTase.84 In the case of 
RabGGTase , an additional REP component is required for the reaction to proceed which adds 
additional complexity to the overall process. In this section, the development and assessment of 
various isoprenoid analogues (Fig. 1.2 and 1.3) and their combination with click chemistry for a 
variety of applications are described (Fig. 1.4). 
A large number of FPP analogues which contain biorthogonal moieties for click chemistry 
that can be recognized as substrates by FTase have been developed by Distefano and coworkers. 
In their initial report, a geranylazide diphosphate (C10-Az-OPP, Fig. 1.3) was synthesized from 
geraniol.85 The product was a mixture of isomers in an approximately 1:1 ratio which was 
inseparable due to the facile sigmatropic interconversion of the allylic azide substrates and/or 
products. Nonetheless, C10-Az-OPP was confirmed as a substrate for FTase when evaluated with 
a peptide substrate N-dansyl-GCVIA (Dn-GCVIA). Although the incorporation of the analogue was 
slower than with FPP, the reaction was complete within a practical time frame (2 h at 30 ºC). The 
azide-functionalized peptide was then reacted with a triphenylphosphine-based reagent that 
contains an electrophilic ester moiety. Interestingly, while the Staudinger reaction showed high 
product conversion, mass spectrometry analysis of the product indicated the presence of an O-
alkyl imidate-linkage instead of the conventional amide-linkage (Fig. 1.1). Based on reports 
suggesting that alkyl azides yield the former while aryl azides yield the latter,86 it was assumed that 




Figure 1.2 Bio-orthogonal isoprenoid analogues for probing protein prenylation. Native substrates 
farnesol (FOH) and geranylgeraniol (GGOH) or their diphosphate forms FPP and GGPP modified 
with azide or alkyne functionalities suitable for CCML. A biotinylated isoprenoid can also be used 
to directly label Rab substrates but not of those for FTase and GGTase-I. 
 
In a subsequent report, Rose et al. reported on C15-Az-OPP (Fig. 1.3).87 The new 
analogue showed similar properties to C10-Az-OPP, in that it was obtained as an isomeric mixture, 
showed similar reaction rates against Dn-GCVIA, and the product of Staudinger ligation again 





Figure 1.3 Additional isoprenoid analogues used in enzymatic C-terminal modification of proteins. 
Isoprenoids are modified with an azide, alkyne, aldehyde, alkene, ketone and fluorophore 
functionalities for selective bioconjugation. 
 
In a more intensive study on the product formed from Staudinger ligation, Xu et al. 
prepared a new azide analogue 6,7-dihydrogeranylazide, which lacks the alkene present at C-6 
(C10-Dh-Az-OPP, Fig. 1.3).88 S-prenylation of Dn-GCVIA with that analogue indicated that the 
absence of the third isoprene unit brings about structural perturbation when bound to the FTase 
active site leading to a rate of reaction that was much slower than FPP. Nonetheless, C10-Dh-Az-
OPP showed similar rates to the previous C10-Az-OPP analogue which was sufficient to be 
completely converted to product with longer reaction times. Interestingly, mass spectrometric 
analysis of the reaction product between the prenylated peptide and a phosphine-based reagent 
indicated the formation of only alkoxyimidate products instead of the predicted amide despite the 
non-allylic nature of the azide. To gain a better understanding, model reactions with simpler  
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compounds were run between the dihydroprenylazide substrate precursor (the unphosphorylated 
alcohol) and three model phosphine reagents. While ESI-MS analysis indicated the formation of 
both imidate and amide products, LCMS and NMR analysis both revealed that in fact the amide is 
the dominant product where in some cases the imidate form was completely undetectable. The 
results suggested that product analysis using mass spectrometry could give contradicting results 
due to potential variations in ionization efficiencies of the products. Nonetheless, the report showed 
evidence of alkoxyimidate products from Staudinger ligation that can form when particular reagent 
types were used. These observations were significant since they highlighted the potential problem 
of product mixtures that can sometimes occur with the Staudinger ligation. 
Duckworth et al. constructed a model protein by fusing a CVIA sequence to the C-terminus 
of GFP, which was then selectively immobilized onto agarose beads by installation of an azide 
moiety via enzymatic S-prenylation followed by capture via CuAAC (Fig. 1.4A).89 Based on the 
study above, the new azide analogue (C15-Dh-Az-OPP) was composed of three isoprenoid units 
but lacked the alkene present in the terminal isoprene unit. Investigation of the rate of S-prenylation 
with Dn-GCVIA showed that 10,11-dihydrofarnesylazide diphosphate (C15-Dh-Az-OPP, Fig. 1.3) at 
saturating concentrations (10 µM) was only 2.7-fold slower than with FPP, while the previously 
reported C10-Dh-Az-OPP showed a significantly reduced catalytic efficiency, which indicated that 
the presence of a third isoprene unit and the absence of an alkene in that unit makes the azide-
containing analogue a much better substrate for FTase. After enzymatic labeling with C15-Dh-Az-
OPP of GFP-CVIA, CuAAC with alkyne-functionalized agarose beads was carried out for 15 h at 
25 ºC. Analysis of the fluorescence intensity of the beads indicated a 96% immobilization efficiency. 
Interestingly, 8% of GFP-CVIA was shown to be immobilized under the same click conditions even 
in the absence of the clickable azide, which was presumably due to nonspecific interactions caused 
by Cu(I)-induced activation of the alkyne-agarose.90 Selective capture could be obtained from 
protein mixtures containing as little as 1% GFP-N3 on account of the highly efficient click reaction. 
Poulter and coworkers prepared GFP- and GST-(glutathione S-transferase) immobilized 
glass surfaces exploiting Staudinger ligation or CuAAC (Fig. 1.4B) using similar chemistry.91 Target 
proteins were enzymatically labeled with an azide- or alkyne-containing farnesyl diphosphate 
 13
analogue (C10-Et-Az-OPP or C10-Et-Alk-OPP, Fig. 1.3) followed by click reaction with phosphine- 
or azide-derivatized glass slides that resulted in regio- and chemoselective protein immobilization. 
Although nonspecific binding of proteins lacking the clickable moiety was also observed, proteins 
covalently immobilized via click chemistry were found to be more robust; click-immobilized proteins 
were found remaining attached to the slides after treatment with an acidic saline solution for 2 h at 
80 ºC, which was sufficiently harsh to strip antibodies bound to their respective antigenic proteins, 
and remained bound to slides after 4 days in buffer while nonspecifically bound proteins had fully 
dissociated. 
In a follow-up report, Poulter and coworkers described eleven additional farnesyl 
diphosphate analogues each bearing azide or alkyne functionality, where five were shown to be 
substrates for yFTase (the yeast enzyme).92 Comparison of the steady-state kinetic parameters of 
the analogues with Dn-GCVIA indicated that the presence of a bulky or branched w-isoprenoid unit, 
charged amino groups, or rigid chains may hinder their compatibility with the active site of yFTase. 
Azide-farnesylated Dn-GCVIA products showed two closely eluting species with identical mass 
determined via LC-MS, which indicated isomeric products resulting from either incorporation of both 
regio-isomers of the azide analogue or incorporation of a single isomer which subsequently 
undergoes rearrangement. 
By exploiting CuAAC with a model protein GFP-CVIA site-specifically labeled with an 
alkyne-functionality, Duckworth et al. performed surface-immobilization and fluorophore labeling of 
proteins (Fig. 1.4A and 1.4C).93 A continuous fluorescence-based enzyme assay was employed to 
evaluate the C10-Alk-OPP as a substrate for yeast FTase (yFTase). Although farnesylation of Dn-
GCVIA with the isoprenoid analogue was approximately 12-fold slower than the natural substrate 
FPP, GFP-CVIA was fully converted to the alkyne-product within a timeframe (3 h at 30 ºC) suitable 
for downstream applications. The alkyne-labeled GFP was then immobilized onto azide-
functionalized agarose beads under CuAAC conditions. Interestingly, while immobilization of GFP-
alkyne on azide-agarose and GFP-azide on alkyne-agarose both showed highly efficient 
immobilization in 1 h (93% for both), conjugation to the alkyne-resin was shown to result in a higher 
degree of nonspecific binding. These results indicated that even for the same CuAAC reaction, 
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immobilization characteristics could vary upon the choice of functionality carried by each clickable 
reagent. For instance, in proteomic studies, using an azide-resin to prevent false-capturing of 
undesired proteins would be especially important.90 Fluorophore labeling of GFP-alkyne was 
achieved with Texas Red bearing an azide, demonstrating the wide applicability of the reported 
site-specific labeling method. Förster resonance energy transfer (FRET) calculations gave a 
Förster distance of 40 Å, which was consistent with the R-distance of 37 Å predicted by a model of 
the GFP-Texas Red conjugate. 
Distefano and coworkers synthesized protein-DNA conjugates which self-assembled into 
tetrahedral nanostructures (Fig. 1.4D).94 The model protein GFP-CVIA was farnesylated with azide 
functionality, which was exploited to conjugate with an alkyne-containing oligonucleotide 33 bases 
in length. The GFP-DNA was initially shown to form a complex with a Texas Red carrying a 
complementary 33-mer DNA strand evidenced by FRET. The hybridization of complementary DNA 
strands was further utilized in constructing a tetrahedral structured GFP-DNA nanoassembly by 
mixing four types of GFP-DNA conjugates and briefly annealing the mixture at 54 ºC. The number 
of GFP molecules per tetrahedron, observed by single molecule spectroscopy, could be controlled 
by changing the composition of the oligonucleopeptide building blocks. Overall, the advantage of 
having a compact recognition tag for site-specific protein conjugation was demonstrated through 
its application towards GFP-DNA nanostructure assembly that requires precisely spaced and 
oriented proteins. 
Waldmann and coworkers studied the effects of the isoprenoid analogue structure on S-
prenylation and click chemistry.95 Four isoprenoid analogues were synthesized, each containing a 
diene (HOM-GPP, Fig. 1.3), either an amide-linked (AAA-GPP, Fig. 1.3) or aliphatic azide (APO-
GPP, Fig. 1.3), or biotin (BGPP, Fig. 1.2). Affinity assays indicated all four analogues bind to the 
active site of FTase despite differences in length compared to the native FPP. However, while the 
azide and diene analogues showed product formation with Dn-GCVLS and the TKCVIM-tagged 
model proteins cyan fluorescent protein (CFP), RFP and small GTPase Ypt7, the biotin analogue 
did not show conversion. Reaction with GGTase-I failed to process the biotin analogue as well, 
which indicated that the complexity of analogue design involves factors beyond simply length. The 
 15
azide-functionalized proteins obtained via FTase were shown to maintain solubility and functionality 
post-labeling and underwent Staudinger ligation with a model phosphine. The azide analogue 
containing the amide-linkage was shown to react much faster than the aliphatic analogue due to its 
stronger electrophilicity. Functionalization of the diene-labeled protein via Diels-Alder cycloaddition 
was shown, which required a higher excess of dienophile and low pH conditions. 
Wollack et al. studied methods to improve the solubility of proteins functionalized via 
farnesylation.96 Following the farnesylation with a truncated alkyne-prenyl analogue (C5-Alk-OPP, 
Fig. 1.3) composed of a single isoprenoid unit, the last three amino acids of the “Ca1a2X” box were 
enzymatically removed, which resulted in site-specifically alkyne-labeled peptides or proteins with 
a net gain of only a single cysteine and nine additional non-hydrogen atoms. Although kinetic 
assays with OrG-RTRCVIA-OH (OrG: Orange Green) showed that the C5-alkyne analogue, C5-
Alk-OPP, was a poor substrate for yFTase compared with FPP, near-complete (>85%) labeling was 
achieved upon extended incubation. Carboxypeptidase Y (PY) could be utilized to cleave off the -
a1a2X  residues without yielding undesired proteolytic degradation of the peptide. The minimalistic 
labeling methodology was applied for immobilization of alkyne-mCherry on azide-functionalized 
agarose, in which the absence of the “VIA” sequence did not affect immobilization efficiency, 
demonstrating the innocuousness of the method on protein stability and click reactivity. Comparison 
of C5-Alk-OPP and the dihydro analogue C5-Dh-Az-OPP for Hcp1 labeling demonstrated that 





Figure 1.4 Applications of site-specific enzymatic protein labeling through C-terminal cysteine 
prenylation with FTase and N-terminal acylation with NMTs. (A) Immobilization of proteins 
enzymatically prenylated with clickable isoprenoids on beads functionalized with clickable moieties. 
(B) Immobilization of tagged proteins on glass or gold surfaces coated with clickable functionalities. 
(C) Direct protein modification of lipidated proteins with various payloads such as fluorophores, 
affinity handles, polymers, drugs, or antibodies. (D) Generation of DNA-protein crosslinks through 
reaction between functionalized DNA and proteins prenylated with clickable isoprenoid analogues. 
A nucleotide base is modified with a biorthogonal moiety prior to DNA synthesis. (E) Incubation of 
myristoyl probes in bacteria enables visualization of N-myristoylation of heterologously expressed 
proteins. Bio-orthogonal fluorophores are reacted with the tagged proteins inside live bacteria. 
 
The range of exploitable click chemistries that could be employed via FTase-catalyzed 
labeling was expanded by Rashidian et al. who developed an aldehyde-containing analogue of 
FPP (C15-Ald-OPP, Fig. 1.3).97 The catalytic efficiency of the aldehyde analogue was shown to be 
comparable to previously developed azide or alkyne analogues. Dn-GCVIA was successfully 
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farnesylated with the analogue by FTase which could subsequently undergo fluorophore addition. 
While the C15-Ald-OPP-labeled Dn-GCVIA rapidly formed an oxime-ligated product with aminooxy-
AlexaFluor-488 in the presence of aniline, reactions with Texas-red hydrazine were shown to be 
unsuccessful, suggesting that low µM reaction conditions are not suitable for hydrazone formation 
due to its lower equilibrium constant. Farnesylation of GFP-CVIA with the aldehyde analogue 
manifested complete product formation within 2 h at 30 ºC in the presence of FTase. Oxime ligation-
induced surface labeling of aldehyde-functionalized GFP with aminooxy-agarose beads in the 
presence of 100 mM aniline was achieved with ~30% efficiency, while labeling with aminooxy 
AlexaFluor-488 and 100 mM aniline showed 60% efficiency. Overall, oxime ligation was shown an 
efficient bio-orthogonal functionality for labeling chemistry, which could be a potential alternative to 
CuAAC where copper-free conditions are necessary such as in cellular environments. 
Tate and coworkers utilized site-specific labeling with GGPP analogues using RabGGTase 
and REP-1 in tandem with click chemistry to functionalize a series of target proteins.98 C20-Az-
OPP (Fig. 1.2) was synthesized, which despite the interconversion between 14-azido and cis/trans 
16-azido regio-isomers, was successfully transferred to a range of recombinant Rab proteins 
containing both single (Rab18) and dual (Rab6, GST-tagged Rab11, Rab27a, Rab38, Rab1a) S-
prenylation motifs. Comparison of CuAAC, phosphine-mediated ligation, and strain-promoted 
cycloaddition, using the requisite biotin derivatives showed that CuAAC is the most efficient and 
selective click reaction. That method was then used to detect geranylgeranylated proteins in cells 
which is described above in Section 7.1.1.  
Proteins farnesylated with the natural substrate FPP were shown to undergo oriented 
immobilization via thiol-ene click reactions.99 H-, N-, and K-Ras were farnesylated with FPP using 
FTase, followed by immobilization on thiol-poly(amidoamine) (PAMAM) functionalized SiOx/Si 
slides (Fig. 1.4B) by exposure to UV light through a photomask. Immunodetection of surface-bound 
Ras with an anti-Ras-Cy3 antibody revealed fluorescent micropatterns indicating successful 
immobilization. Interestingly, the labeling efficiency of farnesylated K-Ras was ~20 fold higher than 
the others, which could be attributed to the interaction between the C-terminal polylysine domain 
of K-Ras and the carboxylic acid groups present on the glass-bound PAMAM. Based on that 
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observation, mCherry and Rab6A each containing 4 or 6 lysines at their C-termini were generated, 
respectively. Farnesylated products from both proteins underwent efficient immobilization even 
directly from crude lysate. The method was extendable to a co-expression system, in which the 
engineered mCherry was farnesylated with endogenous FPP by FTase in E. coli. The resulting 
modified proteins in crude lysate could be immobilized using a longer thiol linker and with extended 
UV exposure time. Utilizing proteins prenylated with the natural substrate FPP for biotechnological 
applications was an interesting approach, obviating the development and assessment of analogues 
that contain a click-reactive functionality. Similar work was reported recently where Distefano and 
coworkers exploited the site-specifically labeled lipid groups for binding of multivalent protein 
scaffolds to cells via hydrophobic interaction.100 While the work was unique in that it utilized protein 
S-prenylation for protein-conjugation without the involvement of covalent interactions, it should be 
noted that the work could be expanded to incorporate click chemistry for a stronger and more 
selective binding-interaction between multiple target substrates. 
Taton and coworkers synthesized protein-oligodeoxynucleotide (protein-ODN) conjugates 
by combining farnesylation and copper-free click chemistry.101 Conjugation of ODN was carried out 
by farnesylation with either C10-Az-OPP or C15-Az-OPP of GFP or mCherry, followed by SPAAC 
with a DIBO-modified ODN. SPAAC proceeded over a range of pH values (3.5-12.3) and 
temperature (room temperature and 4 °C), and the product yield was comparable to CuAAC, 
demonstrating its wide applicability, simplicity, and high efficiency. ODN-conjugated proteins were 
utilized for supramolecular assembly via hybridization of the complementary DNA sequences. To 
this end, GFP and mCherry were each conjugated with complementary DBCO-ODNs and 
dimerized either at room temperature or 55 °C. Interestingly, while CuAAC-generated conjugates 
formed heterodimers under both annealing conditions, SPAAC-generated conjugates only 
dimerized at elevated temperatures presumably due to the more hydrophobic strained-alkyne 
moiety. Surface immobilization of protein-ODN conjugates on ODN-functionalized agarose beads 
was shown, which demonstrated the usefulness of SPAAC as an alternative to CuAAC in 
functionalizing proteins at low concentrations.  
Rashidian et al. utilized oxime and hydrazone formation to reversibly immobilize or label 
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proteins in crude cell lysate.62 In addition to the previously reported C15-Ald-OPP alternative 
substrate containing an alkyl aldehyde,97 a geranylaldehyde analogue containing an aryl aldehyde 
(C10-BA-OPP) was developed. Although the catalytic efficiency of the aryl analogue was 4-fold 
lower than the alkyl-substituted compound, higher synthetic yields gave it the advantage of being 
much easier to produce. Reactions of aldehyde-functionalized Dn-GCVIA and GFP-CVIA with 
Texas red hydrazide or AlexaFlour-488 aminooxy indicated that while the reaction rate is much 
faster for hydrazone formation, oxime ligation shows higher conversion due to higher association 
constants. Fluorophore labeling of GFP could be achieved using either hydrazone or oxime 
formation, in which the products displayed FRET. Reversible immobilization was achieved by 
utilizing the two click reactions sequentially. GFP-aldehyde was initially captured on hydrazide-
functionalized agarose beads (Fig. 1.4A), followed by release with high concentrations of 
hydroxylamine, where aniline was employed as a catalyst in both reactions. The method was highly 
reversible with a 95% immobilization efficiency and 80% release efficiency, and could be applied to 
selective functionalization of proteins from crude lysate without purification. As an example, a 
therapeutically relevant glucose-dependent insulinotropic polypeptide (GIP-CVIM) was PEGylated 
from crude extract using this chemistry. 
While the high chemoselectivity and reversibility of imine-based reactions make them a 
useful click reaction, they suffer from slow reaction kinetics especially for ketones and therefore 
often require catalysts. Rashidian et al. screened various catalysts for oxime and hydrazone 
formation and found that m-phenylenediamine (mPDA) is up to 15 times more efficient than 
aniline.60 At identical concentrations, mPDA was about 2-fold more efficient than aniline, but its 
higher water solubility allowed reactions to proceed at much higher concentrations which resulted 
in much greater acceleration since the rate of reaction is first order in catalyst. At pH 7, oxime 
ligation between an aldehyde-functionalized GFP and a dansylated aminoooxy reagent was 
completed in 90 s with 750 mM mPDA while 100 mM aniline only showed minimal product 
conversion (<7%). It was noted that both catalysts were less effective for protein aldehydes than 
simple model aldehydes, suggesting that the species conjugated to the aldehyde can modulate its 
reactivity. Protein labeling via reversible immobilization using mPDA resulted in faster and higher 
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yields compared to aniline. It was found that Schiff base formation starts to compete with oxime 
ligation at high mPDA/aminooxy ratios, and therefore ratios below 250:1 were recommended. 
Fluorophore labeling of a therapeutically relevant protein ciliary neurotrophic factor (CNTF) via 
oxime ligation with aminooxy AlexaFluor-488 was achieved using 80 mM mPDA. The mPDA 
catalyst was shown to be effective for labeling ketone-containing proteins as well. PEGylation of an 
aldehyde-containing DHFR with 500 mM mPDA manifested a 2.5-fold increase in rate while 100 
mM aniline had negligible enhancement. A number of other groups have reported other efficient 
aniline-based catalysts for this reaction as well.24 
 
 
Figure 1.5 Simultaneous protein labeling through prenylation. (A) Simultaneous labeling of a 
protein using a tri-orthogonal isoprenoid analogue containing both alkyne and aldehyde for CuAAC 
and oxime ligation, respectively. (Ref. 542) (B) One-pot dual labeling using orthogonal isoprenoid 
analogues for tail-to-tail protein bioconjugation. FTase and GGTase-I have substrate preferences 
for the length of isoprenoid used. (Ref. 385) 
 
The orthogonality between CuAAC and oxime ligation to achieve simultaneous dual 
protein labeling was exploited by Rashidian et al.102 A tri-orthogonal molecule incorporating an 
aldehyde and alkyne functionality on an allylic diphosphate (C10-BA-Alk-OPP) was synthesized 
and confirmed as an alternative substrate for FTase by farnesylation of Dn-GCVIA and GFP-CVIA. 
Simultaneous oxime ligation and CuAAC with aminooxy-PEG and azido-TAMRA (Fig. 1.5A) was 
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shown with GFP and CNTF that had been labeled with the tri-orthogonal analogue. Under the 
conditions employed, oxime ligation was found to be more efficient than CuAAC, but nonetheless 
both reactions reached near completion within 12 h. The method was applied towards constructing 
chemically self-assembled nanoring structures (CSANs) by mixing a dual-functionalized GFP 
labeled with aminooxy-TAMRA and azido-bis-MTX with dimeric DHFR proteins functionalized with 
anti-CD3 antibodies. The resulting protein nanostructure was shown to undergo selective 
membrane binding and energy-dependent endocytosis when treated with CD3+ T-leukemia cells, 
where the GFP and TAMRA components could be detected by both fluorescence and FRET 
measurements. In a subsequent methods article, Mahmoodi et al. provided a detailed description 
of the procedures for protein immobilization and release exploiting the reversible imine-base 
reaction and simultaneous protein labeling utilizing CuAAC and oxime click chemistry.103 In 
comparing m-PDA versus p-PDA in oxime and hydrazone ligation, the authors noted that at higher 
catalyst concentrations, m-PDA favors Schiff base formation over the desired product, while p-PDA 
does not exhibit such limitations and therefore allows faster reactions. However, p-PDA was shown 
to be prone to oxidation in air, especially in the presence of copper catalysts, which  suggested 
that m-PDA would be more suitable for reactions that require prolonged incubations or 
simultaneous click conditions. 
Maynard and coworkers utilized oxime and CuAAC click chemistry for chemoselective 
protein immobilization on gold surfaces (Fig. 1.4B).104 For covalent immobilization, two sets of 
proteins and gold surfaces were functionalized with two different types of complementary click 
components. Horse heart myoglobin (HHMb) was modified at its N-terminus with an aldehyde via 
a PLP reaction with pyridoxal 5’-phosphate, and mCherry-CVIA was farnesylated with C15-Alk-
OPP. Complementary gold surfaces were functionalized with an aminooxy-alkanethiol or azide-
alkanethiol by microcontact printing with a PDMS stamp. Immobilized proteins were visualized via 
fluorescence microscopy which demonstrated the potential of the method in applications that target 
uniformly oriented proteins. 
Poulter and coworkers constructed uniformly oriented antibody arrays on site-specifically 
immobilized antibody-binding proteins (Fig. 1.4C).105 Truncated recombinant forms of antibody-
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binding proteins A, G, and L were constructed to include five antibody-binding domains from wild-
type S. aureus protein, an N-terminal His6-tag, and a C-terminal CVIA motif. The chimeric proteins 
were farnesylated with C10-Et-Alk-OPP and immobilized onto azide-functionalized glass slides. 
The high selectivity and binding affinities of the immobilized antigens were shown through a series 
of assays involving various concentrations and mixtures of protein A, G, and L. The surface-bound 
antigens were utilized to fabricate an array of antibodies by a “sandwich” procedure, where glass-
bottomed slides (with silicone isolators) were coated with recombinant antibody-binding protein L 
followed by incubation with monoclonal antibodies directed to either GFP or GST. A mixture of GFP 
and GST was added to the wells and the captured proteins were visualized using fluorescent 
antibodies, which indicated selective antibody-dependent protein detection without cross-reactivity. 
The antigen-bound slides could be reused by treatment with acidic buffer to strip away the antibody 
layer while leaving the covalently immobilized antigens attached for use in another round of protein-
detection. In a follow-up paper, they showed that their “sandwich-type” antibody arrays that exhibit 
regioselectively immobilized antigens show superior properties compared to randomly oriented 
antigens immobilized on commercially epoxy-modified slides.106 As described in their previous work, 
a sandwich structure for detecting GFP was constructed by immobilizing an alkyne-functionalized 
recombinant protein L onto azide-glass slides, followed by incubation with a mouse anti-GFP IgG 
antibody. Captured GFP was detected with D7Light 680-labeled mouse anti-GFP IgG with high 
sensitivity and low cross-reactivity against the components of the sandwich array. For comparison, 
a sandwich structure with random orientation was constructed by immobilizing protein L on 
commercial epoxy-modified slides in a non-specific fashion. Regioselectively immobilized slides 
showed superior fluorescent outputs demonstrating the advantages that result from site-specific 
immobilization. Slides showed unaltered detection sensitivities after up to 6 cycles of regeneration. 
Poulter and coworkers subsequently expanded the scope of their immobilization methodology from 
glass to gold surfaces.107 Thiol or dithiocarbamate (DTC) self-assembled monolayers (SAMs) were 
prepared on gold slides for subsequent azide surface-functionalization. Alkyne functionalized GFP 
or GST, prepared by S-prenylation with an isoprenoid analogue was immobilized onto the gold 
surface via CuAAC and visualized with complementary fluorescent antibodies. A concentration 
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dependent increase in immobilization was observed only under click conditions, indicating a low 
degree of nonspecific binding. While the immobilized proteins could be released with β-
mercaptoethanol (BME) from both types of gold surfaces, proteins on DTC SAMs were shown to 
be much more resistant to displacement, indicating a more robust sulfur-gold linkage in the case of 
DTC over thiols. 
Trans-cyclooctene (TCO) functionality was site-specifically incorporated by protein 
farnesylation for subsequent functionalization via tetrazine ligation.108 Successful labeling of an 
Oregon Green-CVIA peptide and GFP-CVIA showed that the developed TCO geranyl diphosphate 
analogue (C10-TCO-OPP) was a substrate for yFTase. The relatively compact volume of 
cyclooctene and hydrophobic characteristics of the analogue were thought to be the key factors of 
substrate-compatibility of the analogue in the FTase active site. The TCO-labeled peptide and 
protein both rapidly reacted with dipyridyl-tetrazine known to exhibit cell-penetrating properties, 
which combined with the copper-free click features of this chemistry has important implications for 
experiments that require protein lipid modification in live cells. 
Dozier et al. examined the kinetic behavior of mutated FTases to study how the enzyme’s 
active site could be expanded to improve the catalytic efficiencies for bulkier FPP analogues.83 
Docking experiments suggested that positions W102β, Y154β, and Y205β were important for 
controlling the volume of substrates that could be accommodated. Thus, those positions were 
altered to alanine via site directed mutagenesis which yielded mutants W102Aβ, Y154Aβ, and 
Y205Aβ. When tested using a Dn-GCVLS substrate, some FTase mutants were found to exhibit 
substantial improvements. For example, mutant W102Aβ showed a 43-fold higher catalytic 
efficiency for processing a benzaldehyde-containing analogue over FPP, and mutant Y205Aβ 
showed improved activities for a cyclooctene analogue and a dramatic 300-fold increased  
catalytic efficiency for a coumarin-containing analogue (C10-Cou-OPP). Some mutations however 
gave only minimal improvements such as the mutant Y154Aβ which displayed improved binding 
affinities (lower Km) for the benzaldehyde analogue which, however, was offset by a decreased kcat. 
Overall, it was shown that mutagenesis of FTase could be exploited to expand the variety of 
susceptible FPP analogues, that could potentially broaden the types of click chemistry applications 
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associated with protein S-prenylation. 
In a related work, Zhang et al. employed simultaneous enzymatic labeling of two different 
target proteins each selectively with different functionalities by exploiting the distinct specificities of 
rat GGTase-I (rGGTase-I) and rat FTase (rFTase).109 Based on a previous report which showed that 
rGGTase-1 has a larger binding pocket compared to that of rFTase, various isoprenoid analogues 
that contain a clickable functionality were evaluated as substrates for the two enzymes in search 
for candidates that exhibit enzyme specificity. When tested with GFP-CVIA, C10-Alk-OPP was 
shown to be a substrate for rFTase and an aryl ketone containing C10 isoprenoid (C10-BK-OPP) 
for rGGTase-I, and no cross-reactivity between the enzymes and substrates was observed. rFTase 
was shown to be able to prenylate CVIA substrates with C10-Alk-OPP but not related CVLL 
substrates while C10-BK-OPP and azide-containing C20-Az-OPP could be transferred to CVLL 
substrates only with rGGTase-I. Exploiting the substrate selectivity and noncomplementary Ca1a2X 
sequences, an all-in-one reaction was shown to successfully label GFP-CVLL and RFP-CVIA 
simultaneously with C10-BK-OPP and C10-Alk-OPP, respectively, in the presence of both rFTase 
and rGGTase-I (Fig. 1.5B). Utilizing the methodology further, a one pot site-specific dimerization of 
proteins was carried out by selectively labeling GFP-CVLL with C15-Az-OPP and GFP-CVIA with 
C10-Alk-OPP, followed by addition of CuAAC reagents which produced GFP-GFP homodimers in 
high yield. A similar reaction was carried out to synthesize GFP-RFP heterodimers demonstrating 
the generality of the developed method to form site-specific tail-to-tail protein dimers. 
DNA-protein cross-links (DPCs) are important DNA lesions that interfere with DNA 
processing which leads to various mutations and cytotoxicity. However, studies on DPCs have been 
limited due to difficulties in obtaining structurally defined site-specific DPCs. Tretyakova and 
coworkers investigated the effect of DPCs on DNA replication by exploiting S-prenylation and click 
chemistry for the preparation of site-specific DNA-protein or -peptide crosslinks (Fig. 1.4D).110 SDS-
PAGE and tandem mass spectrometry confirmed the successful site-specific crosslinking between 
prenylation-induced GFP-C15-Dh-Az-N3 and an alkyne-labeled 23-mer oligodeoxynucleotide via 
CuAAC. DNA-peptide crosslinks were generated using synthetic azide-containing 10- or 23-mer 
peptides, which were both produced in high yields. The DPCs were subjected to primer extension 
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with translesion synthesis (TLS) polymerases hpol k, n and t either through a standing start or 
running start assay with an 18-mer template. In both assays, TLS polymerases showed successful 
extension of the primer for control templates, while complete obstruction for all three types of TLS 
polymerases was observed for  both GFP and 23-mer conjugated DPCs. For the DPC containing 
the 10-mer, polymerases were shown to bypass the lesion and extend the primer with different 
efficiencies. Overall, these assays demonstrated how different peptide/protein sizes have an effect 
on primer extension near the site of DNA adduction and suggest that large DPCs would require a 
proteolytic mechanism for them to be processable by TLS polymerases. 
Combination of S-prenylation and click chemistry was utilized for the synthesis of 
homogenous protein-drug conjugates. Kim and coworkers site-specifically linked a toxic 
monomethyl auristatin F (MMAF) warhead to repebodies, which are protein scaffolds with a high 
affinity for epidermal growth factor receptor (EGFR).111 Repebodies were engineered with a C-
terminal CVIM, which was exploited for S-prenylation with a geranyl ketone diphosphate (GKPP). 
Subsequent oxime ligation with a β-glucuronide-linked and aminooxylated MMAF without the 
employment of a catalyst under acidic conditions produced a homogenous repebody-MMAF 
conjugate (RDC). The site-specific RDCs showed high serum stability in human plasma due to the 
hydrolysis-resistant oxime linkage which is advantageous in targeted drug delivery. Towards EGFR-
positive cell lines, RDCs showed higher efficacy compared to cell-impermeable MMAF, where the 
RDC with the highest binding affinity showed the highest cytotoxicity. RDCs had negligible effect 
on EGFR-negative MCF7 cells, indicating receptor-specific cytotoxicity. Mouse studies revealed 
that RDCs exhibit antitumor activities, although complete tumor suppression could not be achieved 
presumably due to the short half-life of RDCs in blood due to the small size of the protein.  
Shin and coworkers developed an LC-MS/MS based method to assess the linker stability 
of ADCs (antibody-drug conjugate).112 The ADC used in their study was a HER2-targeting antibody 
that was site-specifically conjugated with an MMAF via methods similar to those reported by Kim 
and coworkers, using site-specific GKPP labeling with FTase followed by payload-conjugation via 
oxime chemistry.111 Evaluation of the pharmacokinetic profile of the ADC was accomplished by 
quantifying the drug component of the ADC remaining in plasma. For this, the plasma MMAF 
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concentrations were determined from integration of LC-MS/MS analysis previously standardized 
using a range of concentrations (19 - 960 ng/ml) fit to a quadratic equation. That method was used 
to assess the linker stability of ADCs in rat plasma, where 85 % of MMAF was found to remain 
bound to the ADC after incubation in rat plasma for 7 days at 37 °C. In vivo rat studies showed a 
similar half-life for the ADC to that of trastuzumab, demonstrating the stability of the oxime linkage. 
Distefano and coworkers functionalized Designed Ankyrin Repeat Proteins (DARPins), a 
type of a small protein scaffold, with a fluorophore using S-prenylation and click chemistry.113 The 
DARPin used in the study was engineered to bind to epithelial cell adhesion molecules (EpCAM) 
which is a well-known marker overexpressed in certain cancer cells, and to contain a C-terminal 
CVIA motif to be recognized by the FTase. Site-specific labeling with C10-Az-OPP followed by 
SPAAC with a TAMRA-DBCO yielded functionalized DARPins with high yields (>85%). The 
EpCAM-binding affinities of the fluorophore functionalized DARPins were assessed by flow 
cytometry. A high degree of binding activity was observed in EpCAM-overexpressing MCF-7 cells 
which was absent in EpCAM-negative U87 cells, and the high binding affinity to MCF-7 could be 
turned off when cell surface EpCAMs were blocked with incubation with an excess of unlabeled 
DARPins. Overall, site-specific labeling of a fluorophore to DARPins allowed high retention of the 
protein function and did not introduce non-specific interactions. 
 
1.3.2 N-terminal protein functionalization through N-myristoylation 
 
N-myristoylation of various myristic acid analogues allows the site-specific N-terminal 
modification of various POIs. The acid analogue requires conversion to a myristoyl-CoA thioester by 
an endogenous E. coli enzyme acyl-CoA synthetase in order to be recognized as a substrate by the 
enzyme N-myristoyl transferase (NMT). Therefore, protein conjugation via NMT-mediated labeling 
and click chemistry has mostly been performed at the cellular level, either in (live) cells or crude 
lysates prior to POI purification. Examples of such applications are imaging of specific protein 
functions in (live) bacteria in which the small tag allows minimal adverse effect on the native protein 
function,114,115 or surface immobilization of POIs from crude lysate in which purification of the excess 
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myristic acid analogues is unnecessary as opposed to conjugation of a molecular payload.116,117 
While most of the prior work has been focused on click reactions that involve an azide, it would be 
interesting to see future development of new myristic acid analogues that could expand the range 
of utilizable click chemistries. 
 
 
Figure 1.6 Clickable analogues of myristic acid and myristate-S-CoA for metabolic and in vitro 
labeling of myristoylated proteins. These probes are more selective for labeling N-myristoylated 
proteins. 
 
Tate and coworkers were the first to report site-specific labeling exploiting a combination 
of N-myristoylation and click chemistry.118 Az-C12-CoA (Fig. 1.6) was incubated with C. albicans 
NMT (CaNMT) and a model peptide that possesses the canonical GXXXS N-terminal N-
myristoylation target motif. Incubation of equimolar substrates with a catalytic quantity of CaNMT 
(0.25%) led to a complete enzymatic reaction with rates comparable to that of the native substrate 
myristoyl-CoA. P. falciparum ADP ribosylation factor 1 (PfARF1), a natural substrate of NMT, was 
functionalized with an azide exploiting N-myristoylation which was subsequently captured by a 
phosphine-labeled biotin via Staudinger ligation with high efficiency (>99%). The method was 
utilized for a one-pot biotin labeling by feeding an azide-containing myristic acid to an engineered 
E. coli co-expressing CaNMT and PfARF1, followed by addition of biotin-phosphine to the resulting 
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lysate. Pull-down with avidin-beads indicated successful in cellulo functionalization of PfARF1 with 
>99% efficiency, which indicated successful uptake of the azido-myristic acid into the cells followed 
by transformation to the active CoA analogue via endogenous E. coli enzyme acyl-CoA synthetase. 
In a subsequent report, Tate and coworkers expanded the scope of click reactions utilizing a new 
alkyne-analogue.119 The azide- or alkyne-containing myristoyl-CoA analogues Az-C11-CoA (Fig. 
1.7) and Alk-C14-CoA (Fig. 1.6), which were designed so that the chain length and flexibility closely 
adhere to the native substrate, were both successfully transferred to a model peptide that contains 
the N-terminal region of PfARF1.  
 
 
Figure 1.7 Additional myristoyl analogues used in enzymatic N-terminal modification of proteins. 
These analogues are functionalized with azides or ketones and vary in length compared to Az-C12 
and Alk-C14. 
 
While both reactions were rapid and comparable to the native substrate, the alkyne 
analogue was found to be two-fold faster. Both analogues were subjected to a one-pot labeling 
experiment in an E. coli co-expression system similar to the one described in their previous report, 
where the functionalized PfARF1 was subsequently reacted with biotin-capturing reagents 
containing either an alkyne, azide, or triarylphosphine. While capturing via both CuAAC and 
Staudinger ligation were shown to be successful, CuAAC was found to be more efficient similar to 
prior reports.23 Within CuAAC approaches, conjugating alkyne-payloads to the azide-labeled 
protein was shown more effective than the converse,90 presumably due to the benefits of having a 
large excess of activated alkyne when used as the capturing reagent. The labeling methods 
mentioned above were described in detail in a subsequent protocol paper, in which a multifunctional 
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alkyne-reagent carrying a biotin and TAMRA was labelled to an azide-containing PfARF1 by 
CuAAC.120 
Tirrell and coworkers exploited the bio-orthogonality of NMT-catalyzed protein labeling 
and click chemistry for fluorophore labeling and immobilization of a target protein from crude cell 
lysate.121 Two types of GFPs were engineered with different NMT recognition sequences, yARF-
GFP which contained a motif from yeast ADP-ribosylation factor, and Fyn-GFP which featured a 
motif from the Src family tyrosine-protein kinase Fyn. Co-expression of each GFP with human NMT 
in E. coli with Az-C12, followed by lysis of the cells and CuAAC with the resulting lysate with an 
alkyne-TAMRA yielded selectively and site-specifically conjugated GFP-TAMRA. Incubation of the 
azide-labeled GFP-containing cell lysate on strained cyclooctyne-coated glass slides resulted in 
successful surface immobilization of GFP. While strained alkynes could undergo various side 
reactions, including processes involving free thiols present in GFP, SPAAC was found to be faster 
than those non-specific reactions, allowing control over the orientation of immobilized proteins by 
site-specific conjugation through the N-terminus. 
NMT-mediated protein labeling was applied to calmodulin (CaM), a biologically relevant 
Ca2+-binding protein.116 The solvent-accessible N-terminus of CaM was engineered to display an 
NMT recognition sequence, derived from either human calcineurin B (CaN) or yeast ADP 
ribosylation factor. In addition, two types of linkers were employed to connect the NMT recognition 
sequence to the protein which led to a total of five engineered CaM constructs. All five were 
successfully labeled with an azide moiety when co-expressed in E. coli with human NMT1 in the 
presence of Az-C12 and were shown to maintain Ca2+-binding and CaN-activating abilities 
comparable to that of wild type (WT) CaM. As the NMT-motif derived from CaN showed superior 
activity, it was selected for one-pot fluorophore labeling by subjecting the cell lysate containing the 
azide-labeled construct to CuAAC with alkyne-TAMRA. A single fluorescent band was observed by 
SDS-PAGE analysis which indicated selective labeling of the target protein as a result of the bio-
orthogonality of NMT-mediated labeling and CuAAC. Various CaM-immobilized resins were 
prepared and tested for their capability to bind to and purify CaN. CaM-resins prepared via SPAAC 
with chemoenzymatically generated azide-CaM and azadibenzocyclooctyne-functionalized resins 
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(ADIBO-resins) showed CaN yields 10-fold higher than resins prepared by immobilizing WT CaM 
on NHS-ester or cyanide activated resins, demonstrating the advantage of protein immobilization 
in a site-specific fashion. 
Tirrell and coworkers also utilized the NMT labeling system to visualize proteins in 
bacteria.114 The target proteins were chemotaxis proteins Tar and CheA, and cell division proteins 
FtsZ and FtsA, which were each co-expressed in an E. coli system with NMT and methionyl 
aminopeptidase. The addition of Az-C12 or Az-C11-alkoxy simultaneously during the induction 
stage of protein expression, followed by the addition of a bicyclononyne-containing BODIPY 
reagent to the subsequently produced lysate led to complete modification of all four target proteins. 
In situ imaging of fixed and permeabilized cells was conducted on cells expressing each of the 
target proteins equipped with C-terminal myc tag fusions for immunofluorescence confirmation 
using an anti-myc AF647-conjugated antibody. Polar localization of Tar and CheA and septal 
localization for FtsZ and FtsA could be visualized in both BODIPY and AlexaFluor-647  channels; 
the former allowed imaging of the myristoylated proteins while the latter was used to detect myc.  
This demonstrated the utility of NMT-catalyzed fluorophore labeling for imaging bacterial proteins 
in cells, which could even be applied to live cells. The details of the sample preparation and labeling 
protocols for live cell imaging of bacterial proteins were further described in a follow-up methods 
paper.115  
In a related work, Zhang and coworkers assessed whether the labeling of myristic acid 
analogues instead of the natural substrate alters protein function using a model protein ADP-
ribosylation factor (Arf1).122 Arf1 was myristoylated with five myristic acid analogues resulting in 
modified proteins that showed membrane-associating and GTP-hydrolyzing activities similar to 
endogenous Arf1 while non-myristoylated Arf1 lacked either properties. Additionally, an Arf1 
labeled with Az-C14-ketone (Fig. 1.7) could be conjugated with a fluorescent hydrazine reagent. 
Importantly, in these studies, the authors described a methodology that could be used to determine 
the suitability of lipid-modification methods to monitor protein function in cells. 
Calmodulin (CaM) conjugated Sepharose resin was prepared by a combination of N-
myristoylation and click chemistry, which led to improved purification efficiencies of CaM-binding 
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proteins.117 Azide-functionalized CaM was prepared by N-myristoylation with Az-C12, which was 
subsequently immobilized onto DBCO- or alkyne-functionalized Sepharose resin via SPAAC or 
CuAAC. DBCO-resin was shown to immobilize larger amounts of CaM compared to simple alkyne-
resin and was shown to outperform commercial resin in purifying a CaM-binding protein calcineurin 
(CaN). CaM-resin was prepared directly from azide-CaM present in clarified lysate, which showed 
higher CaN purification efficiencies compared to resin prepared from purified azide-CaM. CaM-
resin was tested for purification of calcium/calmodulin dependent kinase II alpha (CaMKII) which 
has traditionally been isolated using IMAC purification. Exploiting the CaM-resin yielded a product 
with higher purity and less degradation compared to purification using Ni-NTA resin. In their 
following methods paper, Kinzer-Ursem and coworkers described the details of CuAAC-mediated 
functionalization of CAM myristoylated with Az-C12.123 In addition to fluorophore labelling with an 
alkyne-functionalized AlexaFluor-647, protein-immobilization on gold nanoparticles (AuNP) was 
shown where it was noted that cyclooctyne-functionalized AuNP resulted in aggregation leading to 
inferior conjugation with SPAAC compared to CuAAC.  
Tirrell and coworkers expanded their work from 2016 by imaging bacterial proteins in live 
cells with nanometer resolution.124 To exploit direct stochastic optical reconstruction microscopy 
(dSTORM), two cell-permeable photo-switchable rhodamine spirolactam dyes were developed. 
These dyes exhibited photon budgets comparable to conventional STORM dyes in the absence of 
additives such as oxygen-scavenging buffers or reducing agents that are usually required for 
facilitating the photo-switching of conventional dyes. Following the co-expression of target proteins 
with NMT in E. coli in the presence of Az-C12, bicyclononyne-functionalized dyes were added, 
which yielded live cells containing the fluorophore-labeled proteins that were then subjected to 
imaging without fixation or permeabilization. Chemotaxis proteins Tar and CheA and cell division 
proteins FtsZ and FtsA were observed with a mean localization precision in the nanometer range. 
While modification of the N-terminus presumably caused minimal perturbation of protein function, 
indicated by the successful imaging of live cells, the effect of the peptide tag and fluorophore were 
shown to vary for each protein of interest. 
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Table 1.1 Summary of click chemistry conditions and yields that involve site-specific protein 
labeling via lipid modifying enzymes 
Entry Application Analogue & Click Conditions Yield Ref 
Farnesyl transferase  














0.9 mM Dn-GCVIA-N3 








0.9 mM Dn-GCVIA-N3 









 AAA-GPP, APO-GPP 
0.5 nmol GPP-N3 
2.5 nmol phosphine 
25 mM HEPES pH 7.2, 40 mM NaCl, 2 mM 
MgCl2 
8 h rt 
 
Completion 
in 1.5 h 
 
Completion 







0.1 mM GFP-N3, Alkyne-beads 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 














1-20 µM GFP- or GST-alkyne 
N3-slides 
1:3 glycerol/water 
1.7 mM CuSO4/TBTA/TCEP 















50 µM GFP-alkyne and -N3 
Corresponding agarose (-N3 or -alkyne) 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 
overnight 25ºC 
 
25 µM GFP-alkyne 
Texas red-N3 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 

















20 µM GFP-N3 
22 µM DNA-alkyne 
50 mM NaH2PO4, pH 7.3 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 






80 µM mCherry-alkyne 
Agarose-N3 
50 mM NaH2PO4 pH 7.3 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 














14 µM Protein-N3 






1 mM CuSO4, 1 mM TCEP, 0.2 mM TBTA 







0.1 mM mCherry-alkyne 
N3-gold 
1 mM CuSO4, 1 mM TCEP, 0.1 M TBTA 
43 mM NaH2PO4 pH 7.3 














100 µM antibody-alkyne 
Glass-N3 
0.7 mM CuSO4, 0.7 mM TCEP, 0.35 mM 
TBTA 
PBS pH 7.4 









5 or 80 µM Protein-alkyne 
Gold-N3 
0.5 mM CuSO4, 0.5 mM TCEP, 50 µM TBTA 
PBS pH 7.4 








10 µM DNA-alkyne 
60 µM GFP-N3 
1 mM CuSO4, 1 mM TCEP, 0.1 mM TBTA 
50 mM PB pH 7.5 









50 µM GFP-N3 
50 µM RFP(or GFP)-alkyne 
















1 µM REP-1-N3 
50 µM Biotin-alkyne 
1 mM CuSO4, 10 mM sodium ascorbate, 0.1 
mM TBTA 
40 min 37 ºC 
 
NA  98 









1 : 3.85 : 15 ratio  
40 mM mPDA 
















20 µM GFP-aldehyde 
Alkyne-agarose 
100 mM aniline 
0.1 M PB pH 7.0 










25 µM GFP-aldehyde 
125 µM AF488 
100 mM analine 
0.1 M PB pH 7.0 








54 µM GFP-aldehyde 
Hydrazide-agarose 











0.1 M PB pH 7.0 







200 mM Hydroxylamine 
100 mM aniline 
0.2 M PB pH 7.0 










10 µM GFP-aldehyde 
50 µM Dn-aminooxy 
750 mM mPDA 
100 mM PB pH 7.0 






12 µM repebody-aldehyde 
120 µM beta-glucuronide MMAF 
200 mM Na-acetate buffer pH 4.5 10% DMSO 







14 µM GFP-N3 
4.6 µM ODN-DIBO 
H2O or 0.1 M NaCl PB pH 3.5-12.3 






















1 : 5 molar ratio 
PBS (400 mM NaCl) 
3 h rt 
 
Tetrazine ligation 
25 Proof of 
concept 
C10-TCO-OPP 
33 µM GFP-TCO 
530 µM benzylamino-tetrazine 






20 µM OrG-TCO 








0.1-100 µM Farnesylated protein 
Thiol-functionalized slides 
2.5 mM DTE, 20% glycerol 
UV 365 nm 
10 min 6 Jcm-2 (H, -N-, and K-Ras & Rab6A) 





27 Proof of 
concept 
HOM-GPP 
50 µM CFP-alkene 
40 eq 6-maleimidohexanoic acid 
50 mM Na2HPO4 pH 6, 40 mM NaCl, 2 mM 
MgCl2 






28 Biotin labeling Az-C11-CoA 
3 nmol PfARF1-N3 
200 µM Biotin-phosphine 
2 h 37 ºC 
 
>99% 119t 
CuAAC  Az-C12 (for entries 29-32)  
29 Biotin and 
fluorophore 
labeling 
100 µg PfARF1-N3 
50 µM Alkyne-biotin/TAMRA 
0.5 mM CuSO4, 0.5 mM TCEP, 50 µM TBTA 






GFP-N3 (in cell lysate) 
5.2 µM TAMRA-alkyne 
3.5 mM CuSO4 
(Modified InvitrogenTM Click-iT Kit instructions) 
50 Tris-HCl pH 8.0 1% SDS 





CaM-N3 (in cell lysate) 
5.2 µM TAMRA-alkyne 
3.5 mM CuSO4 
(Modified InvitrogenTM Click-iT Kit instructions) 




1, 2 or 5 mg ml-1 CAM-N3 
Alkyne-resin 




SPAAC Az-C12 (for entries 33-38), Az-




GFP-N3 (in 0.25-1 mg ml-1 cell lysate) 







0.5 mg ml-1 CaM-N3 








1, 2 or 5 mg ml-1 CAM-N3 
DBCO-resin 
20 mM HEPES pH 7.5 







Cells expressing recombinant protein-N3 
20 µM BODIPY-BCN 
PBS 






Cells expressing recombinant protein-N3 
200 nM Rhodamine-BCN 
PBS 







Protein-N3 (in 0.4 mg ml-1 cell lysate) 
2 µM BODIPY-BCN 
PBS 








1 mM Fluorescein-hydrazide 
PBS 






Click chemistry has played a critical role in illuminating the process of protein lipidation, as 
well as in discerning their roles in controlling protein function, localization, and protein-protein 
interactions. The ability to use metabolic labeling to incorporate lipid analogues containing 
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functionality that can be subsequently modified for various analyses has proved to be a versatile 
strategy. Click reactions with affinity handles have allowed proteins to be pulled down and identified 
by proteomic methods. Incorporation of quantitative mass spectrometric methods into such 
workflows have made it possible to study the regulation of protein lipid modification and the impact 
of specific inhibitors. Click reactions with fluorophores have enabled the localization of lipidated 
proteins to be studied and their levels quantified. Overall, much information has been gained 
concerning the biology of protein S-prenylation using this approach. However, as mentioned, most 
of the currently available tools are only applicable to fixed cells and therefore efforts into applying 
click chemistry in molecular imaging inside live cells or tissues needs to be pursued moving forward. 
In a similar way, the use of click chemistry in conjunction with protein lipidation has proved 
to be a powerful approach for site selective protein modification. Site-specific enzymatic 
incorporation, either in vitro or in cellulo, of lipid substrates bearing appropriate functional groups 
has enabled a diverse range of modifications to be performed on either the N-termini (via N-
myristoylation) or C-termini (via S-prenylation) of target proteins. Applications include 
immobilization, fluorescent labeling and drug conjugation; this approach has also proved useful for 
the construction of more complex architectures including protein nanostructures and protein-DNA 
conjugates. On the other hand, enzymatic S- and N-acylation has been applied in only developing 
platforms for screening of fatty acylation inhibitors. There are no reports so far in using such types 
of lipid modification for bioconjugation strategies, which can be attributed to their lack of sequence 
specificity (e. g. unclear recognition motifs) and the susceptibility of S-acylated substrates to 
hydrolysis. 
Throughout the above studies, click chemistry has played a central role. A summary of the 
features of different click chemistries that have been used for studying and exploiting protein lipid 
modification is shown Fig. 1.8. This graphic emphasizes that individual click reactions have different 
attributes that make them more or less suitable for different applications and illustrate that there is 
no one single reaction that is best for all applications. For example, while the alkene and tetrazine 
reactants are somewhat large, making it difficult to incorporate them into substrates without 
attenuating their enzymatic reactivity, the inverse electron demand Diels Alder (iEDDA) reaction is 
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the fastest click reaction discovered to date. The superior kinetics of iEDDA that does not require 
toxic catalysts allows click reactions to be applicable for live cell studies, which could even be 
expanded to in vivo environments. Among click reactions that involve azides and alkynes, the 
copper-catalyzed version (CuAAC) is not compatible with live-cell experiments due to toxicity 
issues while the strain-promoted (SPAAC) reaction is considerably slower and the presence of a 
large hydrophobic moiety appended to a protein can create solubility/stability problems. 
Nonetheless, both reactions remain to be a powerful tool especially for in vitro studies due to the 
robustness of the reaction, and since the small size of azide and alkyne groups that can be readily 
introduced into the protein substrates without abrogating their reactivity. Oxime and hydrazone 
forming reactions are particularly attractive due to the structural innocuity of small aldehyde and 
ketone groups but that is partially offset by slower reaction rates, incomplete orthogonality (due to 
the presence of some aldehydes and ketones in cells) and hydrolytic instability; at the same time, 
oxime and hydrazone products manifest the highly useful feature that their formation is reversible 
that has been utilized for one-pot labelling and purification of protein-conjugates. Alternative ligation 
reactions with aldehydes that forms a stable C-C bond instead of an imine have been reported as 




Figure 1.8 Considerations in the applicability of click chemistry in protein or cellular environments. 
Individual reactions were given a rating from 5 (highest) to 0 (lowest) for each category based on 
how much they satisfy each of the following criteria. Kinetics: High rate constant; Selectivity: 
Selective reaction between click functionalities without side reactions with biologically endogenous 
functionalities; Stability: High stability of the resulting linkage; Structural Innocuity: Minimal adverse 
effect of the coupling partners and/or resulting linkage on cellular or protein activity; Biocompatibility: 
Applicability of the reaction conditions for live cell or in vivo experiments; Reversibility: Reversibility 
of the click chemistry product. 
 
For studies of protein lipid modification to advance further, both the understanding of 
enzyme-substrate interaction and click chemistry will need to evolve. Developing enzymes that are 
more tolerant towards a wider variety of analogue substrates would broaden the scope of applicable 
click reactions, that is currently heavily focused on alkyne and azide functionalities due to their 
small size. In terms of potential improvements in click chemistry, new functionalities will need to be 
developed that allow minimalist additions to enzyme substrates that have limited impact on enzyme 
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recognition, while exhibiting increased click reactivity to allow the detection of modified proteins 
present at very low concentrations in cells. The further development of click chemistries that permit 
experiments with live cells and that have minimal effects on the structure, function, stability and 
solubility of proteins will significantly broaden the types of questions that can be addressed using 
in cellulo metabolic labeling and in vitro modification. For instance, click reactions with rates 
comparable to iEDDA that do not require bulky ring systems would be particularly useful. Click 
reactions that proceed at equimolar concentrations compared to the target protein, even in the 
absence of catalysts, would open up in vivo applications where localized high concentrations are 
difficult to achieve. Applying two-photon chemistry to thiol-ene click chemistry could be utilized for 
experiments that require spatiotemporal control in in cellulo or in vivo applications due to the low 
toxicity and tissue penetrating capabilities of that method. While these future directions are raised 




Chapter 2. Targeted drug delivery and imaging with site-specific DARPin-
polymer constructs 
 
Therapeutic proteins exhibit highly specific functions, few side effects, and low immune responses, 
which are often difficult to achieve with small-molecule drugs. Despite its distinctive advantages, 
the innate structural instability of proteins remains to be one of their main drawbacks, which has 
led to studies that involve the conjugation of synthetic polymers to enhance the half-life of the 
polypeptide-based drugs in the bloodstream. Key factors to consider in the conjugation step are 
site-specificity, yield, and ease of purification, as they directly affect protein activity, product 
homogeneity, and scaleability. The most commonly used polymer-conjugation method, direct 
chemical modification with presynthesized polymers, lacks site-specificity that often leads to 
reduced protein activity. In addition, the steric effects related to the size of the polymer often causes 
low conjugation yields which in turn leads to difficulties in purification. Therefore, new strategies 
are in demand. 
In this work, protein prenylation and in situ controlled radical polymerization are exploited to 
overcome the limitations in conventional protein-polymer conjugation techniques. A tumor-targeting 
antibody mimetic DAPRin (Designed Ankyrin Repeat Protein) is site-specifically functionalized with 
an ATRP (Atom Transfer Radical Polymerization) initiator moiety via protein prenylation. In situ 
polymerization is then employed from the DARPin-macroinitiator with a variety of customized 
monomers to yield DARPin-polymer constructs capable of tumor-targeted imaging and drug 
delivery. We demonstrate that utilization of the described methods results in DARPin-polymer 
constructs with high therapeutic efficacies due to the highly retained protein activity, enhanced 
pharmacokinetics, and high drug-to-antibody ratios (DAR). 
 
2.1 Introduction 
 Protein-based therapeutics continue to dominate the drug market. As of 2019, 7 out of 10 
top-selling drugs were therapeutic proteins.126 This wide use of protein-drugs comes from its unique 
advantages that are often difficult to achieve with small molecule therapeutics. To name a few, 
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proteins exhibit highly specific functions, few side effects, and low immune response, which render 
them ideal for therapeutic applications. Antibodies are particulary important protein therapeutics 
due to their capability to perform targeted imaging and drug delivery based on the high affinity their 
of epitopes against specific antigens.127 However, like many proteins, antibodies cab suffer from 
short half-life in the circulation which can impair their broader applicability. Conjugation of 
hydrophilic polymers such as polyethylene glycol (PEG) to extend the circulation time of proteins 
has been a widely used strategy to combat this limitation. Many FDA-approved PEGylated protein 
products have been released in the market, with many more under development.128  
 It is important to maximize the protein activity and yield for the product derivatization 
method to be widely applicable to therapeutically relevant proteins. The polymerization method is 
one aspect that can be optimized for higher drug efficacies. The grafting-from conjugation method 
which involves synthesis of the polymer directly from the protein-macroinitiator has been gaining 
attention over the conventional grafting-to method which requires the conjugation of a 
presynthesized polymer to the target protein. The key first step for this method is the installation of 
a polymerization initiator moiety into the target protein to render it a macroinitiator. This in situ 
polymerization method exhibits several advantages over the grafting-to method. The first of these 
is easier purification, as the method only requires separation of large macromolecular products 
from small monomers, while the grafting-to products require a more vigorous separation between 
macromolecules both large in size.129 The yield tends to be higher as well compared to grafting-to 
methods due to the lower steric hindrance between the initiator molecule and protein compared to 
protein-macromolecule interactions.130 This advantage becomes even more apparent when 
conjugating branched polymers as they are especially difficult to give high conjugation yields using 
grafting-to methods due to the bulky side chains.131 Since earlier reports based on model 
proteins,132–134 the use of grafting-from techniques has steadily expanded into the realm of 
therapeutically relevant proteins.135,136  
 
 Another important aspect to consider in protein-polymer conjugation is the site of 
modification. Conventional protein labeling methods have involved maleimide or activated-ester 
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functionalized molecules that react with the thiol or amine moieties present in the protein of interest. 
However, proteins that undergo direct chemical modification methods have often shown to suffer 
from reduced bioactivity due to the lack of control over the site of modification that leads to 
heterogeneous product mixtures. Uncontrolled labeling of the protein may also obstruct the 
binding/active site leading to deactivated protein products. Therefore, new methods that enable 
site-specific conjugation has been necessitated.129,137 One solution is to exploit the promiscuity of 
various enzymes to site-specifically conjugate various probes that are analogous to the native 
substrate of the enzyme. Enzymatic protein labeling allows precise control of the site of modification 
and the number of modification sites under mild reaction conditions, in contrast to chemical 
conjugation which lacks site-specificity and can require more vigorous conditions. While unnatural 
amino acid (UAA) incorporation allows site-specific installment of specific functionality of interest, 
that method can be difficult to optimize and often leads to low protein production yields.138 The 
unique advantages of enzymatic labeling has led to increased application in biotechnology, often 
in conjunction with click chemistry for site-specific introduction of fluorophores, drugs, or 
polymers.13,139 
Protein prenylation is an important post-translational modification involving the attachment 
of a C15 or C20 isoprenoid to target proteins that contain a C-terminal CaaX recognition motif 
catalyzed by prenyltransferases.11 The modification occurs site-specifically at the cysteine residue 
of the CaaX box through formation of a covalent C-S bond. The promiscuity of the protein 
farnesyltransferase (PFTase) has been exploited in prior studies to site-specifically install various 
chemical moieties that include azides, alkynes, cyclooctenes, or aldehydes or ketones, followed by 
subsequent click-chemistry with fluorophores, polymers, or toxins to prepare functional protein-
conjugates.13,139 Such application of farnesylation towards biotechnological applications exhibit 
unique advantages. The modification occurs stoichiometrically and site-specifically with high yield 
which produces homogenous protein products. The labeling occurs at the C-terminal cysteine 
which is usually distanced from the active site, hence leading to highly retained post-modification 
protein activity. The method is highly versatile, as PFTase can selectively recognize virtually any 
type of protein by simply attaching a the CaaX-box sequence to the protein of interest. As the 
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recognition motif is only four amino acids long, minimal perturbation is introduced to the target 
protein structure. 
In this study, protein prenylation was utilized to create site-specific protein-polymer 
conjugates for tumor-targeted imaging and drug delivery (Fig. 2.1). While there have been prior 
studies that utilized enzymatic labeling for site-specific polymer conjugations, they are limited to 
sortase-136,140 or intein-mediated labeling.141 Therefore, we sought to expand the scope of enzymes 
by utilizing yeast PFTase (yPFTase). In this work, the protein of interest was a Designed Ankyrin 
Repeat Proteins (DARPins), a protein scaffold genetically engineered and selected to bind to 
specific tumor-associated antigens. DARPins have been shown to be a promising alternative to 
immunoglobin G (IgG) antibodies due to its many important advantages. DARPins exhibit high 
rigidity and stability against proteases, they are easy to produce in bacteria in high yields, they can 
be easily engineered, and they are small size in (20 kDa) that facilitates tumor penetration. In 
contrast, IgGs require a more complex mammalian expression system and often suffer from poor 
tumor penetration due to their large size (150 kDa).142 The DARPin construct chosen for this study 
was one that targets epithelial cell adhesion molecules (EpCAM), which is a useful cancer target 
due to its overexpression in solid tumors and its ability to internalize that can be exploited to 
facilitate intracellular delivery of cytotoxic payloads.143 Previous reports have demonstrated the use 
of EpCAM-targeting DARPins for tumor-targeted delivery of a toxin or an imaging agent.144–146 
Grafting-to PEGylation of DARPins was shown to improve the therapeutic efficacy in mouse studies 
by increasing the serum half-life.144 Here, we aimed to improve the therapeutic efficacy of DARPins 
with a site-selectively conjugated and payload-functionalized polymer prepared by in situ 
copolymerization and copper-free click chemistry. Conjugation of a hydrophilic polymer was found 
to enhance the pharmacokinetic properties of DARPins, and taking advantage of the hydrophilic 
polymer as a “trailer” attached to the DARPin “vehicle” allowed loading of multiple hydrophobic 
payloads without diminishing the stability of the protein. While the focus of this effort was tumor-
targeted imaging and drug delivery, the modular characteristics of this approach should allow a 




Figure 2.1 DARPin-polymer conjugates prepared by site-specific enzymatic labeling and in situ 
polymerization for tumor targeted imaging and drug delivery. (A) ATRP from the site-specific 
DARPin-Br macroinitiator with functional monomers of interest yields DARPin-polymer conjugates 
carrying toxins, fluorphores, and so on. (B) The DARPin-vehicle allows targeted delivery of the 
payloads to the tumor, and the overexpressed EpCAM on the tumor surface prompts receptor-










Compounds S2 and S3 were prepared as previously described (Mapping the Isoprenoid Binding 
Pocket of PDEd by a Semisynthetic, Photoactivatable N-Ras Lipoprotein). S3 (2 g, 7.86 mmol) and 
TEA was added to 50 mL dry CH2Cl2 and cooled to 0 °C in ice bath. 2-bromoisobutyryl bromide 
(2.42 g, 11.8 mmol) was added dropwise to the reaction mixture which was stirred at 0 °C for 1 h 
followed by overnight stirring at rt. After washing three times each with HCl (0.5 M) and H2O, the 
organic phase was collected and dried over Na2SO4. Solvent was removed in vacuo and the 
product was purified by silica gel flash column chromatography (9:1 Hex:EtOAc, v/v) to afford S4 
(2.79 g, 93%) as a yellow oil. 
1H NMR (300 MHz, CDCl3)  ppm 0.06 (s, 6H), 0.89 (s, 9H), 1.81 (s, 3H), 1.61 (s, 3H), 1.66 (s, 3H), 
1.92 (s, 6H), 2.01-2.20 (m, 4H), 4.18 (d, J = 6.6 Hz, 2H), 4.53 (s, 2H), 5.30 (m, 1H), 5.48 (m, 1H) 
13C NMR (75 MHz, CDCl3) 4.3, 14.5, 17.0, 26.6, 26.7, 31.4, 39.5, 56.5, 72.1, 125.5, 130.2, 130.4, 
146.8, 172.0 
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HRMS (m/z): [M + H]+ calcd for [C15H27O3]+ 433.1695, found 433.1692. 
 
(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl 2-bromo-2-methylpropanoate (S5) 
To a solution of S4 (1 g, 2.31 mmol) in dry THF (15 mL) was added TBAF (1.21 g, 4.61 mmol) at 
0 °C and stirred for 15 min followed by stirring at rt for 2.5 h. After quenching the reaction by adding 
CH3OH (15 mL), and the reaction mixture was concentrated in vacuo and purified by silica gel flash 
chromatography (7:3 Hex:EtOAc, v/v) to afford 570 mg (0.5 g, 68 %) of S5 as a clear oil.  
1H NMR (300 MHz, CDCl3)  ppm 0.06 (s, 6H), 0.89 (s, 9H), 1.42 (s, 6H), 1.94 (s, 6H), 2.10-2.20 
(m, 4H), 4.14 (d, J = 6.6 Hz, 2H), 4.53 (t, J = 6.6 Hz, 2H), 5.39-5.41 (m, 2H) 
13C NMR (75 MHz, CDCl3) 14.4, 14.5, 16.8, 18.9, 26.5, 31.4, 39.4, 59.7, 70.9, 72.1, 124.7, 126.1, 
130.4, 139.1, 172.1 
HRMS (m/z): [M + H]+ calcd for [C15H27O3]+ 433.1695, found 433.1692. 
 
(2E,6E)-8-bromo-2,6-dimethylocta-2,6-dien-1-yl 2-bromo-2-methylpropanoate (S6) 
PPh3 (polymer-supported beads, 1.31 g, 3.92 mmol) was added to a solution of S5 (0.5 g, 1.57 
mmol) in dry CH2Cl2 (15 mL), and the reaction solution was stirred for 30 min at rt to let the beads 
swell. After slowly adding CBr4 (0.779 g, 2.35 mmol), the reaction mixture was stirred at rt overnight. 
Once full conversion top product was confirmed via TLC analysis, the reaction mixture was filtered 
to separate the beads and concentrated in vacuo. After removing the CBr4 using a Waters Sep-Pak 




C10-iBr) and (2E,6E)-8-(methacryloyloxy)-3,7-dimethylocta-2,6-dien-1-yl diphosphate (OPP-C10-
Acr) 
S6 (0.393 g, 0.923 mmol) and [(nBu)4N]]3HP2O7 (1.39 g, 1.38 mmol) was added to dry CH3CN (5 
mL) and was left to stir overnight at rt. The reaction mixture was concentrated in vacuo, and the 
product was converted to the ammonium salt form using an ion exchange column (Dowex 50W-
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W8 ion exchange resin). Briefly, a column packed with the resin was washed with three column 
volumes of H2O/conc. NH4OH (2:1, v/v), followed by equilibration with solvent A (49:1 25 mM 
NH4HCO3:iPrOH, v/v). The crude product was loaded onto the column in 1 mL solvent A and eluted 
with additional solvent A, lyophilized, and purified by RP-HPLC with a semipreparative column 
using a gradient of 25 mM NH4OCO3 (A) and CH3CN (B). OPP-C10-Acr started to elute from 12% 
B, followed by elution of OPP-C10-Br. Fractions containing OPP-C10-Br were collected and 
lyophilized to yield white powder. OPP-C10-Acr was shown to form as side product, which was 
collected separately but not used in this work.  
For OPP-C10-Br, 
1H NMR (500 MHz, D2O)  ppm 1.54 (s, 3H), 1.58 (s, 3H), 1.78 (s, 6H), 1.97 (t, J = 7.5 Hz, 2H), 
2.06 (q, J = 7.4 Hz, 2H), 4.32 (t, J = 6.5 Hz, 2H), 4.42 (s, 2H), 5.32 (t, J = 7.0 Hz, 1H), 5.40 (t, J = 
7.2 Hz, 1H) 
31P NMR (203 MHz, D2O) -6.52 (d, J = 26.4, 1P), -10.4 (d, J = 26.4, 1P) 
HRMS (m/z): [M - H]- calcd for [C14H24Br1O9P2]- 477.0085, found 476.9947. 
For OPP-C10-Acr, 
1H NMR (300 MHz, D2O)  ppm 1.41 (s, 3H), 1.45 (s, 3H), 1.74 (s, 3H), 1.91-2.05 (m, 4H), 4.27 (t, 
J = 6.8 Hz, 2H), 4.39 (s, 2H), 5.27 (t, J = 6.8 Hz, 1H), 5.35 (t, J = 6.8 Hz, 1H), 5.52 (s, 1H), 5.93 (s, 
1H) 
31P NMR (121 MHz, D2O) -9.72 (d, J = 22.6, 1P), -5.81 (d, J = 22.6, 1P) 
HRMS (m/z): [M - H]- calcd for [C14H23O9P2]- 397.0823, found 397.0397. 
 
Synthesis of sacrificial initiator resin 
 
The synthesis method was adopted from Maynard (citation). Briefly, to 1500 mg of NovaSyn TGA 
resin (90 µm, loading capacity 0.2 - 0.3 mmol/g) in 40 mL dry CH2Cl2, was added 2-bromo-2-
methylpropionic acid (1303 mg, 7.80 mmol), DCC (2414 mg, 11.7 mmol), and DMAP (238 mg, 1.95 
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mmol). After an overnight reaction at rt, the resin was washed with CH2Cl2, water, then THF, 
followed by drying under vacuum for 3 days. The conjugation of the initiator moiety was confirmed 
by NMR spectroscopy (150 mg/mL in solvent).  
1H NMR (400 MHz, CDCl3)  ppm 1.75-2.16 (6H), 2.90-5.00 (100H), 4.40-4.60 (2H), 5.02-5.34 (2H), 
6.76-7.50 (4H) 
 
Synthesis of azide-methacrylate (Az-MA) 
 
A mixture of 2-[2-(2-azidoethoxy)ethoxy]ethanol (701 mg, 4 mmol) and TEA (294 µL, 4 mmol) in 25 
mL dry CH2Cl2 was cooled down to 0 °C. Methacryloyl chloride (492 µL, 4.4 mmol) was added 
dropwise to the reaction mixture which was left to stir overnight at rt. The solvent was removed in 
vacuo and the crude product was purified by silica gel flash column chromatography (3:1 
Hex:EtOAc, v/v) to afford Az-MA (325 mg, 33%) as a colorless oil. 
1H NMR (400 MHz, CDCl3)  ppm 1.93-1.98 (m, 3H), 3.39 (t, J = 4.8 Hz, 2H), 3.64-3.72 (m, 6H), 
3.76 (t, J = 4.0, 2H), 4.31 (t, J = 4.0 Hz, 2H), 5.58 (m, 1H), 6.13 (m, 1H) 
HRMS (m/z): [M + Na]+ calcd for [C10H17N3O4Na1]+ 266.1111, found 266.1122. 
 
Synthesis of azide-methacrylamide (Az-MAm) 
 
A mixture of 11-azido-3,6,9-trioxaundecan-1-amine (220 mg, 1.0 mmol) and TEA (74.1 µL, 1.0 
mmol) in 5 mL dry CH2Cl2 was cooled down to 0 °C. Methacryloyl chloride (135 µL, 1.2 mmol) was 
added dropwise to the reaction mixture which was left to stir overnight at rt. The solvent was 
removed in vacuo and the crude product was purified by silica gel flash column chromatography 
(1:19 CH3OH:CH2Cl2, v/v) to afford Az-MAm (265 mg, 92%) as a colorless oil. 
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1H NMR (400 MHz, CDCl3)  ppm 1.95-1.98 (m, 3H), 3.39 (t, J = 4.8 Hz, 2H), 3.48-3.55 (m, 2H), 
3.57-3.71 (m, 12H), 5.58 (m, 1H), 5.70 (m, 1H) 
HRMS (m/z): [M + Na]+ calcd for [C12H22N4O4Na1]+ 309.1533, found 309.1535. 
 
Synthesis of rhodamine-methacrylate (Rhod-MA) 
 
A mixture of rhodamine B (1 g, 2.09 mmol), 2-hydroxyethyl methacrylate (279 µL, 2.30 mmol), and 
DMAP (25.5 mg, 0.209 mmol) in 30 mL dry CH2Cl2 was cooled down to 0 °C. The reaction was 
then initiated by adding DIC (234 µL, 2.30 mmol) dropwise, which was stirred overnight at rt under 
Ar (g). The solvent was removed in vacuo and the crude product was purified by silica gel flash 
column chromatography (gradient from 0:100 to 100:0 iPrOH:EtOAc, v/v) to afford Rhod-MA (825 
mg, 71%) as a sticky solid. 
1H NMR (400 MHz, CDCl3)  ppm 1.33 (t, J = 8.0 Hz, 12H), 3.65 (q, J = 8.0 Hz, 8H), 4.15-4.21 (m, 
2H), 4.27-4.33 (m, 2H), 5.55 (s, 1H), 6.02 (s, 1H), 6.81 (d, J = 4.0 Hz, 2H), 6.93 (dd, J = 8.0, 4.0 
Hz, 2H), 7.07 (d, J = 12 Hz, 2H), 7.32 (d, J = 8.0 Hz, 1H), 7.74 (td, J = 8, 1.6 Hz, 1H), 7.84 (td, J = 
8, 1.6 Hz, 1H), 8.29 (d, J = 8 Hz, 1H) 
HRMS (m/z): [M]+ calcd for [C34H39N2O5]+ 555.2853, found 555.2856. 
Synthesis of doxorubicin-PEG4-DBCO (Dox-DBCO) 
 
To a mixture of doxorubicin hydrochloride (5.52 mg, 10.2 µmol) and DBCO-PEG4-NHS ester (6 mg, 
9.2 µmol) in 6 mL dry DMF was added DIPEA (2.98 mg, 23.1 µmol). After stirring at rt for 20 h, the 
solvent was removed in vacuo. TLC and LCMS analysis indicated (near) complete conversion to 
the product. Therefore, the crude product was used without further purification. Yield was 43%, 
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which was determined by measuring the absorption at 485 nm in 1:99 DMSO:water (ε = 11,500 
L·mol-1·cm-1 at 25 °C). 
HRMS (m/z): [M + Na]+ calcd for [C57H63N3O18Na1]+ 1100.3999, found 1100.3999. 
 
Expression and purification of the CVIA-proteins 
Plasmids encoding the POI with an N-terminal His-tag and C-terminal CVIA tag were co-
transformed into BL21 (DE3) cells. The E. coli cells were plated on LB-Agar plates containing 50 
µg/mL kanamycin and grown overnight at 37 °C. A single colony was selected to inoculate 50 mL 
of LB media containing 50 µg/mL kanamycin, which was grown overnight at 37 °C with shaking at 
250 rpm. 10 mL of the culture media was added to 1 L of LB media containing 50 µg/mL kanamycin. 
Once the cell culture was grown at 37 °C 250 rpm to an OD600 of 0.6 - 1.0, protein expression was 
induced by adding 0.5 mM IPTG. The cells were grown for another 4 h at 37 °C 250 rpm and 
harvested by centrifugation at 5,400 g for 10 min. The cell pellet was resuspended in 50 mL of 
buffer A (20 mM Na2HPO4/NaH2PO4, 500 mM NaCl, 50 mM Imidazole, 10 % Glycerol) containing 
1 mL of inhibitor cocktail (Sigma Aldrich P8340) and lysed by pulse sonication (10 sec on, 10 sec 
off) at 50 W for 10 minutes total. Centrifugation of the lysis extract was performed at 13,000 g for 
30 min, and the soluble fraction was collected and purified by immobilized metal ion affinity 
chromatography (IMAC) using Ni-NTA Agarose (Qiagen). 
 
Enzymatic incorporation of OPP-C10-iBr or C10-azide 
Enzymatic reaction mixtures (15 mL) contained Tris·HCl (50 mM, pH 7.5), MgCl2 (10 mM), KCl (20 
mM), ZnCl2 (100 μM), DTT (5.0 mM), D1-CVIA (D4-CVIA, GFP-CVIA) (5 μM), OPP-C10-iBr or C10-
azide (30 μM), and yPFTase (600 nM). The reaction mixture excluding the isoprenoid analogue and 
yPFTase was incubated on ice for 0.5 h, followed by addition of the two reagents and incubation 
for 6 h at 30 °C. The product mixture was then buffer exchanged (x3) into PBS and concentrated 
to 100 µL using an Amicon Centriprep centrifugation device (10,000 MW cut-off, 15 mL). The 
product was characterized by LCMS and SDS-PAGE analysis. The subsequent protein 
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concentration was calculated by BCA assay for the DARPin conjugates and UV absorbance at 488 
nm (ε=55,000 M-1·cm-1) for the GFP conjugate. 
 
In situ ATRP from the site-specific protein-macroinitiator 
OEGMA500 monomer (273 µmol) and sacrificial initiator resin (10.5 mg, 2.65 mol) was added to 100 
µL of the protein-macroinitiator solution (75 nmol). Az-MA (8.18 - 24.5 µmol) or Rhod-MA (8.18 - 
24.5 µmol) was also added to this solution depending on the intended application. To this solution 
was added 400 µL of a catalyst solution composed of CuBr2 (2.65 µmol) and TPMA (26.5 µmol) in 
PBS. Polymerization was initiated by adding 50 µL of ascorbic acid (265 nmol) in PBS. All solutions 
were separately purged with argon for 30 min after formulation. After 6 h of polymerization at rt, the 
reaction was quenched by exposure to air. The product solution was purified from sacrificial initiator 
resin using a 0.22 µm centrifugal filter and subjected to anion exchange chromatography (AExC) 
with a HiTrap Q HP column to remove unreacted monomers from the products. A linear gradient of 
2.5% per min from Buffer A (20 mM HEPES, pH 8.0) to Buffer B (20 mM HEPES, 1 M NaCl, pH 
8.0) was applied. The fractions containing the D1-polymer conjugates were collected and 
concentrated using an Amicon Centriprep centrifugation device (10,000 MW cut-off) and subjected 
to purification and analysis by size exclusion chromatography (SEC) with a Superdex 200 10/300 
column (GE Healthcare) with PBS. For samples that require the functionalization with a DBCO 
reagent, click reaction was employed to the AExC-purified product followed by SEC purification. 
The FPLC used for chromatography purifications was a Knauer AZURA BioLC device. The 
collected SEC fractions were concentrated using an Amicon Centriprep centrifugation device 
(10,000 MW cut-off), which was subjected to 12 or 15% SDS-PAGE for purity analysis and BCA 
assay for concentration analysis. 
 
Characterization of the grafted polymer  
For the characterization of the polymer-component without the protein, size exclusion 
chromatography analysis was carried out after trypsin digestion of the protein-component following 
a protocol adapted from Thermo Scientific. Briefly, the protein-polymer conjugate in 50 mM Tris·HCl 
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(pH 8.0) was incubated with 8 M urea and 5 mM DTT at 37 °C for 1 hour. After adding 15 mM 
iodoacetamide, the mixture was incubated in the dark at rt for 30 min, followed by dilution with 50 
mM Tris·HCl to produce a urea concentration below 2 M, after which 5 µg/µL trypsin and 1 mM 
CaCl2 were added and incubated overnight. The mixture was concentrated using an Amicon 
Centriprep centrifugation device (10,000 MW cut-off), purified with a PD-10 column equilibrated 
with milli-Q water, lyophilized, solubilized in THF, and subjected to a THF-solvent system Wyatt 
device SEC with a Phenogel 5 µm 10E3A column. 
 
Functionalization of the protein-polymer conjugates via copper-free click chemistry 
For protein-polymer species containing clickable azide-functionality in the polymer, payload-
conjugation was performed with the AEx-purified mixture by adding a 3-5 fold molar excess of the 
DBCO-reagent. The reaction was allowed to proceed overnight at 4 °C and was subjected to SEC 
purification as described above. 
 
Quantification of the incorporated clickable- or dye-monomers 
For individual characterization of the protein and fluorophore concentrations of D1-POEGMA-
TAMRA, absorbance measurements were taken at two different wavelengths. The protein 
concentration was measured using a standard BCA assay protocol (Thermo Scientific). However, 
absorbance was measured at 640 nm instead of 565 nm to avoid spectral overlap with TAMRA. 
The fluorophore concentration was measured similarly using a standard curve that was obtained 
using rhodamine B solutions of varying concentrations. The absorbance was measured at 475 nm 
to maximize the range of measurable concentrations. All measurements were performed in a 96- 
well plate. The volume of solution was 210 µL for BCA assays (200 µL BCA solution and 10 µL 
protein solution) and 100 µL for fluorophore concentration measurements.  
 
Serum stability of D1-POEGMA 
The stability of the ester linkages in D1-POEGMA-TAMRA was investigated by serum stability 
experiments. Mouse plasma (lithium heparin plasma, BiolVT) was filtered through a 0.22 µm 
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syringe filter. D1-POEGMA-TARMA in PBS were then added to the mouse plasma to obtain a final 
concentration of 1 µM in 50% (v/v) mouse serum and divided into 80 µL aliquots. After 0, 6, 24, and 
48 h incubation in a 37 °C water bath, each aliquot was flash-frozen in liquid nitrogen and stored 
at -20 °C. For SDS-PAGE analysis of the serum-incubated D1-POEGMA-TARMA, 12 µL of Ni-NTA 
resin (Qiagen) in PBS was added to each aliquot after thawing to capture the His8-tagged D1. After 
incubation for 1 h in the dark at rt, the supernatant was removed by centrifugation and the resin 
was washed with PBS (x2). For the release of the captured protein, 20 µL of Laemmli buffer 
containing 1 M imidazole was added to each aliquot and incubated at rt for 10 min and then 95 °C 
for 10 min. The resulting samples were was then loaded into individual wells of a 15% SDS-PAGE 
gel and subjected to electrophoresis. In-gel fluorescence analysis was performed using a Typhoon 
FLA 9500 biomolecular imager.  
 
Preparation of D1-TAMRA 
To a solution of D1-azide in PBS, 5-fold molar excess of the TAMRA-DBCO was added. The 
reaction proceeded overnight at 4 °C and was subjected to a series of buffer exchanges using an 
Amicon Centriprep centrifugation device (10,000 MW cut-off). Product was characterized by SDS-
PAGE. 
Flow cytometry 
The binding affinity of the DARPin-polymer conjugates was characterized by flow cytometry. Briefly, 
cells (MCF7, HT29, or U87) were grown to ~70% confluency, washed twice with PBS, detached 
with trypsin, and divided into aliquots of 1x105 cells in PBSA (PBS containing 1 mg/mL BSA). After 
pelleting via centrifugation and removal of the PBSA, cells were treated with 100 µL of 100 nM 
DARPin at 4 °C for 45 min, followed by washing with PBSA (x3), and incubation with 25 µL of Alexa 
Fluor 488-conjugated Anti-6x-His Tag Monoclonal Antibody (Invitrogen, MA121315A488, 1:500) in 
PBSA for 45 min at 4 or 37 °C. Cells were quantified using a BD Fortessa X-30 H0081 flow 




Cell binding and internalization of DARPin-polymer conjugates were characterized by confocal 
microscopy. Briefly, 1x104 cells (MCF7, HT29, or U87) were transferred to a glass-bottom dish (35 
mm) and incubated overnight at 37 °C 5% CO2 to allow for adhesion. After decanting the DMEM 
media, cells were washed with DPBS (x3) and incubated with 200 µL of 100 nM DARPin for 1 h at 
4 °C. The cells were then washed with DPBS (x3) and subjected to a secondary incubation with 
200 µL of Alexa Fluor 488-conjugated Anti-6x-His Tag Monoclonal Antibody (Invitrogen, 
MA121315A488, 1:500) in PBS for 45 min at 4 or 37 °C. After washing with DPBS (x3), cells were 
stained with 500 µL of 0.5 µg/mL Hoechst dye for 10 min at rt, washed with DPBS (x3), and fixed 
with 500 µL of 4% paraformaldehyde for 15 min at rt. After washing with DPBS (x3), cells were 
imaged with a Nikon A1Rsi Confocal microscope with SIM Super Resolution. Data analysis was 
performed with Image J software.  
 
In vitro toxicity of DARPin-POEGMA-MMAE constructs 
An XTT-assay was utilized to assess the toxicity of D1-POEGMA-MMAE against three cell lines, 
HT29, MCF7, and U87. Briefly, 2,000 cells in 50 µL DMEM media were aliquoted into each well of 
a 96-well plate and incubated for 24 h in the 37 °C 5% CO2 incubator. After decanting the media, 
50 µL of media containing serial dilutions of D1-POEGMA-MMAE was added and incubated for 96 
h. The media was decanted once again followed by addition of 50 µL XTT reagent. Absorbance 
was measured at 480 nm and 650 nm (reference wavelength) after 1, 2, and 3 h incubation. Data 
was analyzed in Excel and plotted using the software Prism.  
 
2.3 Results and Discussion 
yPFTase-mediated site-specific installation of the initiator moiety 
 Ac2 and E3_5 DARPin constructs146 that contain an N-terminal His8-tag and a C-terminal 
CVIA-tag were expressed in E. coli and purified using an IMAC column. Both the EpCAM-binding 
Ac2-CVIA construct (D1-CVIA) and the negative control E3_5 construct (D4-CVIA) were obtained 
with high yield (>10 mg/L of liquid culture). The OPP-C10-Br isoprenoid analog that contains the 
ATRP-initiator moiety was prepared from geraniol through a six-step synthesis. A side product to 
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OPP-C10-Br was also produced via elimination of the bromide which is denoted as OPP-C10-Acr. 
The two products were separable by HPLC. This work only focused on utilizing OPP-C10-Br for in 
situ polymerization from DARPins, and it was later found that the yield of OPP-C10-Br could be 
improved by utilizing a THP protecting group instead of the TBDMS, as the elimination of the 
bromide occurs during the TBDMS deprotecting step. However, it should be noted that OPP-C10-
Acr is a potentially valuable isoprenoid analog that has potential for related applications. For 
instance, one could envision a grafting-through preparation of protein-polymer conjugates with 
acrylate-labeled proteins that behave as a macromonomer, and hence becomes incorporated into 
the polymer chain via copolymerization with other synthetic monomers. 
Farnesylation of D1- and GFP-CVIA with OPP-C10-Br was assessed by LCMS. Analysis 
of the D1 and GFP reaction solution by LCMS showed high product conversion to the D1-Br and 
GFP-Br (>90% for both), indicated by the near-complete shift of the starting material peak (28159 
and 19359 Da, respectively) to the product peak (28461 and 19660 Da, respectively) which exhibits 
a higher retention time. Deconvolution of the product peak revealed a mass increase consistent 
with the addition of a single isoprenoid derived from OPP-C10-Br, indicating site-specific and 
stoichiometric labeling of the C-terminal cysteine residue (Fig. S2.1). While a peak at a retention 
time that corresponds to the unmodified CVIA-protein was observed, the intensity was much lower 
than the product peak and was insufficient for deconvolution, which overall indicated that the 
amount of starting material was quite small (<10% of product) and that farnesylation with OPP-
C10-Br was highly efficient. Control experiments lacking the yPFTase or OPP-C10-Br in the 
reaction mixture did not show any prenylated protein, indicating that the product conversion was 
indeed formed an enzymatic reaction (data not shown).  
Exploiting the stability of DARPins, farnesylation conditions were adjusted to higher 
protein concentrations to maximize the material obtainable per reaction batch. While previous 
studies had set the target protein concentration to 2.4 µM, D1-CVIA could be farnesylated at 
concentrations up to 10 µM. The OPP-C10-Br and yPFTase concentrations were changed 
accordingly to 40 µM and 600 nM, respectively. Although some protein precipitation was observed, 
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the highly concentrated protein solutions required a lesser number of post-prenylation buffer 
exchanges, making this the preferred method.  
 
In situ ATRP and click chemistry for functionalized D1-POEGMA conjugates 
 Grafting-from polymerization was performed in PBS based on an AGET-ATRP protocol 
adopted from Maynard and coworkers.135 Briefly, the DARPin-macroinitiator was subjected to 
polymerization with sacrificial initiator resin which was included to facilitate the reaction by 
increasing the effective initiator concentration.132 The resulting DARPin-POEGMA conjugates were 
found to be stable and soluble after the polymerization reactions consistent with the mild reaction 
conditions employed for AGET ATRP. The resin was easily removed post-reaction by simple 
filtration. In these reactions, copolymerization with various monomers was performed where the 
monomer type and composition were varied based on the desired product characteristics. The main 
component of the monomer mixture was oligoethylene glycol methacrylate (OEGMA500, POEGMA 
once polymerized), a commercial PEG-branched monomer that has been shown to enhance the 
pharmacokinetics of the protein-polymer conjugates.136,140 For DARPin-POEGMA conjugates 
purposed for fluorescence imaging studies, a TAMRA-fluorophore was incorporated into the 
polymer using two different methods. The first employed direct incorporation by copolymerization 
with a rhodamine-methacrylate monomer. The other method required a two-step procedure where 
the polymer was first functionalized with azides through copolymerization with an azide-
methacrylate monomer, followed by labeling with a TAMRA via copper-free click chemistry with a 
TAMRA-DBCO reagent. While the former method was simpler, it required custom-developed 
monomers for alternative applications due to the lack of methacrylate-functionalized payloads 
available in the market. In contrast, installing an azide within the polymer, capitalized on the various 
DBCO-containing reagents that are commercially available including fluorophore, toxins, and 
ligands for metal-mediated PET imaging. 52 Work with the fluorescent polymers for cellular imaging 
is presented below with additional examples using toxins and metal chelators in subsequent 
sections. 
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 DARPin-POEMGA products were purified and analyzed using a combination of anion 
exchange chromatography (AExC) and size exclusion chromatography (SEC). Peaks that shifted 
to a shorter retention time in SEC and bands that appear in the higher molecular weight region in 
SDS-PAGE both indicated successful polymerization (Fig. 2.2B and 2.2C). As reported in prior 
studies, macromolecular species unrelated to the DARPin were observed in addition to the 
DARPin-POEMGA product, which were suspected to be a result of uncontrolled polymerization 
from monomers in the reaction solution or polymers cleaved from the sacrificial resin.135 The 
formation of these impurities could not be prevented even after adding excess ligand to stabilize 
the copper catalyst. Nonetheless, the quantity of these macromolecules was relatively low 
compared with the protein-polymer product and could be efficiently separated from the product by 




Figure 2.2 In situ ATRP from D1-Br. (A) Schematic of the AGET ATRP reaction from D1-Br that 
yields site-specific D1-POEGMA (x : y : z = 70 : 0-3 : 0-3). (B) SEC trace of D1-CVIA and D1-
POEGMA. The zoom-in region shows the overlap between the D1-monomer and D1-polymer which 
is presumed to be causing incomplete separation of the two macromolecular species. (C) SDS-
PAGE of D1-CVIA and D1-POEGMA (lane 1, protein ladder; lane 2, D1-CVIA; lane 3, D1-POEGMA). 
The left shows a Coomassie stained gel, and the right shows a fluorescence-scanned image of the 
identical gel before Coomassie staining. 
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Despite the subjection to a series of anion exchange and size exclusion column 
chromatographies, some residual D1-monomer species was found to be present in the D1-
POEMGA solution, indicated by the band near the 20 kDa region observed in SDS-PAGE analysis 
(Fig. 2.2C). This was found to be due to the distinctive SEC elution pattern of D1-monomers (Fig. 
2.2B, Fig. S2.2). Instead of eluting as a sharp peak in the SEC analysis, D1-CVIA eluted over a 
broad range of retention volume that overlaps with D1-POEGMA, causing insufficient separation of 
the two species (Fig. 2.2B, Fig. S2.2). Use of reducing agents in the buffer did not narrow the D1-
CVIA peak in the SEC, indicating that the broad peak is not due to the protein dimerization of D1 
but rather a characteristic of the protein itself, perhaps due to some interaction with the column 
material. SDS-PAGE of D1-POEGMA performed without reduction or heating prior to loading did 
not intensify the D1-monomer band, demonstrating that the cleavage of the protein-polymer linkage 
is unlikely a contributing factor to the issue with D1-monomer impurities (data not shown). 
Nonetheless, as both the farnesylation and ATRP initiation efficiency was high, the purity of the 
DARPin-POEGMA over DARPin-monomers was shown to be over 80%.  
To assess the physical properties of the POEGMA component, SEC analysis was 
performed on D1-POEGMA after trypsin digestion of the D1. The results revealed a highly 
converted product with low dispersity (Mn = 35.1 kDa, D = 1.27), which was especially noteworthy 
as the reaction time was much shorter compared with then previous reports.135 We hypothesized 
that this high ATRP efficiency results from having the initiation-site located at the easily assessable 
C-terminus of D1-Br, suggesting the advantages of exploiting protein prenylation for in situ polymer 
conjugation reactions.  
 D1-POEGMA polymer, copolymerized with the azide- or rhodamine-monomer (D1-
POEGMA-Azide or D1-POEGMA-Rhodamine) were subjected to an spectrophotometric analysis 
to quantify the number of incorporated functionalized monomers per one D1-POEGMA.147 First, the 
protein concentration was quantified by performing a BCA assay evaluated at 640 nm (Fig. 2.3). 
The azide (following the conjugation of TAMRA-DBCO) or rhodamine concentration was quantified 
by measuring the absorbance at 475 nm (Fig. 2.3). The two wavelengths were selected to minimize 
spectral overlap. Dividing the fluorophore concentration by the protein concentration yielded the 
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ratio of functionalized monomers per D1 in the D1-polymer conjugate. This ratio could be easily 
tuned by altering the monomer concentrations in the polymerization reaction solution, and a 
correlation was observed between the composition of the monomer mixture and the polymer 
product. This was presumably due to the similar reactivity ratios between the monomers as they all 
contain the same unhindered alkene. 
 
Figure 2.3 Working curves for the calculation of D1 and TAMRA concentrations, and hence the D1 
to TAMRA ratio in D1-POEGMA-TAMRA. (A) Absorbance at 475 nm for various rhodamine B 
solutions with varying concentrations. (B) Absorbance at 640 nm for various BSA solutions after 
incubation in BCA solutions. 
 
Having the protein-vehicle carry multiple payloads is an important feature in the ADC field 
as it allows maximization of the therapeutic effect. For instance, antibodies carrying multiple 
fluorophores allows enhanced signals in tumor imaging studies147,148 and multiple toxins allow 
increased tumor-specific toxicity.149–152 However, attaining this high cargo : protein ratio is currently 
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a difficult challenge with ADCs since the hydrophobicity of the payload often causes protein 
instability or aggregation.153,154 Therefore, it was noteworthy that a high number of functionalized 
monomers per D1 could be achieved without negatively affecting the stability of D1. While 3 
fluorophores per D1 was achieved, we are currently in the process of increasing the loading of the 
payload even further. In later sections, we show that D1-POEGMA can be functionalized with up to 
3 MMAE toxins which is well known for its effectiveness against tumors but manifest limitations due 
to its hydrophobicity.155 We hypothesize that the high loading capacity obtained here was enabled 
by conjugating the payloads to the POEGMA instead of directly to the DARPin. The hydrophilicity 
of the polymer may mask the hydrophobicity of the payloads, and the distance introduced between 
the payload and DARPin may reduce the interaction of the two, both serving to minimize protein 
destabilization. We also anticipated that the high loading of cargo could result in enhanced 
therapeutic efficacy, which is discussed in later sections of this paper.  
 
Serum stability 
 Previous studies have shown that ester bonds can be susceptible to carboxylesterase-
mediated hydrolysis under physiological conditions, which could lead to undesired loss of the 
payload and hence non-target toxicity for ADCs carrying an ester-linkage.156 This effect was shown 
to be much more apparent in mouse serum or mouse animals due to the higher carboxylesterase 
activity that is present in mice compared to human.156 Prior research from Distefano and coworkers 
conducted with a payload conjugated D1 has also shown that the ester-linkage bridging the two 
molecules is susceptible to hydrolysis in mouse serum, and that could be a source of non-specific 
toxicity in EpCAM-negative cell lines.157 As the protein-polymer conjugates reported here contained 
multiple esters, between the protein and polymer and between the polymer backbone and side 
branches, the serum stability of D1-POEGMA-TAMRA was assessed. We hypothesized that the 
steric hindrance of the branched-POEGMA may protect the ester-linkages from enzymatic 
hydrolysis. Indeed, even after 48 h in mouse serum, the ester-linkage connecting D1 to POEGMA 
was found to be stable. The D1-monomer band in SDS-PAGE remained unchanged throughout the 
48 h incubation, indicating that POEGMA remained linked to D1 (Fig. 2.4). The ester bonds linking 
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the TAMRA fluorophores to the backbone of POEGMA was also found to be stable in mouse serum 
evidenced by the consistent fluorescence signals of the D1-POEGMA-TAMRA band in SDS-PAGE 
across all time points. The stability of the ester-bonds in the polymer side branches suggested that 
other payloads including toxins would remain stably bound to D1-POEGMA as well, and that the 
toxin loaded D1-POEGMA conjugates would be capable of targeted drug delivery without exhibiting 
non-specific toxicity due to the loss of the toxin.  
 
 
Figure 2.4 Stability of D1-POEGMA-TAMRA in mouse serum. Incubation of the DARPin-polymer 
conjugate up to 48 h did not result in increased intensity of the band near 20 kDa which corresponds 
to the DARPin-monomer, indicating that the ester-linkage connecting the two macromolecules 
remain intact. TAMRA-signals remained constant as well which indicated that the esters connecting 




Figure 2.5 Flow cytometry analysis of EpCAM-selective cell surface binding of D1-POEGMA-
TAMRA. A) MCF7 cells monitored by AlexaFluor-488 channels after treatment with D1- conjugates. 
D1-POEGMA-TAMRA shows exhibit similar binding to MCF7 cells compared with the non-polymer 
conjugated D1-TAMRA. B) MCF7 cells monitored by TAMRA channels after treatment with D1- 
conjugates. Increasing fluorophore-loading in D1-POEGMA-TAMRA results in higher MFI. C) 
Competition studies with MCF7 cells. Blocking cell surface EpCAMs with D1-CVIA before 
incubating the cells with D1-conjugates nullifies their cell binding activity. D) U87 cells monitored 
by AlexaFluor-488 channels following treatment with D1-conjugates. Due to the low expression of 
EpCAM in U87 cells, cell-binding activity of D1-conjugates are not observed. MFI: Mean 
fluorescence intensity. 
 
High retention of cell binding affinity of D1-POEGMA 
 Macromolecule-conjugated antibodies often manifest diminished affinity towards their 
epitopes. One of the main factors that contribute towards this reduced activity is the polymer-
induced steric hindrance that interferes with the antibody-antigen interaction.144,158,159 This 
detrimental effect becomes even more exacerbated when the conjugation occurs non-specifically 
near or directly on the variable region of the antibody that is crucial for antigen-recognition.160,161 
As the DARPin-polymer conjugates described contain branched polymers that have been reported 
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to minimize activity loss of the modified protein,162 their ability to bind to cells expressing cell surface 
cancer markers was investigated. For this, flow cytometry assessment of D1-POEGMA-TAMRA 
was performed (Fig. 2.5). The EpCAM-specific binding affinity of D1-POEGMA-TAMRA was 
explored with MCF7 cells serving as an EpCAM positive cell line163,164 and U87 as a negative 
control (low EpCAM expression).164 Cell-binding was analyzed using two fluorescence channels. 
One channel detected the fluorescence emitted from TAMRA that is conjugated to POEGMA, and 
the other detected AlexaFluor-488 signals emitted from anti-His-AlexaFluor-488 antibodies bound 
to the His8-tag of D1 through a secondary antibody staining protocol. The former was monitored to 
evaluate whether multiple fluorophores can enhance EpCAM detection through signal amplification, 
and the latter was utilized to assess the binding affinity of site-specifically modified D1. 
 D1-POEGMA-TAMRA was found to bind effectively to EpCAM-expressing MCF7 cells. 
Two different D1-POEGMA-TAMRA conjugates were assessed, one that carries 0.7 TAMRA per 
D1 and one that carries 1.5. For convenience, the number of payloads will be further denoted by 
adding the number at the end of the name of the conjugate. Cells analyzed by flow cytometry in 
the presence of D1-POEGMA-TAMRA-1.5 gave a mean AlexaFluor-488 fluorescence of 6,402 
compared to the cells alone that yielded a mean fluorescence of 214 (Fig. 2.5A). Its binding activity 
could be completely nullified by preincubating the MCF7 cells with D1-CVIA lacking the TAMRA 
fluorophore (Fig. 2.5C). In that case, a mean AlexaFluor-488 fluorescence of 194 was observed. 
Binding to EpCAM-negative U87 cells was not observed; the mean fluorescence of U87 cells was 
2,844 in the presence of D1-POEGMA-TAMRA and 2,361 it its absence, respectively (Fig. 2.5D). 
These results suggests that the binding affinity of D1-POEGMA-TAMRA was indeed specific for 
EpCAM. Both TAMRA and AlexaFluor-488 fluorescent signals were observed together via flow 
cytometry analysis with MCF7 cells treated with D1-POEGMA-TAMRA, indicating that the labeling 
of cells with TAMRA is caused by the D1-targeting moiety. Most importantly, the EpCAM-specific 
binding affinity of D1 was well preserved despite being conjugated to a macromolecule. D1-TAMRA 
prepared by farnesylation of a single azide followed by copper-free click reaction with a TAMRA-
DBCO, which is denoted as D1-TAMRA, exhibited similar AlexaFluor-488 signal intensities with 
D1-POEGMA-TAMRA when incubated with MCF7 (MFI = 6,086 for D1-TAMRA vs. 6,402 D1-
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POEGMA-TAMRA-1.5). The similar binding affinities regardless of the presence of POEGMA 
suggests that there is no significant loss of binding activity upon polymerization and that steric 
hindrance is a complicating factor. We hypothesize that this is a result of the site of polymer-
conjugation being located at the C-terminus of D1. There, the covalent modification should have 
minimal effect on three internal repeat units of D1 that comprises the antigen binding domain since 
they are remote from the C-terminal capping repeat motif whose purpose is to shield the core to 
enhance protein stability and increase overall molecular mass. The branched rod-shaped 
morphology of POEGMA is expected to point away from the protein rather than encapsulating it as 
a linear PEG would do, which may also have a positive effect in maintaining the binding activity of 
D1. We do note that despite the site-specific nature of the farnesylation-induced protein 
modification, there is some loss in activity of the D1-conjugates compared to D1-CVIA (MFI = 6,402 
for D1-POEGMA-TAMRA-1.5 vs. 19,402 for D1-CVIA), which we assume is an inevitable cost for 
proteins undergoing covalent modifications.  
 The advantage of incorporating payloads through the backbone of the hydrophilic polymer 
of D1-POEGMA could be readily observed by flow cytometry. D1-POEGMA-TAMRA carrying a 
higher number of dyes displayed higher TAMRA fluorescence signals (MFI = 1,097 for D1-
POEGMA-TAMRA-0.7 vs. 3,813 for D1-POEGMA-TAMRA-1.5) (Fig. 2.5.B). We hypothesize that 
even higher fluorescence signals would be obtainable by increasing the number of fluorophores 
even further. In such case, while there may be some loss in activity due to the covalent protein-
modification, the overall efficacy of DARPins can be compensated by the unique advantage of 
carrying payloads.  
 
Tumor cell targeted imaging 
 The EpCAM-specific binding activity of the DARPin-polymer conjugates was also 
evaluated via confocal imaging. Briefly, the D1-POEGMA-TAMRA and D4-POEGMA-TAMRA were 
each incubated with MCF7 and U87 cells, followed by washing and incubation with anti-His6-
AlexaFluor-488 antibodies. The binding experiments were conducted at both 4 and 37 °C (Fig. 2.6). 
Fluorescent signals were only observed for the D1-POEGMA-TAMRA treated EpCAM-positive 
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MCF7 cells. The absence of signals in U87 cells indicated that the conjugated POEGMA does not 
induce non-specific binding (data not shown); furthermore, the imaging results indicate that D1-
POEGMA-TAMRA retained its specificity towards EpCAM after conjugation with a polymer. Those 
results are consistent with the flow cytometry data noted above. D1-POEGMA-TAMRA was 
observed to be bound to the surface of MCF7 cells when incubated at 4 °C and internalized when 
the temperature was raised to 37 °C. Cell entry at elevated temperatures is consistent with 
receptor-mediated endocytosis of D1 by EpCAM. The TAMRA (linked to the POEMGA) and 
AlexaFluor-488 (bound to D1) signals on the cell surface were found to colocalize, indicating that 
the delivery of the fluorescent payload is facilitated by the D1 protein, and that the ester-linkages 
within on the protein-polymer conjugate are stable under physiological conditions. 
 
 
Figure 2.6 Confocal imaging of the EpCAM-specific binding of D1-POEGMA-TAMRA on MCF7 
cells. (A) At 4 °C, D1-POEGMA-TAMRA bind to the cell surface, and (B) at elevated temperatures 
of 37 °C they undergo receptor-mediated endocytosis. Colocalization of the TAMRA and 
AlexaFluor-488 signals indicate that the fluorescent payload is delivered to cells by the D1-binding 
activity to EpCAM. 
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Tumor cell targeted drug delivery 
 To target tumor cells, D1-POEGMA was functionalized with multiple cytotoxic drug 
molecules utilizing the same synthetic strategy that was employed for fluorophore-conjugation. The 
toxin chosen was a commercially available DBCO-labeled monomethyl auristatin E (MMAE) 
derivative that incorporates a valine-citrulline-p-aminocarbamate (vc-PABC) linker that allows 
intracellular release of the payload in its unmodified form.165 For convenience, the toxin will be 
further denoted as MMAE-DBCO. The number of MMAEs per D1 could not be directly quantified 
due to technical limitations. However, a prior study had demonstrated that MMAE-DBCO is 
efficiently conjugated to azide-labeled proteins even at low concentrations.157 Therefore, we 
assumed that the amount of MMAE per D1 would be most likely the same as the number of TAMRA 
per D1. It was worth noting that low concentrations (2 eq to the azide) were adapted not by choice, 
but due to the extremely low water-solubility of MMAE-DBCO, which caused precipitation of the 
reagent when conditions identical to TAMRA-DBCO labeling (5 eq) were used. This demonstrated 
the high hydrophobicity of MMAE and indicated how it becomes a major challenge in achieving 
high DAR.166 Despite labeling of multiple MMAEs, D1-POEGMA-MMAE was impressively stable in 
solution without precipitation, demonstrating the advantage of linking multiple hydrophobic 
payloads through the hydrophilic polymer.  
 Targeted toxicity of D1-POEGMA-MMAEs (carrying 1 or 3 MMAEs per D1) were evaluated 
via cell-based studies using an XTT assay that detects the presence of live cells (Fig. 2.7). Three 
cell lines were evaluated. HT29 cells were added here to serve as a cell line that exhibits higher 
EpCAM-expression levels compared with MCF7 cells. U87 cells were employed as an EpCAM-
negative control. As expected, the level of toxicity showed a correlation with EpCAM-expression 
levels. D1-POEGMA-MMAE-3 exhibited the highest toxicity for HT29 cells (IC50 = 6.16) and the 
lowest for U87 cells (IC50 = 116). Higher toxicity (lower IC50) was also observed with increasing 
number of MMAEs per D1-POEGMA (in HT29 cells, IC50 = 6.16 vs. 28.2 for D1-POEGMA-MMAE-
3 and D1-POEGMA-MMAE-1, respectively), demonstrating the advantage of increasing the DAR 
for ADCs and related molecules. D1-POEGMA-MMAE-1 was shown to exhibit low IC50 values in 
the nanomolar range for both EpCAM-positive cell lines, demonstrating its therapeutic efficacy. 
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However, its toxicity was less effective than that of MMAE-DBCO itself or the D1-MMAE (non-
polymer conjugate) from previous studies.157 This may result from the effect of the conjugated 
POEGMA, which in addition to reducing the EpCAM-binding affinity, causes impaired internalization 
of D1.167 However, what was important was how increasing the DAR from one to three in D1-
POEGMA-MMAE was able to reduce the IC50 to single digit nanomolar concentrations, resulting in 
potency that is comparable to the non-polymer conjugated D1-MMAE. Thus, similar to other 
polymer-conjugated ADCs, we expect that the conjugated POEGMA would add another advantage 
in animal systems, elongated circulation, which would more than compensate for the loss of binding 
affinity and result in an overall positive effect.144,167 
 The EpCAM selectivity of D1-POEGMA-MMAE was demonstrated, indicated by the 
difference in IC50 values between HT29 and U87 (6.16 vs. 116 for D1-POEGMA-MMAE-3).The IC50 
of U87 was below of that of MMAE-DBCO (31.0), indicating that the D1 conjugation plays a key 
role in preventing non-selective internalization of the toxins. However, it was notable how D1-
POEGMA-MMAE was still exhibited some level of toxicity even for the negative control U87 cells. 
Interestingly, the IC50 values did not change upon the number of MMAE per D1 (IC50 = 114 and 116 
for D1-POEGMA-1 and D1-POEGMA-3, respectively) as opposed to how it correlated with the level 
of toxicity in EpCAM-positive cells. This suggests that the source of toxicity in U87 cells could be 
due to something other than the D1-mediated delivery of MMAE. At this point, we presume that 
free-unconjugated MMAE that has been hydrolytically cleaved from POEGMA is what is causing 
off-target toxicity, leading to elevated potency in U87 cells. While it was confirmed that the ester 
bonds located in the side branches of POEMGA were stable, we hypothesize that once the MMAE-
DBCO, which itself contains a lengthy (PEG)4-vc-PAB linker, is conjugated to the azide moieties on 
POEGMA, the length of that side-branch may extend enough to expose the vc-PAB linker to 
enzymes present in the environment. Although the vc-PAB linker was originally developed to 
selectively release payloads only inside tumor cells due to the effect of cathepsin B enzymes that 
are upregulated in tumor cells,168 several recent studies have reported that the linker can be 
cleaved by other biological entities including carboxylesterase 1C169 or other types of cysteine 
cathepsins.170 Studies have also indicated that some types of cancer cells that include U87 cells 
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secrete proteolytic enzymes such as cathepsins in the surrounding media, resulting in extracellular 
proteolytic activity against ADCs that contain vc-PAB linkages.171 In an actual tumor environment 
in a living organism, extracellular release of the payload could be a beneficial bystander effect 
which would contribute towards combating not only antigen-positive but also antigen-negative 
cancer cells in a heterogeneous tumor population.171 Despite loss of payload during plasma 
circulation, in vivo tolerance would be high as the release would occur only at the vicinity of 
tumors.172 The wide use of the FDA approved ADCs that utilize the MMAE-vc-PAB warhead173 also 
indicates that the overall efficacy using the cleavable linker prevails over its negative effects. 
Therefore, we believe the limited in vitro selectivity results we show are an artifact from selecting 
an inappropriate negative control U87 together with the enzymatic degradability of the vc-PAB linker. 
In the near future, we aim to perform alternative studies that could properly demonstrate the 
EpCAM-selective toxicity of D1-POEGMA-MMAE. Some options would be trying other EpCAM-
negative cell lines such as HEK293T or RL cells that may not secrete proteolytic enzymes and was 
confirmed a suitable EpCAM negative cell line in prior studies,144 adding D4-POEGMA-MMAE as 
the negative control DARPin, or using a D1-POEGMA-MMAE in which the MMAE-linker does not 




Figure 2.7 EpCAM-targeted cytotoxicity of D1-POEGMA-MMAE. The cytotoxicity against EpCAM-
positive HT29 and MCF7, and EpCAM negative U87 were determined by XTT assays. Three toxins 
were compared, D1-POEGMA carrying 1 (green) or 3 (red) MMAEs, and DBCO-MMAE (blue).   
 
Toxin D1-POEGMA-MMAE-3 DBCO-MMAE 
IC50,U87 / IC50,HT29 18.8 6.00 
 
Table 2.1 Selectivity ratios of cytotoxicity. The IC50 of the toxins in U87 were divided by the IC50 in 
HT29 cells to demonstrate the capability of D1 to selectively deliver toxins to EpCAM positive tumor 
cells. 
 
Radiolabeled D1-POEGMA for in vivo imaging 
To use the above strategy for in vivo imaging applications via positron emission 
tomography (PET) imaging, some modification to the above design were made. For PET imaging, 
the focus was to decrease the molecular weight to shorten the circulation time in the system. While 
this may seem counterintuitive since targeted cancer therapies with antibodies often favor using 
elongated polymers for enhanced pharmacokinetics, procedures for PET imaging are typically 
different. Due to the high sensitivity of the PET reagents, it was preferable that the imaging reagent-
conjugates clear from the bloodstream quickly to decrease background and improve contrast.  
Therefore, we aimed to reduce the molecular weight of POEMGA by replacing the OEGMA500 
monomer with OEGMA200. It was deemed that simply changing the length of the side branch would 
be easier than readjusting the polymerization conditions such as the monomer concentration or 




Figure 2.8 Preparation of D1-POEGMA-DFO for in vivo tumor PET imaging. AGET-ATRP from D1-
Br with OEGMA200 and Az-MA followed by SPAAC with DFO-DBCO yields D1-POEGMA-DFO (x : 
y = 100 : 0-9). Subsequent incubation with 89Zr renders the radionuclide to bind to the DFO-chelator, 
hence allowing the DARPin-polymer conjugate to be used for PET imaging. 
 
 Polymerization with OEGMA200 was shown to be successful as indicated by SEC analysis 
(Fig. S2.3). Trypsin digestion of D1 and subsequent analysis of the liberated polymer showed a 
molecular weight (Mn = 12.8 kDa, D = 1.28) that was 35% of the polymer produced with OEGMA500 
(Mn = 35.1 kDa, D = 1.27). As the percent-reduction of molecular weight indicated that the degree 
of polymerization (DP) between POEGMA from OEGMA500 and OEGMA200 were nearly identical, it 
was assumed that the number of incorporated Az-MA per D1 should be similar as well. Interestingly, 
that was not the case, and it was shown that the number of azides incorporated in POEGMA is 
reduced to nearly half. In other words, the comonomer mixture with OEGMA500 that yielded 4 azides 
per D1 was only resulting in 2 azides per D1 when OEGMA200 was used instead. Nonetheless, the 
number of incorporated azides in POEGMA showed a correlation with the concentration of the 
starting mixture, and therefore the desired azide to D1 ratio could be achieved by increasing the 
Az-MA concentration in the comonomer mixture.  
 Following the characterization of D1-POEGMA-Azide synthesized with OEGMA200, the 
azides were further conjugated with DFO-chelators by SPAAC with DFO-DBCO. DFO was chosen 
as it is a well-known chelator of 89Zr that is widely used for radiolabeling antibodies for PET 
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imaging174. The labeled samples are currently being characterized by flow cytometry to confirm that 
D1 maintained its binding activity post-functionalization. Afterward, the radiolabeled D1-POEGMA 
will be administered to mice bearing an EpCAM-positive tumor for subsequent tumor analysis.  
 
2.4 Conclusion 
 Site-specific DARPin-polymer conjugates were synthesized via enzymatic labeling and in 
situ polymerization methods. The resulting polymers could be easily customized with various 
functionalities by adjusting the composition of the copolymerization reaction solution. Two 
applications with these protein-polymer conjugates were pursued in this study including tumor 
selective imaging and toxicity. By having the hydrophilic polymer that is conjugated to the protein 
carry the fluorophore and toxins rather than directly conjugating the payloads to the protein itself, 
increased loading capacity of the payload could be achieved. For instance, three molecules of 
MMAE toxins known for its hydrophobicity could be loaded onto a single D1. Currently we are in 
the process of aiming for an even higher number. Having multiple fluorophores per D1 increased 
the tumor detecting abilities of DARPins, and increased toxin loading per D1 enhanced its tumor 
specific in vitro toxicity to levels similar to the non-polymer conjugated D1-MMAE. This was an 
especially noteworthy performance as conjugating polymers to antibodies are known to adversely 
affect the toxicity in cell-based studies as the added polymer frequently impedes the ability of the 
protein to bind to cell surface receptors and undergo endocytosis. Tumor targeted PET imaging of 
a tumor embedded in a mouse model is currently in progress using radiolabeled D1-POEGMA. We 
expect the hydrophilic POEGMA that allows conjugation of multiple hydrophobic DFO 89Zr-
chelators would enable efficient PET imaging of the tumor. In the future, it will be interesting to 
assess the ability of DARPin-polymer-toxin conjugates to target and kill solid tumors in an animal 
model, since what makes polymer conjugation particularly useful is the elongated circulation time 
in the system due to the increased molecular weight that leads to a prolonged effect and hence 




Figure S2.1 Farnesylation of OPP-C10-Br with D1-CVIA. (A) Scheme of the prenylation reaction 
of D1-CVIA with OPP-C10-Br (1) to yield the site-specific D1-macroinitiator (5). (B) In situ AGET 
ATRP from 5 that yields DARPin-POEGMA-Rhodamine conjugates. 
 
 
Figure S2.2 SEC trace of D1-CVIA compared to D1-POEGMA. While the SEC trace in Figure 2.2B 
was obtained using a Superdex 200 column, the trace in Figure S2.2 was obtained using a 
Superdex 75 column. Both columns use similar resins (dextran and agarose) but differ in the 
separation range (10-600 kDa for Superdex 200, 3-70 kDa for Superdex 75). The SEC trace 
collected with Superdex 75 more clearly demonstrated the widely ranged retention volume of D1-




Figure S2.3 SEC trace of D1-CVIA overlapped with D1-POEGMA prepared with OEGMA. Shift in 




Chapter 3. Site-specifically immobilized enzymes for antifouling applications 
 
3.1 Introduction 
 Biofilm formation results from surface-attached microorganisms that aggregate within its 
self-produced extracellular polysaccharides.175 For humans, this phenomenon is disadvantageous 
in many ways. Bacterial infections are the most common type of acute and chronic infection that 
increases patient mortality and morbidity. Surfaces of medical devices have been shown to induce 
formation of biofilms, being a challenge for patients.176,177 From a naval industry standpoint, biofilms 
are problematic as they often lead to biofouling that causes microbiologically influenced corrosion 
(MIC) or biocorrosion of metal surfaces, which leads to significant costs in cleaning of the surface 
and reapplying of protectants.178 Biofilm covered surfaces also facilitate the adhesion of larger 
organisms such as algae and mussels, which causes an even more significant cost due to 
increased fuel consumption from higher frictional drag. The cost that results from combating 
biofilms in the United States marine industry alone has been reported to be 55 billion USD per 
year.179–181  
 Methods to prevent biofilm formation in the marine industry have been developed based 
on a variety of different approaches. The most traditional and common strategy is the use of 
biocides. However, on top of tolerance, due to the bacterial resistance182 that occurs when 
organisms exist in a biofilm, the overall resistance of bacteria toward biocides and antimicrobial 
agents has been reported to have increased up to 1000 times, diminishing the effectiveness of this 
method.183 The toxic effects of biocides on the marine environment also remain an issue. While 
organic biocides and copper oxides have been introduced as a replacement for the more toxic 
tributyltin, there has not yet been enough evaluation of how these substances impact the 
environment.184 Therefore, alternative methods to biocides have been gaining attention. One 
example is the use of small molecule inhibitors that inhibit the gene expression of key virulence 
factors.185 While the field is developing rapidly, the mechanism of action of these molecules are still 
not fully understood, which has hindered their application especially in the medical device area. 
Anti-adhesion coating is another growing field, which aims to prevent surface attachment of the 
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microbes without necessarily eradicating them. The coating often exhibits hydrophilic or ionic 
properties that lead to the formation of a hydration layer, which in turn prevents the adsorption of 
biomolecules to the surface. As that method does not involve potency against microbes, it does not 
produce dead microorganisms which may attach to the surface and become a site for biofilm growth. 
Hydrophilic polymer coatings that use PEG (Poly(ethylene glycol) are a good example of anti-
adhesive coatings. Polymer brushes with PEG side chains have been demonstrated to be effective 
in reducing bacterial adhesion on surfaces in lab settings.186 Other alternatives to PEG have been 
demonstrated as well which include zwitterionic or amphiphilic polymers.187 However, the long term 
stability of these polymeric coatings has been an issue, especially for marine antifouling 
applications which require prolonged stability and antibacterial effectiveness for durations of years. 
 Application of quorum quenching (QQ) enzyme has recently arisen as a method that 
achieves antibacterial effects through an alternative mechanism, interference of bacterial cell 
communication. Quorum sensing (QS) is a communication mechanism that bacteria exploit by 
secreting chemicals known as autoinducers to the environment, purposed to regulate collective 
behavior. Once the accumulated autoinducers reach a certain threshold, a “quorum” is reached, 
which triggers signaling that prompts gene expression and various physiological activities.188 QQ 
enzymes such as lactonases prevent biofilm formation by degrading these AHL autoinducers, thus 
disrupting QS.  
The use of QQ enzymes holds many advantages over the traditional biofilm prevention 
methods. It is environmentally friendly as the antibacterial effect is localized to the ship hull, and 
the enzymes released to the environment do not lead to toxic effects, since unlike tributyltin or 
copper, these proteins naturally degrade and do not bioaccumulate. The environmental impact is 
even further mitigated since these enzymes can be used in small catalytic quantities. Strategies 
using QQ enzymes can be more effective, especially against gram-negative bacteria that utilize 
small molecules such as N-acyl homoserine lactones (AHLs) as the autoinducer, since they are 
more resistant to antibiotics from having thick impermeable cell walls. Since QQ enzymes prevent 
biofilm formation by disrupting communication of bacteria rather than by directly affecting their 
survival, the chances of developing resistance against QQ methodologies are low. Finally, the 
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strategy does not have to consider delivery mechanisms into the cell as the antibacterial effect 
does not require endocytosis of any of the involved substances. 
The effectiveness of surface immobilized QQ enzymes for antifouling purposes has been 
demonstrated in several cases. Seah and coworkers demonstrated antifouling activities of AHL-
degrading SsoPox enzymes immobilized in alumina fibers via electrostatic interactions.189 Since 
then, various studies have been reported where QQ enzymes were immobilized onto various 
substrates such as membranes,190 capsules,191 mesoporous silica,192 and steel coupons.180 
However, most studies have implemented a non-covalent immobilization strategy and have 
monitored only short periods of effectiveness. These bring into question whether the strategies 
could be implemented into field applications that require potency for a minimum of 6 months. Ones 
that did exploit covalent interactions required the use of crosslinking reagents such as 
glutaraldehyde, and the non-specific conjugations that resulted from it were shown to result in 
substantial loss of enzyme activity post-immobilization.193  
Among various QQ enzymes, SsoPox, a hyperthermostable phosphotriesterase-like 
lactonase (PLL) isolated from the archaeon Sulfolobus solfataricus, is a particularly promising 
enzyme due to its wide applicability and robustness.194 The SsoPox-W263I variant was developed 
based on SsoPox, in which the W236I mutation was found to enhance both AHL and 
organophosphorous-degrading activities while maintaining high thermal stability (Tm = 88 °C), high 
catalytic activity at a wide range of temperatures (-18 to 70 °C), high tolerance to a wide range of 
organic solvents, and high promiscuity which allows high activity against a variety of lactones.195 
Promising biofouling and biocorrosion inhibition activities were reported in preliminary studies of 
SsoPox-W236I where the enzyme was applied to steel surfaces in the form of a silica gel-
immobilized coating.180 However, non-specific covalent immobilization using glutaraldehyde was 
shown to result in only 15% retention of the enzyme activity.195 Non-covalently immobilized 
enzymes coatings resulted in significantly diminished antibacterial activities due to the low durability 
of the coating method, where enzyme leakage and deterioration of the silica coating was not able 
to remain effective even for a short term 8-week study.180  
In this study, Ssopox-W236I was site-specifically modified with various chemical 
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functionalities for immobilization or visualization purposes. Site-specific labeling was achieved by 
exploiting protein farnesylation, in which the promiscuity of the farnesyltransferase (PFTase) allows 
the enzyme to modify most proteins that contain a C-terminal CaaX sequence with analogs of its 
natural substrate farnesyl diphosphate (FPP).13 Previous studies by Distefano and coworkers  
showed various biotechnological applications using the FTase enzyme,85,93,102 often in combination 
with click chemistry.139 Compared to non-selective chemical modification methods, site-specific 
enzymatic labeling allows highly retained activity of the protein-product, since the method allows 
control over the site of modification. Labeling only occurs at the C-terminal cysteine residue of the 
CaaX motif, which is often distant from the active site. Reactions occur under mild conditions in 
aqueous buffer which is beneficial for proteins in general. Exploiting this methodology, incorporation 
of three types of functionalities were focused on here: diazirine, isobutyryl bromide, and azide. The 
labeled enzymes were subsequently subjected to light-induced covalent immobilization, protein-
polymer conjugation for immobilization, fluorophore conjugation for visualization, and quantification, 
respectively. Preliminary lab-based studies are shown, which are expected to soon develop into a 
long term (>6 months) field study at locations including the Duluth Superior Harbor. 
 
3.2 Experimental 




3-(3-methyldiaziridin-3-yl)propanoic acid (S7) 
Levulinic acid S6 (2 g, 17.2 mmol, 1 eq) was dissolved in 7 N NH3 in CH3OH (17.2 mL, 120.7 mmol, 
7 eq). The resulting solution was stirred under N2 in an ice-bath for 3 h. A solution of hydrolxylamine-
O-sulfonic acid (2.30 g, 20.64 mmol, 1.2 eq) in CH3OH (12 mL) was added dropwise at a rate of 1 
s-1. The reaction mixture was stirred for 20 h and allowed to warm to rt. N2 was bubbled through 
the solution for 1 h to remove NH3 gas. Vacuum filtration and concentration resulted in a yellow oil 
that was used in the next step without purification.196 
 
3-(3-methyl-3H-diazirin-3-yl)propanoic acid (S8) 
Diaziridine S7 was dissolved in CH3OH (15 mL) and stirred on ice for 5 min in a tin foil-covered 
flask. Triethylamine (4.6 mL, 33.5 mmol) was added and allowed to stir for 5 min. Slowly, chips of 
I2 were added until the solution remained a brown-red color for longer than 5 min after the last 
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addition. The reaction solution was diluted with EtOAc and washed with 1 M HCl and aqueous 10% 
sodium thiosulfate until the organic layer was colorless. The aqueous layer was further extracted 
with EtOAc (2 × 20 mL). The organic layers were combined, dried over MgSO4, and concentrated 
to afford diazirine acid S8 as a brown residue (1.07 g, 50%). Spectral data obtained were in good 




S3 was prepared as previously described62. To a solution of protected alcohol S6 (0.575 g, 4.49 
mmol, 1 eq) and DMAP (55.0 mg, 0.45 mmol, 0.1 eq) in CH2Cl2 (6 mL) was added a solution of the 
diazirine acid S3 (1.260 g, 4.94 mmol, 1.1 eq) in CH2Cl2 (6 mL). DIC (0.679 g, 5.39 mmol, 1.2 eq) 
was added, and the resulting solution was stirred at rt for 16 h. The reaction mixture was filtered 
and concentrated. Purification by flash chromatography (4:1 Hex:EtOAc, v/v) aff orded 848 mg 
(53%) of diazirine S9 as a clear oil. Spectral data obtained were in good agreement with those 
reported in the literature.196 
 
(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate (S10) 
To a solution of S9 (800 mg, 2.2 mmol, 1 eq) in CH2CH2OH (12 mL) was added PPTS (55.2 mg, 
0.22 mmol, 0.1 eq). The reaction flask stirred at 60 °C for 2 h. The reaction mixture was 
concentrated in vacuo and purified by flash chromatography (7:3 Hex:EtOAc, v/v) to aff ord 570 mg 
(93 %) of diazirine alcohol S10 as a clear oil. Spectral data obtained were in good agreement with 
those reported in the literature.196 
 
(2E,6E)-8-bromo-2,6-dimethylocta-2,6-dien-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate (S11) 
Diazirine alcohol S10 (100 mg, 0.357 mmol, 1 eq) was converted to the corresponding bromide in 
the presence of resin-bound PPh3 (374 mg, 1.43 mmol, 4 eq) and CBr4 (474 mg, 1.43 mmol, 4 eq) 
dissolved in CH2Cl2 (8 mL). The resulting solution was allowed to stir for 2 h at rt. After the reaction 
was complete, excess CBr4 and resin-bound PPh3 were removed from the mixture by filtration. 
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Removal of the solvent aff orded 105 mg (60%) of diazirine bromide S11 as a clear oil. Spectral 




The crude bromide S11 (122 mg, 0.357 mmol) was dissolved in dry acetonitrile and a solution of 
(n-Bu4N)3HP2O7 (644 mg, 0.714 mmol) in dry acetonitrile was added into the reaction mixture at rt. 
After initiating the reaction, an ion-exchange column (Dowex 50WX8, 50-100 mesh, Sigma Aldrich, 
217492) was prepared and washed with 3 bed volumes of 3:1 H2O:(conc.) NH4OH (v/v) and 
equilibrated with 4 bed volumes of 25 mM 49:1 NH4HCO3:i-PrOH (v/v), i.e., solvent C. After stirring 
for 4 h, the crude product was loaded on the ion-exchange column and eluted with solvent C. 
Fractions containing the product were combined and concentrated by lyophilization. After adding 3 
mL 0.1 M NH4HCO3, the product was extracted with 1:1 CH3CN:iPrOH (x2) and purified by cellulose 
column chromatography using a cellulose-packed column (2.0 x 14 cm2) equilibrated with 9:1 THF: 
0.1 M NH4HCO3 (v/v). Step-elution was performed with THF:0.1 M NH4HCO3 (200 mL of 9:1, 200 
mL of 8:2, and 100 mL of 7:3, v/v) at a flow rate of 5.0-6.0 mL/min. Fractions containing the 
phyrophosphates were determined by ESI-MS, combined, and concentrated by lyophilization. Yield 
was determined as 13 mg (17%) by 31P NMR spectroscopy using an internal standard (Na2HPO4). 
1H NMR (400 MHz, D2O):  ppm 5.45 (d, J = 5.9 Hz, 1H), 5.36 (s, 1H), 4.43 (s, 2H), 4.36 (t, J = 6.0 
Hz, 2H), 2.22 (t, J = 7.0 Hz, 2H), 2.15-2.08 (m, 2H), 2.06-1.99 (m, 2H), 1.66-1.50 (m, 8H), 0.93 (s, 
4H) 
31P NMR (162 MHz, D2O):  ppm -6.54 (d, J = 21.8 Hz), -10.31 (d, J = 21.8 Hz). 
HRMS (m/z): [M - H]- calcd for [C15H25N2O9P2]- 439.1041, found 439.1062. 
 
Mutagenesis, expression, and purification of SsoPox-CVIA 
Strain E. coli BL21 (DE3) were transformed with plasmids pGro7/GroEL and pET22b SsoPox-
W263I for chaperone and SsoPox-W263I expression, respectively. The linker sequence for KCVIA, 
GSGTKCVIA, or GGKKKKKKTKCVIA was added to the C-terminal end of the SsoPox-W261I 
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template for 3 different types of SsoPox-constructs. A first preculture of 100 mL was made from 
adding a glycerol stock in LB medium containing 100 µg/mL ampicillin and 34 µg/mL 
chloramphenicol, which was grown at 37 °C with shaking at 180-200 rpm until the OD600 reaches 
0.6. This preculture was used to inoculate the second preculture in the same medium and grown 
in the same conditions until the OD600 reaches 0.6, which was again used to inoculate the ZYP-
5052 medium containing 1000 µg/mL ampicillin and 34 µg/mL chloramphenicol and incubated at 
37 °C with shaking at 180-200 rpm. Once the OD600 reached 0.6, protein production was induced 
by adding 100 µM CoCl2 and 0.2% (w/v) L-arabinose, and the temperature was reduced to 18 °C 
with shaking at 220 rpm. After 16 h, cells were harvested by centrifugation at 4,400 g for 20 min. 
The cell pellet was resuspended in lysis buffer (50 mM HEPES, 150 mM NaCl, 200 µM CoCl2, 250 
µg/mL DNAse 1, 0.1 mM phenylmethylsulfonylfluoride (PMSF), 20 mM MgSO4, pH 8.0) and lysed 
by sonification (3x30 sec cycles at 45% amplitude, QSonica sonicator Q700). The lysis extract was 
centrifuged 14,000 g for 30 min, and the soluble fraction was collected and heated at 80 °C for 20 
min, followed by another round of centrifugation. SsoPox-CVIA was precipitated and concentrated 
by incubation in 75% ammonium sulfate overnight at 4 °C. Followed by resuspension in HEPES 
buffer (50 mM HEPES, 150 mM NaCl, pH 8.0), the protein solution was filtered through a 0.22 µm 
syringe filter, followed by buffer exchange to remove ammonium sulfate and concentration with an 
Amicon Centriprep centrifugation device (30,000 MW cut-off). The proteins were finally purified by 
SEC with a HiLoad 16/600 Superdex 75 pg column (GE Healthcare) with HEPES buffer. The purity 
of the collected fractions after concentration using an Amicon Centriprep centrifugation device 
(30,000 MW cut-off) was analyzed by 12.5% SDS-PAGE, and the concentration was measured 
using a NanoDrop 2000 spectrophotometer (Thermo Scientific). 
 
Paraoxonase activity measurements of SsoPox-CVIA 
The phosphotriesterase activity was measured following a method that was described previously.195 
Briefly, 5 µL of enzyme solution and 185 µL of activity buffer (50 mM HEPES, 150 mM NaCl, 0.2 
mM CoCl2, pH 8.0) was added to a 96-well plate. The enzyme reaction was initiated by adding 10 
µL of 20 mM ethyl paraoxon, which was followed by measuring the production of p-nitrophenolate 
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via absorption at 405 nm for 40 min. 
 
Enzymatic incorporation of the diazirine into GFP-CVIA or SsoPox-CVIA 
Enzymatic reaction mixtures (15 mL) contained Tris·HCl (50 mM, pH 7.5), MgCl2 (10 mM), KCl (20 
mM), ZnCl2 (100 μM), DTT (5.0 mM), GFP-CVIA or SsoPox-CVIA (5 μM), C10-DA (40 μM), and 
PFTase (800 nM). The reaction mixture excluding the isoprenoid analogue and PFTase was 
incubated on ice for 0.5 h, followed by addition of the two reagents and incubation for 6 h at 30 °C. 
The product mixture was then buffer exchanged (x3) to x1 PBS and concentrated to 100 µL using 
an Amicon Centriprep centrifugation device (10,000 MW cut-off). The product was characterized 
by LCMS (xx ) and SDS-PAGE analysis. The subsequent protein concentration was calculated by 
BCA assay for the SsoPox-product and UV absorbance at 488 nm (ε=55,000 M-1·cm-1) for the GFP-
product. 
 
Enzymatic incorporation of an azide into SsoPox-CVIA 
Enzymatic reaction mixtures (4 mL) contained Tris·HCl (50 mM, pH 7.5), MgCl2 (10 mM), KCl (20 
mM), ZnCl2 (100 μM), DTT (5.0 mM), SsoPox-CVIA (20 μM), C10-Az (100 μM), and PFTase (7 µM). 
The reaction mixture excluding the isoprenoid analogue and PFTase was incubated on ice for 0.5 
h, followed by addition of the two reagents and incubation for 6 h at 30 °C. The product mixture 
was then buffer exchanged (x3) to x1 PBS and concentrated to 100 µL using an Amicon Centriprep 
centrifugation device (10,000 MW cut-off). The product was characterized by LCMS and SDS-
PAGE analysis. The subsequent protein concentration was calculated by BCA assay. 
 
Enzymatic incorporation of an alkyne into SsoPox-CVIA 
Enzymatic reaction mixtures (15 mL) contained Tris·HCl (50 mM, pH 7.5), MgCl2 (10 mM), KCl (20 
mM), ZnCl2 (100 μM), DTT (5.0 mM), SsoPox-CVIA (2.5 μM), C15-Alk (40 μM), and PFTase (800 
nM). The reaction mixture excluding the isoprenoid analogue and PFTase was incubated on ice for 
0.5 h, followed by addition of the two reagents and incubation for 6 h at 30 °C. The product mixture 
was then buffer exchanged (x3) to x1 PBS and concentrated to 100 µL using an Amicon Centriprep 
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centrifugation device (10,000 MW cut-off). The product was characterized by LCMS and SDS-
PAGE analysis. The subsequent protein concentration was calculated by BCA assay. 
 
Enzymatic incorporation of an ATRP-initiator into SsoPox-CVIA 
Enzymatic reaction mixtures (6 mL) contained Tris·HCl (50 mM, pH 7.5), MgCl2 (10 mM), KCl (20 
mM), ZnCl2 (100 μM), DTT (5.0 mM), SsoPox-CVIA (20 μM), OPP-C10-iBr (100 μM), and PFTase 
(3 µM). The reaction mixture excluding the isoprenoid analogue and PFTase was incubated on ice 
for 0.5 h, followed by addition of the two reagents and incubation for 6 h at 30 °C. The product 
mixture was then buffer exchanged (x3) to x1 PBS and concentrated to 100 µL using an Amicon 
Centriprep centrifugation device (10,000 MW cut-off). The product was characterized by LCMS and 
SDS-PAGE analysis. The subsequent protein concentration was calculated by BCA assay. 
 
Covalent incorporation of GFP-DA or SsoPox-DA into paint 
For covalent incorporation of the protein into paint, diazirine labeled proteins were added to paint 
for a final concentration of 1.2-3.4 µM. 500 µL of the protein-paint mixture was aliquoted on a 12-
well plate (Corning, CLS3513) and dried overnight under a stream of air. Photocrosslinking was 
conducted upon UV irradiation at 365 nm and 100 µJ·cm-2 for 10 min (Analytik Jena, CL-1000L). 
Minimal photobleaching was observed for the GFP-DA. For control studies, non-labeled proteins 
that lack the diazirine were subjected to the same procedure.  
 
Surface immobilization of GFP-DA or SsoPox-DA on paint 
500 µL of paint was aliquoted on a 12-well plate (Corning, CLS3513) and dried overnight under a 
stream of air. To the layer of paint on the bottom of the wells, 10-30 µL of 60-100 µM diazirine 
labeled protein solution was aliquoted and dried overnight under a stream of air. Photocrosslinking 
was conducted upon UV irradiation at 365 nm and 100 µJ·cm-2 for 10 min (Analytik Jena, CL-
1000L). Minimal photobleaching was observed for the GFP-DA. For control studies, non-labeled 
proteins that lack the diazirine were subjected to the same procedure.  
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Quantification of the retained GFP-DA in or on paint 
The 12-well plate containing paint-immobilized GFP-DA was immersed a 1 L beaker containing 
water and stirred in the dark. The beaker was exchanged with fresh water every 2 days. The amount 
of immobilized protein retained in or on paint was analyzed by taking out the plates periodically and 
quantifying the fluorescence intensities with a Typhoon FLA 9500 biomolecular imager. 
 
In situ ATRP from the site-specific SsoPox-macroinitiator 
OEGMA500 monomer (273 µmol) and sacrificial initiator resin (10.5 mg, 2.65 mol) was added to 100 
µL of the SsoPox-macroinitiator solution (120 nmol). To this solution was added 400 µL of the 
catalyst solution composed of CuBr2 (2.65 µmol) and TPMA (26.5 µmol) in PBS. Polymerization 
was initiated by adding 50 µL of ascorbic acid (265 nmol) in PBS. All solutions were separately 
purged with argon for 30 min after formulation. After 6 h of polymerization at rt, the reaction was 
quenched by exposure to air. The product solution was purified from sacrificial initiator resin using 
a 0.22 µm centrifugal filter and subjected to anion exchange chromatography (AExC) with a HiTrap 
Q HP column to remove unreacted monomers from the products. A linear gradient of 2.5% per min 
from Buffer A (20 mM HEPES, pH 8.0) to Buffer B (20 mM HEPES, 1 M NaCl, pH 8.0) was applied. 
The fractions containing the SsoPox-polymer conjugates were collected and concentrated using 
an Amicon Centriprep centrifugation device (10,000 MW cut-off) and subjected to purification and 
analysis by size exclusion chromatography (SEC) with a Superdex 200 10/300 column (GE 
Healthcare) with PBS. For samples that require the functionalization with a DBCO reagent, click 
reaction was employed to the AExC-purified product followed by SEC purification. The FPLC used 
for chromatography purifications was a Knauer AZURA BioLC device. The collected SEC fractions 
were concentrated using an Amicon Centriprep centrifugation device (10,000 MW cut-off), which 
was subjected to 12% SDS-PAGE for purity analysis and BCA assay for concentration analysis. 
 
3.3 Results and Discussion 
Screening of the SsoPox-CVIA constructs for site-specific modification via protein 
farnesylation 
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SsoPox proteins were engineered by mutagenesis with a C-terminal CVIA sequence for 
recognition by the PFTase enzyme. Three different SsoPox-CVIA constructs were prepared with 
differing spacer sequences, SsoPox-KCVIA, SsoPox-GSGTKCVIA, and SsoPox-
GGKKKKKKTKCVIA. The first was the minimal linker sequence, the second linker was designed 
to be flexible, and the third was adopted from the C-terminal sequence of the K-Ras protein which 
is a native substrate for the PFTase.197 Prenylation reactions containing the three constructs were 
tested with the isoprenoid analogs OPP-C10-iBr, OPP-C10-Acr, C10-Az85, C10-DA, and C15-
Alk,198 and the products were characterized by LC-MS. As the HPLC retention volume of SsoPox 
enzymes overlapped with yPFTase, analysis was focused on the deconvoluted mass. While none 
of the analogs were shown to react with the first and third constructs, the second construct SsoPox-
GSGTKCVIA (will be denoted as SsoPox-CVIA from hereon for simplicity) was shown to undergo 
enzymatic labeling with most of the isoprenoid analogs. However, efficiencies varied between 
analogs and therefore farnesylation conditions were adjusted accordingly. For OPP-C10-iBr, 10 µM 
analog with 200 nM PFTase was able to result in near full conversion of 2.5 µM SsoPox to the 
farnesylated product, similar to conditions utilized in previous studies.102 However, in the cases of 
C10-Az and C15-Alk, the isoprenoid analog and PFTase concentrations had to be elevated to 40 
µM and 800 nM, respectively, to achieve the same degree of labeling. OPP-C10-Acr did not show 
any modified protein products despite optimization of the labeling conditions and was therefore 
excluded from further studies. As for the C10-DA, reaction with D1-CVIA and GFP-CVIA showed 
fully converted products with 10 µM isoprenoid analog and 200 nM PFTase, indicating efficient 
recognition and turnover of the analog by the PFTase. However, to guarantee full conversion of the 
SsoPox-CVIA to the DA-labeled product, the conditions were adjusted to higher concentrations, 40 
µM and 800 nM isoprenoid analog and PFTase, respectively. 
Following enzymatic labeling, the modified SsoPox enzymes exhibited a tendency to 
adhere to the centrifugal filters employed during the buffer exchange procedures. Hydrophilic 
enzymes including SsoPox contain a large number of salt bridges uniformly localized on the protein 
surface. These salt bridges are involved in complex interactions including dimerization of the two 
subunit termini that results in the overall increase in stability of the protein.199 Therefore, we 
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presume that covalent modification of SsoPox at the C-terminus, despite its site-specific 
characteristics, may be causing interference of the ionic interaction between the two termini which 
in turn was leading to protein aggregation and precipitation.200,201 However, it is important to note 
that most of the precipitated proteins could be re-solubilized back into solution by simple vortexing. 
Nonetheless, to maximize yield, farnesylation conditions were optimized to minimize protein loss 
during purification steps. A significant effort was made to increase the protein concentration in the 
reaction solution to minimize the number of post-farnesylation buffer exchange steps. Interestingly, 
SsoPox-CVIA was shown to be stable even at 20 µM farnesylation conditions, indicating its 
extremely high stability. To accommodate the increase in the protein substrate concentration, the 
analog concentration was also increased to 40-100 µM and the PFTase to 4-7 µM. While high 
concentrations for both the analog and enzyme were chosen to ensure that the reaction proceeds 
with high efficiency, this may have been excessive, as according to steady state kinetics, analog 
concentrations above Km would not bring any benefit. Further optimization will probably be 
necessary for each individual reaction 
 
Bioorthogonal fluorophore labeling of prenylated SsoPox 
Based on the demand for a method to quantify surface applied SsoPox to easily visualize 
and quantify the degree of application and to track the remaining enzymes over time, this question 
was investigated first. One way to realize this is to modify the enzyme with fluorophores that would 
allow both qualification and quantification via optical measurements. Therefore, bioorthogonal 
fluorophore labeling was conducted on SsoPox-CVIA prenylated with either an azide or alkyne 
probe. While CuAAC of TAMRA-azide to SsoPox-Alkyne did appear to be successful to some 
extent as evidenced by the fluorescing protein solution after purification of the product, the 
recovered yield was too low for it to be applicable for actual use. This low yield was presumably 
due to the instability of SsoPox-Alkyne compared to other site-specific SsoPox products, which was 
indicated by the distinctly low recovery yields after farnesylation. The CuAAC reaction conditions 
are presumed to have an effect as well since they require a copper catalyst that may contribute 
towards protein oxidation and aggregation.32 The azide labeled SsoPox was shown to successfully 
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undergo SPAAC with TAMRA-DBCO with high efficiency (>90%) as indicated by SDS-PAGE, also 
with a reasonable recovery yield (~15%) (Fig. 3.1). The activity of the modified SsoPox enzyme 
was measured to see whether the site-specific fluorophore conjugation introduces a detrimental 
effect to the enzyme’s antifouling efficacy. However, in the process of doing so, it was found that 
enzyme activity varies widely upon post-purification storage conditions. Therefore, activity 
comparisons before and after fluorophore labeling were postponed, and optimized storage 
conditions are currently under investigation. 
 
 
Figure 3.1 SDS-PAGE of TAMRA-labeled SsoPox. The fluorophore was site specifically labeled 
through farnesylation of an azide followed by copper-free click reaction with TAMRA-DBCO. The 
upshifted in band that fluoresces indicates successful fluorophore labeling with high yield (lane 1, 
3 and 5, protein ladder; lane 2, SsoPox-CVIA; lane 4 and 6, SsoPox-TAMRA). Lanes 1-4 shows 
Coomassie stained gels, and lanes 5 and 6 shows a fluorescence-scanned image of the identical 
gel before Coomassie staining. 
 
Bioorthogonal polymer conjugation of prenylated SsoPox 
Prior studies from the Elias group have focused on incorporating SsoPox enzymes into 
silica gels to achieve an antifouling layer on metal coupons.180 Exploiting the high stability of 
SsoPox enzymes under various conditions including high heat and in organic solvents,193 the study 
was later expanded to enzyme immobilization in paint (manuscript in preparation). Despite the 
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harsh organic components of paint, SsoPox enzymes were found to be active, successfully 
exhibiting antifouling properties. However, mere physical entrapment of the enzyme within paint 
was found insufficient to retain the protein in paint for long durations. SsoPox enzymes eventually 
diffuesed out from the paint and therefore the coatings became ineffective over time.  
To increase the degree of physisorption and therefore achieve higher retention of SsoPox 
in paint, site-specific polymer conjugation via protein prenylation was investigated. Two conjugation 
methods were explored, grafting-to and grafting-from. Grafting-to conjugation involves the labeling 
of a pre-synthesized polymer to the protein via complementary reactive handles on each 
component. This method allows easier characterization of the polymer, while it may lead to 
complications in post-conjugation purification, or even low conjugation yields due to steric 
hindrance. The grafting-from method employs the initial installment of an initiator moiety which 
transforms the protein into a macroinitiator, followed by polymerization directly from the protein-
initiator to yield protein-polymer conjugates. The method experiences minimal steric hindrance as 
it only requires incorporation of a much smaller initiator-molecule rather than a macromolecule, 
which often leads to high conjugation efficiencies. As the purification of protein-polymer conjugates 
most often exploit separation by size, the grafting-from method manifests easier purification, as the 
macromolecular products are more easily distinguishable from a mixture with small monomers than 
large macromolecules.  
Exploiting the site-specifically labeled azide, grafting-to PEGylation with PEG10k-DBCO 
was conducted by SPAAC. We were expecting a highly efficient reaction, as we had already shown 
that SPAAC-induced fluorophore labeling with TAMRA-DBCO leads to complete product 
conversion. However, PEGylation was shown to only yield ~70% product conversion (data not 
shown). Increasing the concentrations of the reagents did not lead to improvement. We hypothesize 
that this limitation is due to the effect of steric hindrance when conjugating two macromolecules.  
Grafting-from polymer conjugation was investigated for several reasons. First, this method 
was pursued to overcome the limited conjugation yields that were observed in the grafting-to trials. 
The second reason was for purification purposes. Although thorough purification was not required 
for this particular study since the protein-products would be blended with paint, we deemed that 
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achieving easier purification would be useful for future applications that may require high-purity 
polymer-conjugated products. A third reason was to conjugate a custom “sticky” polymer using 
monomers that contain moieties reactive to paint, which would allow covalent anchoring of the 
SsoPox-polymer conjugates to the substrate. With these goals under consideration, in situ 
polymerization from OPP-C10-Br labeled SsoPox-CVIA was studied. ATRP conditions were 
adopted from prior studies that were conducted with DARPins and GFPs. The monomer employed 
was OEGMA500 as it was shown to successfully polymerize in prior studies, and since the pendant 
hydroxyl groups of the side chains were expected to undergo covalent interactions with the 
molecules that compose paint. SEC analysis of the crude product post-polymerization confirmed 
synthesis of SsoPox-POEGMA conjugates (Fig. 3.2). However, the initiation efficiency and 
therefore product-conversion was extremely low, along with the negligibly low recovery yield after 
purification. Therefore, investigation of the grafting-from method for polymer-conjugation to SsoPox 
was suspended. While it was difficult to pinpoint a specific reason for the unsuccessful outcome 
with the SsoPox enzymes, it was presumed to be at least partially associated with the tendency of 
the modified SsoPox enzymes to aggregate. 
 
 
Figure 3.2 Polymer-conjugation to SsoPox enzymes. Comparison of the SEC traces of grafting-
from conjugated SsoPox-POEGMA and SsoPox-CVIA. Shift in retention time after in situ 
polymerization indicate successful conjugation of a polymer. 
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Covalent surface immobilization of SsoPox on paint  
 Once irradiated upon light, diazirines form a reactive carbene that can covalently bond to 
nearby molecules. The small size of diazirines allows them to be incorporated into probes that can 
be recognized by enzymes, such as how C10-DA can be used with PFTase for site-specific labeling 
of specific target proteins.196 These diazirine based probes have been widely used in the field of 
chemical biology for various purposes such as investigation of ligand-receptor interactions, 
identification of inhibitor binding sites, and identification of protein-protein interfaces.202 Here, we 
envisioned expanding the applicability of site-specifically incorporated diazirines for protein-
immobilization purposes. While there had been studies that focused on surface-
immobilization,203,204 we sought to achieve covalent incorporation of proteins into the substrate as 
well by exploiting the stability of SsoPox in various organic media. 
GFP was first utilized as the model protein since its immobilization efficiency could be 
easily measured by its fluorescence. Preliminary surface immobilization studies of GFP-DA on 
polyacrylamide gels were unsuccessful. We suspected this to be due to the high-water content of 
hydrogels, which may be causing the photoactivated-diazirine to react with water molecules rather 
than the desired substrate. Therefore, paint was chosen as the alternative substrate. To generate 
an even surface, 500 µL of paint was aliquoted to the wells of 16-well plates and dried overnight. 
Using excess amounts of paint led to concave surfaces due to the capillary action of the paint with 
the walls of wells. 34 µM GFP-DA and the negative control GFP-CVIA were each spotted onto 
separate paint-coated wells followed by photoirradiation. The concentration of the protein solution 
was chosen based on microprinting conditions utilized in prior studies205 as it was shown to result 
in successfully physisorbed fibronectin on PDMS. While there was a concern that the 
photocrosslinking conditions may cause photobleaching, GFPs were found to maintain a similar 
level of fluorescence even after photoirradiation, which would therefore allow quantitative analysis 
of the degree of immobilization via fluorescence measurements (Fig. 3.3A). Prior to optical analysis, 
each well was washed with PBS four times to remove unbound-GFP. 
Analysis of the wells using a fluorescence scanner indicated successful immobilization of 
the GFP-DA, unlike GFP-CVIA, which did not show any presence of surface-retained protein. 
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However, the degree of immobilization was low, and instead of an evenly distributed layer of protein, 
GFPs were found to be immobilized only along the circumference of the contact area of the protein-
solution to paint (Fig. 3.3B). This phenomenon called Marangoni effect or coffee-ring effect was 
observed was due to the higher evaporation rate at the contact lines which causes a strong capillary 
flow that leads to accumulation of the particles in solution along those lines.206 To obtain a more 
homogenous layer of immobilized protein, the printing step was modified by adjusting the GFP 
solution to a higher concentration and adding an overnight evaporation step after aliquoting the 
protein solution to each well to further maximize the protein concentration across the surface. GFP-
solutions with and without 10% glycerol were compared, as polymer207 or surfactant208 additives 
have been reported to suppress the Marangoni effect. Overnight evaporation of 60 µM GFP-DA 
and GFP-CVIA in 10% glycerol under a stream of nitrogen was shown to yield a homogenous layer 
of GFP on the surface of paint. However, after being photoconjugated and rinsed in water for a day, 
most of the GFP was again found to have been washed off regardless of the presence of the 
diazirine moiety. While there was a hint of immobilized GFP-DA observed, it still displayed a ring 
shape. Experiments with glycerol-free GFP solutions resulted in a ring-shaped contact area of GFP 
already in the printing step after the overnight evaporation of the protein-solution, demonstrating a 
stronger Marangoni effect in the absence of the glycerol additive. The printed GFP also displayed 
a crispy texture, which presumably indicated protein precipitation due to excessive drying of the 
solvent. As expected, photoconjugation of the printed GFP and submersion of the protein-coated 
wells in water resulted in only a small quantity of immobilized GFP-DA in a ring shape.  
Overall, surface immobilization was shown to be successful for proteins site-specifically 
labeled with a diazirine. The negative control GFP-CVIA did not show any adherence to the surface 
under the conditions that were examined, demonstrating the utility of the photocrosslinking activity 
of diazirines in surface immobilization. However, the effectiveness of the method was unclear, as 
immobilization was only observed along the edge of the protein-solution droplet. The degree or 
efficiency of immobilization was also a deterring factor for scaling up for field applications. Raising 
the protein concentration was shown to have little effect in increasing the amount of surface 
immobilization. Glycerol-free printing conditions required careful control of the extent of solvent 
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evaporation to prevent the proteins from precipitating, and the printed surface displayed ring 
shapes. Adding glycerol to the protein solution did mitigate the coffee-ring effect and protein-
precipitation during the printing step. However, the quantity of immobilized protein was shown to 
be lower compared with glycerol-free conditions, presumably due to quenching of the diazirines by 
glycerol that deters its binding to the paint substrate. Regardless of the homogenous layer that was 
produced immediately after printing, immersion and rinsing in water revealed that the protein 
retained on the surface in a covalent fashion was confined along the edge of the layer, indicating 
that the glycerol had minimal effect in alleviating the ring-shape pattern.  
 
 
Figure 3.3 Immobilization of GFP-DA characterized by a fluorescent scanner. (A) Photoconjugation 
conditions results in minimum photoquenching of the GFPs both on the surface and in paint. (B) 
Photoconjugation of GFP-DA on the paint surface results in a ring-shaped immobilization. GFP-
CVIA is not retained on the surface after PBS washing. (C) Photoconjugation of GFP-DA in paint 
results in higher retention in the substrate than GFP-CVIA. However, failed replications (data not 
shown) indicate the need for longer time-point studies. 
 
 98
Covalent incorporation of SsoPox in paint  
To maximize the degree of protein immobilization, incorporation of the proteins in paint 
was investigated. To this end, varying amounts of 60 µM GFP-DA and GFP-CVIA were mixed with 
500 µL paint and aliquoted into each well of a 12-well plate. Following overnight drying of the paint-
protein mixture under a stream of nitrogen, photoconjugation was conducted to the dried paint. 
Then the protein-paint coated wells were immersed in water to see which ones exhibit higher 
retention of the GFP in paint. An initial trial of duplicates showed a higher retention for the GFP-DA 
over GFP-CVIA, suggesting successful diazirine-induced covalent crosslinking (Fig. 3.3C). 
However, replication of the results was unsuccessful, and both proteins were shown to be retained 
in paint to an equal degree even after being immersed in water for a month. While it is unclear why 
the initial trials had shown promising results, we believe it may have been due to an artifact related 
to the pore sizes of the paint or the fluorescence properties of GFP. It may have been possible that 
the paint polymerized in a different fashion, leading to larger pore sizes that expedited the elution 
process of proteins from paint. On the other hand, the effect that was observed may have been an 
artifact from weakened GFP-fluorescence, and that the difference in signals were representing the 
stability of the entrapped protein rather than the quantity. Importantly, we believe the reason why 
the diazirine-labeling was not able to show a distinctive improvement in immobilization efficiencies 
in subsequent trials is due to the limited time frame of the experiments. In other words, extended 
observations may be necessary to allow validation of the effect of diazirine crosslinking. 
Experiments from the Elias group support this hypothesis, where they confirmed minimal leakage 
of the SsoPox enzymes that do not contain the diazirine moiety in a one month timeframe. The 
enzyme was also shown to maintain its paraxonase activity while entrapped in paint. Therefore, a 
more long-term study is currently under progress, where we hope to see the effect of diazirine-
mediated covalent immobilization. 
 
3.4 Conclusion 
In this work, we demonstrated that PFTase can be utilized to introduce various 
bioorthogonal moieties to the C-terminus of a biotechnologically relevant SsoPox enzyme. The 
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introduced functionalities could be exploited for visualization by fluorophore-labeling, physical 
immobilization by conjugating a polymer to achieve an increase in molecular weight, and covalent 
immobilization mediated by irradiation with UV light. Site-specific labeling with a TAMRA 
fluorophore was shown to be successful with high yield and efficiency. These modified SsoPox 
enzymes will be tested in field studies as antifouling agents on crops once activity measurements 
are completed. The labeled fluorophore is expected to assist in quantitative analysis of the 
remaining enzymes applied on plants. While TAMRA was used as the model fluorophore, it would 
be interesting to expand the types of fluorophores to ones that fluoresce at longer wavelengths as 
it would allow analysis of the enzymes under more innocuous conditions. Aiming to achieve 
immobilization of SsoPox in paint substrates, site-specific polymer conjugation was demonstrated 
by two methods, the grafting-to and grafting-from. Grafting-to conjugation was shown successful 
with a 10 kDa PEG. Interestingly, presumably due to the large size of the molecule, the conjugation 
efficiency was shown to be lower than similar reactions with a fluorophore. The yield and efficiency 
were still adequate for further scale-up studies. Grafting-from conjugation was explored as an 
alternative method with the anticipation of achieving a higher conjugation yield resulting from less 
steric hindrance and higher recovery yields due to easier purification. However, the initiation 
efficiency was shown to be extremely low, therefore further pursuit of that route was deemed 
unsuitable. The model protein GFP-DA showed promising results that indicate the effectiveness of 
site-specifically incorporation of a diazirine for immobilization purposes. While preliminary results 
showed that the protein-diazirine can be covalently bound to paint, longer term studies are required 
for a more detailed assessment. Therefore, studies with SsoPox-DA are currently ongoing to gauge 
whether the implemented methods in this study would be applicable to antifouling industry 




Figure S3.1 Farnesylation of SsoPox-CVIA with OPP-C10-Br, C10-Az, C15-Alk, and C10-DA. Due 
to the overlap in HPLC elution volume between the SsoPox and yPFTase, deconvoluted mass 
spectrum showed multiple small residual peaks along with the dominant peak. Absence of the mass 




Chapter 4. Fabrication of stimuli-responsive hydrogels for mechanistic 
studies on brain cancer 
 
* Due to the highly collaborative nature of this project and the published manuscript thereof, the 
inclusion of this work is divided into two parts. The first encompasses the details regarding the part 
I took in fabricating hydrogels that mimic the brain tissue and the application of that material which 
led to the discovery of a novel biological phenomenon. The second part demonstrates the full story 
of this project, which is a reproduced manuscript that contains my work as well as the work 
accomplished from numerous collaborators which helped to elucidate the mechanism behind my 
initial discovery. While there is inevitably some overlap between the two sections, especially in the 
experimental section, including both parts was deemed necessary for the full description of the 
project. 
 
4.1 Fabrication of photoresponsive hydrogels and its application that led to 
the discovery of negative durotaxis 
Glioblastoma multiforme is the most severe brain cancer with an extremely low recovery 
rate that results from invasion of glioma cells to the surrounding tissue. Among the various factors 
that affect cellular migration, one that is specifically affected by the stiffness gradient of the 
surrounding tissue is a process known as durotaxis. While polyacrylamide hydrogels have been 
widely used as a substrate for cellular studies, elaborate control on its physical properties remains 
to be a challenge which is crucial for examining the mechanism behind durotactic behavior. Here 
we propose a new approach by incorporating novel o-nitrobenzyl (o-NB) based photocleavable-
crosslinkers into polyacrylamide gels which yields stimuli-responsive hydrogels. By controlling the 
exposure of UV light, we show that we can spatiotemporally control the substrate stiffness in a 
precise manner. Taking advantage of the high-tunability of the method, a substrate is fabricated to 
have alternating stiff (15 kPa) and soft (8 kPa) regions connected by steep stiffness gradients, and 
fibronectins lines are printed across the stiffness gradients. Observation of U-251MG human 
 102
glioblastoma cells seeded on the substrates exhibit biased migration toward the softer 
environments. This negative durotaxis behavior is in contrast with the widely accepted wisdom that 
durotaxis always occur towards the direction of increasing stiffness gradient. Collaboration with 
research groups that hold expertise in microbiology and computational modeling leads to 
elucidation of the mechanism behind cellular sensing of its local environment. Overall, the unique 
properties of the photoresponsive gels and the methodologies involved in their fabrication are 
shown effective in mimicking the brain environment, which allows its application as a platform 
material for cellular studies. 
 
4.1.1 Introduction 
While modern technology has been shown effective towards many types of cancers, 
glioblastoma multiforme (GBM) remains to be a major challenge with poor prognosis with a 1-year 
survival rate of 37.2% and a 5-year survival rate of 5.1%.209 One key issue is the highly migratory 
behavior of gliomas that allow them to invade adjacent tissues and vasculature.210 While surgical 
resection of the malignant tumor followed by chemotherapy or radiotherapy remains the standard 
therapeutic method to treat GBM to this day, even a small remaining tumor left behind can go 
through rapid proliferation and migration and soon become a full tumor. Therefore, to develop 
alternative paradigms for brain cancer treatment, there has been an increase in studies focused on 
understanding the migratory pathologies of gliomas. Cell migration can be triggered by various 
gradients of external stimuli including light (phototaxis) and dissolved (chemotaxis) or surface-
attached small molecules (haptotaxis). Durotaxis is cell migration caused by stiffness gradient of 
the substrate.211 While understanding the fundamental mechanism behind different durotactic 
behavior among cell lines is important, it has been a less explored field compared to other types of 
migrations due to several methodological limitations. One of the challenges lies in preparing a 
suitable substrate that fully mimics the brain tissue environment. Some methods that have been 
developed to mimic the stiffness gradients of the brain in a gel-environment exploit the diffusion of 
two prepoloymer solutions,212 tilted-superpositon of two hydrogels,213 freeze-thaw-induced 
crosslinking of polyvinyl alcohol,214 or toehold-mediated strand displacement of DNA215. However, 
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most of these methodologies are incapable of replicating the mechanical properties or stiffness of 
human brain tissues that are reported to be highly heterogeneous. A large percentage (66%) lie in 
the range between 3.5 to 25.9 kPa, with a geometric mean of 9.5 kPa, and the slopes of stiffness 
gradients occur on a micron scale (kPa μm-1).216 Methods for real-time experiments, that enable 
simultaneous observation of cell migration while modifying the stiffness, have not been fully 
developed as well. Light is an external stimulus which allows spatiotemporal control of a from 
outside of a system, which makes it a suitable candidate for controlling the stiffness properties of 
substrates. However, while it has been used in some studies, most have been focused on 
polyethylene glycol (PEG)-based gels aiming for complete degradation of the gel for the fabrication 
of specific morphologies such as channels.217 To our knowledge, there has been one report to this 
date that resulted in photoresponsive polyacrylamide gels, although the methods shown required 
complicated synthesis and fabrication steps which rendered it difficult to use.218 
In this study, a simple one-step synthesis of photoresponsive gels is shown by using a 
novel o-nitrobenzyl bis-acrylate (o-NBbA) crosslinker. 1-D fibronectin patterns are introduced on 
the surface of the gels and stepwise stiffness gradients are created across the fibronectin lines via 
controlled exposure of light. Observation of U-251MG cells on the fabricated substrates reveal 
negative durotaxis, cell movement towards the softer region, which is an unconventional 
phenomenon that has yet been reported.  
 
4.1.2 Experimental 
Synthesis of o-NBbA 
2-nitro-4-ethyl aniline (S2) 
p-Ethyl aniline (5 g, 41.3 mmol) was added dropwise to a cold solution of concentrated H2SO4 (30 
mL) and stirred for 5 min. In a separate flask, 5.3 mL of 70% HNO3 (82.6 mmol) was mixed with an 
equal volume of H2SO4, and added dropwise to the reaction vessel, followed by 15 min stirring at 
0 °C. Thin layer chromatography (TLC) analysis (Hex:EtOAc, 2:1, v/v) indicated complete 
conversion to the product. The reaction was quenched by pouring the mixture into 200 mL ice water. 
The resulting precipitate was filtered and washed with H2O to yield compound S2 (6.2 g, 90%). 
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1H NMR (500 MHz, CDCl3)  ppm 1.099 (t, J = 7.5 Hz, 3H), 2.612 (q, J = 7.0 Hz, 2H), 5.558 (s, 2H), 
6.804 (dd, J = 8.0, 2.5 Hz, 1H), 7.041 (d, J = 2.5 Hz, 1H), 7.095 (d, J = 8.5 Hz, 1 H) 
13C NMR (100 MHz, DMSO-d6) 149.3411, 147.8646, 131.6051, 124.0586, 118.8417, 107.9194, 
24.4890, 15.3093 
HRMS (m/z): [M]+ calcd for [C8H10N2O2]+ 166.0737, found 166.0737. 
 
4-ethyl-3-nitrophenol (S3) 
Compound S2 (6.2 g, 37.3 mmol) was suspended in a mixture of H2SO4 and H2O (1:3, v/v, 25-50 
mL) by sonication (if sonification did not yield a homogenous suspension, a few mL of THF was 
used to dissolve the solid S2, which was then added to the mixture of aqueous H2SO4). NaNO2 
(3.86 g, 56.0 mmol) dissolved in H2O (2.5 mL) was added slowly to the reaction flask and stirred at 
room temperature for 1.5 h. In a separate flask H2SO4:H2O (4:3, v/v, 75 mL) was added and heated 
to reflux. To the refluxing mixture, the S2 solution was added dropwise and stirred for 30 min. The 
mixture was quenched with ice water and extracted with EtOAc (3 x 75 mL). After drying the organic 
layer with Mg2SO4, the solvent was removed in vacuo and the crude product was purified by silica 
gel flash chromatography (Hex:EtOAc, 2:1) to give S3 (3.11 g, 50%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.249 (t, J = 7.5 Hz, 3H), 2.842 (q, J = 8.5 Hz, 2H), 7.030 (dd, J 
= 8.5, 2.5 Hz, 1H), 7.230 (d, J = 8.5 Hz, 1H), 7.383 (d, J = 2.5 Hz, 1H) 
13C NMR (100 MHz, CDCl3) 154.2470, 149.5150, 132.3914, 131.3014, 120.7326, 111.4436, 
25.6617, 15.1987 
HRMS (m/z): [M - H]- calcd for [C8H8NO3]- 166.0510, found 166.0524. 
 
tert-butyl 2-(4-ethyl-3-nitrophenoxy)acetate (S4) 
Compound S3 (3.11 g, 18.6 mmol) and tert-butyl 2-bromoacetate (4.35 g, 22.3 mmol) were 
dissolved in DMF (25 mL). Solid K2CO3 (5.14 g, 37.2 mmol) was added to the reaction flask and 
left to stir at +70 °C for 1.5 h until TLC analysis (2:1 Hex:EtOAc, v/v) indicated complete conversion 
to the product. The solvent was removed in vacuo and redissolved in 100 mL EtOAc. The organic 
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layer was washed with saturated NH4Cl (50 mL) and brine, then dried over Na2SO4. Solvent 
removal in vacuo afforded S4 (4.97 g, 95%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.253 (t, J = 7.5 Hz, 3H), 1.5 (s, 9H), 2.857 (q, J = 7.5 Hz, 2H), 
4.554 (s, 2H), 7.116 (dd, J = 8.5, 2.5 Hz, 1H), 7.277 (d, J = 8.5 Hz, 1H), 7.391 (d, J = 3 Hz, 1H) 
13C NMR (100 MHz, CDCl3) 167.3932, 156.3652, 149.4567, 132.3149, 132.2128, 120.6270, 
110.0036, 83.0951, 66.0518, 28.1809, 25.7638, 15.1222 
HRMS (m/z): [M + Na]+ calcd for [C14H19NO5Na]+ 304.1155, found 304.1160. 
 
tert-butyl 2-(4-(1-bromoethyl)-3-nitrophenoxy)acetate (S5) 
Compound S4 (4.97 g, 17.7 mmol), N-bromosuccinimide (3.8 g, 19.5 mmol) and benzoylperoxide 
(0.2 g, 1 mmol) were dissolved in CCl4 (100 mL) and refluxed for 4 h. The reaction mixture was 
cooled to room temperature and washed with 0.1% NaHCO3 (aq) and brine, then dried over Na2SO4. 
The solvent was removed in vacuo and the crude product was purified by silica gel flash column 
chromatography (3:1 Hex:EtOAc, v/v) to afford S4 (5.7 g, 90%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.498 (s, 9H), 2.054 (d, J = 7 Hz, 3H), 4.571 (s, 2H), 5.787 (q, J 
= 7 Hz, 1H), 7.184 (dd, J = 8.5, 3 Hz, 1H), 7.299 (d, J = 2.5 Hz, 1H), 7.784 (d, J = 9 Hz, 1H) 
13C NMR (100 MHz, CDCl3) 167.0028, 157.7588, 148.0010, 131.1486, 130.8123, 120.7031, 
109.7326, 83.3722, 66.0153, 42.0634, 28.1845, 27.3715 
HRMS (m/z): [M - Br]+ calcd for [C14H18NO5]+ 280.1179, found 280.1163. 
 
2-(4-(1-bromoethyl)-3-nitrophenoxy)ethan-1-ol (S6) 
Compound S5 (5.7 g, 15.9 mmol) was dissolved in 100 mL THF and cooled down to -78 °C. DIBAL- 
H (39.8 mmol) was added to the reaction flask and stirred at -78 °C for 20 min, and then left to stir 
for an additional 2 h at 0 °C. TLC analysis (3:1 Hex:EtOAc, v/v) indicated essentially complete 
conversion to the product. The reaction was quenched by slowly adding 30 mL H2O to the mixture, 
followed by the addition of 5% HCl (aq) solution until the aqueous solution became acidic (pH = ~4, 
as judged by pH paper). After vigorously mixing the biphasic mixture in a separatory funnel, the 
separated organic layer was washed with brine, then dried over Na2SO4. The solvent was removed 
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in vacuo and the crude product was purified by silica gel flash column chromatography to yield S6 
(3.23 g, 60%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 2.056 (d, J = 5 Hz, 3H), 4.006 (dd, J = 4.5, 4.5 Hz, 2H), 4.142 
(dd, J = 4, 4 Hz, 2H), 5.785 (q, J = 7 Hz, 1H), 7.201 (dd, J = 8.5, 2.5 Hz, 1H), 7.356 (d, J = 2.5 Hz, 
1H), 7.783 (d, J = 8.5 Hz, 1H) 
13C NMR (100 MHz, CDCl3) 158.5634, 148.1515, 131.0462, 130.2806, 120.5139, 109.6535, 
70.1749, 61.2504, 42.1290, 27.3423 
HRMS (m/z): [M - Br]+ calcd for [C14H18NO5]+ 210.0761, found 210.0761. 
 
1-(4-(2-hydroxyethoxy)-2-nitrophenyl)ethan-1-ol (S7) 
S6 (3.23 g, 11.1 mmol) was dissolved in 250 mL H2O and refluxed for 1 h. TLC analysis (1:1 
Hex:EtOAc, v/v) indicated essentially complete conversion to the product. The product was 
extracted with EtOAc (3 x 50 mL). The organic layer was washed with brine and then dried over 
Na2SO4. The solvent was evaporated in vacuo and S7 (2.0 g, 80%) was used for the next step 
without further purification. 
1H NMR (500 MHz, CDCl3)  ppm 1.540 (d, J = 6.4 Hz, 3H), 3.997 (dd, J = 4.6, 4.6 Hz, 2H), 4.120 
(dd, J = 7.1, 7.1 Hz, 2H), 5.341 (q, J = 6.2 Hz, 1H), 7.201 (dd, J = 8.8, 2.8 Hz, 1H), 7.410 (d, J = 
2.7 Hz, 1H), 7.734 (d, J = 8.8 Hz, 1H) 
 
1-(4-(2-(acryloyloxy)ethoxy)-2-nitrophenyl)ethyl acrylate (o-NBMA, S8) 
To a solution of S7 (2.0 g, 8.88 mmol) and acryloyl chloride (26.6 mmol) in CH2Cl2 (75 mL), TEA 
(3.5 eq) was added and the mixture was stirred at room temperature for 24 h. The mixture was 
washed with H2O and brine and then dried over Na2SO4. The solvent was evaporated in vacuo and 
the crude material was purified by silica gel flash column chromatography (2.5:1 Hex:EtOAc, v/v) 
to yield S8 (1.79 g, 60%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.653 (d, J = 6.5 Hz, 3H), 4.253-4.272 (m, 2H), 4.517-4.536 (m, 
2H), 5.849 (dd, J = 16.5, 1.5 Hz, 1H), 5.87 (dd, J = 16.5, 1.5 Hz, 1H), 6.135 (dd, J = 33, 10.5 Hz, 
1H), 6.135 (dd, J = 10.5, 1.5 Hz, 1H), 6.333 (dd, J = 6.5, 6.5 Hz, 1H), 6.425 (dd, J = 38.5, 1.5 Hz, 
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1H), 6.425 (dd, J = 4, 1 Hz, 1H), 7.181 (dd, J = 8.5, 2.5 Hz, 1H), 7.471 (d, J = 2.5 Hz, 1H), 7.547 
(d, J = 8.5 Hz, 1H) 
13C NMR (100 MHz, DMSO-d6) 165.3601, 164.6091, 157.8246, 148.5720, 132.2687, 132.0463, 
128.7689, 128.2840, 127.9741, 127.9522, 120.6063, 109.4215, 67.2670, 66.6545, 62.5167, 
21.2189 
HRMS (m/z): [M + Na]+ calcd for [C16H17NO7Na]+ 358.0897, found 358.0888.  
 
Fabrication of photoresponsive polyacrylamide hydrogels 
Photoresponsive polyacrylamide gel substrates were prepared based on a previously reported 
method (44). Briefly, Grid-500 high glass-bottom dishes (Fischer, 50-305-810) were activated for 
gel attachment by sequential treatment with 0.1 M NaOH, 97% (3-aminoproyl)trimethoxysilane 
(Sigma Aldrich, 281778) and 0.5% glutaraldehyde (Polysciences, 01909). A prepolymer mixture of 
40% (w/v) acrylamide solution (25% by volume, Fisher, BP1402), 2% (w/v) bis-acrylamide solution 
(2.5% by volume, Fisher, BP1404), 50 mM o-nitrobenzyl bis-acrylate (in DMSO, 3.25% by volume), 
1M HEPES (pH 7.0, 1% by volume, Sigma Aldrich, H6147) solution, 71.7 mM acrylic acid N-
hydroxysuccinimide ester (in DMSO, 4% by volume, Sigma Aldrich, A8060), and H2O (63.25% by 
volume) was prepared. After degassing for 30 min, polymerization was initiated by adding 10% 
(w/v) APS (0.6% by volume, Bio-Rad, 161-0700) solution and TEMED (0.4% by volume, Fisher, 
BP150). Immediately after initiation, 200 μL of gel solution was pipetted onto the activated glass 
culture dish and covered with a fibronectin-patterned glass coverslip face down (fabricated as 
described below). After 30 min of polymerization, PBS was added on the dish and the coverslip 
was removed. Finally, the gel was washed with PBS. 
Preparation of 1D fibronectin micropatterns 
1D lines of fibronectin were created on the photoresponsive hydrogels following a microcontact 
printing method widely applied in the field of surface protein fabrication (45). Briefly, PDMS stamps 
fabricated by photolithography and containing topographical patterns (21 μm width, 40 μm spacing) 
were obtained from the M. Piel laboratory (Inst. Curie) and used as received (46). The patterned 
side of the stamp was inked with 100 μg/mL fibronectin (Sigma Aldrich, F1141) for 1 h. After drying 
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the stamp using a stream of air, the fibronectin-coated stamp was stamped onto a 12 mm no. 1.5 
circular coverslip (Fisher, 12-545-80), rinsed with ethanol and treated with plasma (Harrick Plasma) 
for 60 sec, and a 20 g weight was placed on top of the stamp. The fibronectin pattern was finally 
transferred to the gel surface by placing the coverslip face down on the prepolymer solution as 
described above, immediately upon the initiation of polymerization. 
 
Fabrication of stepwise stiffness gradients by controlled UV exposure 
Stiffness patterns were fabricated on photoresponsive hydrogels using a Nikon Eclipse Ti-E 
epifluorescence microscope and Plan Fluor 10x/0.30NA objective (Nikon), controlled by NIS- 
Elements software (Nikon). The fibronectin-patterned photoresponsive gel was placed on the stage 
and, using phase-contrast imaging, two regions were selected such that they were ‘A’ mm (A > 2) 
apart. A hypothetical line connecting the two regions ran across the fibronectin patterns 
perpendicularly (Fig. S4.3). The field diaphragm lever was then adjusted so that the diameter of 
the illuminated area on the substrate was 500 μm. Fluorescence imaging using a 395/25 nm LED 
(315 mW) and DAPI filter set with LED fluorescence illumination from a SpectraX light Engine 
(Lumencor) was initiated, and a time lapse movie of the two regions was captured at 0 s intervals 
for ‘15 x A’ min, leaving the active shutter open during stage movement. This led to a 500 μm x ‘A’ 
mm region being photoirradiated to the extent that all the photolabile crosslinkers in the exposed 
region were cleaved. The process was repeated in regions parallel to and 500 μm apart from the 
first irradiated area, resulting in a gel that had alternating, 500 μm wide stiff (~15 kPa) and soft (~8 
kPa) regions. 
 
Stiffness characterization by bead indentation 
The irradiation time-dependent change in the Young’s modulus of the photoresponsive 
polyacrylamide gel was measured using a bead indentation method (17) based on Hertzian 
indentation theory. A thick (>1 mm) hydrogel was created by pipetting 300 μL of prepolymer solution 
onto an activated glass culture dish and covering it with a 25 mm no. 1.5 circular coverslip (Fisher, 
12-545-102). After polymerization, the coverslip was removed in PBS and the gel was washed with 
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additional PBS. A silica bead (Polysciences, 1 mm diameter) was placed on the gel after 200 nm 
crimson fluorospheres were first gravity-settled on the gel surface to function as markers for 
measuring bead contact area with epifluorescence microscopy. At each irradiation time point, the 
bead indentation depth (δ) was calculated from the bead radius (R) and the contact radius (r) 
according to equation (1): 
 =  −  −  (1) 
From this indentation depth, the Young’s modulus (E) was calculated using the Poisson ratio of the 




4     (2) 
For polyacrylamide gels, ν = 0.3‒0.5 (here, ν = 0.3 was used). The glass bead density was 
measured to be ~2600 kg/m3. 
 
Characterization of fibronectin density 
To demonstrate the sustained uniformity of the fabricated fibronectin patterns after UV irradiation, 
immunostaining was performed using primary and secondary antibodies. Briefly, fibronectin-coated 
photoresponsive gels were rinsed five times with PBS after fabrication. After introducing stiffness 
patterns based on the method described above, gels were incubated with rabbit anti-fibronectin 
antibody (1:500, Sigma Aldrich F3648) for 60 min at 37 °C. After rinsing five times with PBS, gels 
were incubated with goat anti-rabbit IgG-rhodamine (1:1000, Invitrogen 31686) for 45 min at rt. 
Gels were rinsed with PBS five times prior to imaging. 
 
Cell culture 
U-251MG human glioblastoma cells were obtained from Dr. G. Yancey Gillespie (U. Alabama- 
Birmingham), authenticated using a short tandem repeat assay (University of Arizona Genetics 
Core) and cultured in Dulbecco’s modified Eagle’s medium (DMEM)/F-12 (Gibco, 11320-074) 
supplemented with 8% fetal bovine serum (Sigma, F7524). U-251MG cells were cultured in T25 
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flasks (Becton Dickinson, 353108) placed in a 37 °C 5% CO2 incubator for 2-3 days with media 
comprising 45.5% F12 GlutaMAX supplement (Gibco 31765-035), 45.5% high glucose Dulbecco’s 
modified Eagle’s medium (Gibco 10566-024), 8% heat-inactivated fetal bovine serum (Gibco 
10438-026), and 1% penicillin/streptomycin solution (Cellgro 30-001-CI). Cells were removed from 
flask by 5 min incubation in 0.25% trypsin with EDTA in Hanks’ balanced salt solution (Gibco 25-
052-CI) and transferred to the fibronectin-coated photoresponsive gels at a concentration of 10,000 
cells per dish. Cell transferred gels were incubated for 30 min prior to imaging. 
 
Brightfield microscopy and analysis of cell migration  
Live phase contrast imaging of U-251MG cells on photoresponsive hydrogels was done using a 
Nikon Eclipse Ti-E microscope and an Andor Zyla 5.5 sCMOS camera (Andor Technology). The 
objective was a Plan Fluor 10x/0.30NA objective (Nikon) and samples were maintained in a Bold 
Line stage top humidified incubator (Okolab) at +37 °C/5% CO2. Time-lapse movies were acquired 
at 20 or 30 min intervals for 45 to 60 hours. The number of cells in the soft and stiff regions of the 
gel, in the beginning and end of the experiment, was quantified. Additionally, the movies were 
analyzed for cells directly on top of a stiffness gradient. Such cells were tracked over time to 
investigate their bias for migrating toward either stiffness. Mitotic, dying or crowded cells were 
excluded from the analysis. 
 
4.1.3 Results and Discussion 
Synthesis of o-NBbA 
 Efficient photolysis and facile incorporation into hydrogels were the two main focuses in 
developing a novel photocleavable crosslinker. Therefore, photocleavage efficiency of various 
photolabile functionalities was first considered, which led to the selection of o-nitrobenzyl (o-NB). 
Due to its high one-photon photolysis efficiency and high deprotection yields,219 o-NB based 
compounds have been widely used in many applications relevant to biological systems, including 
hydrogel-based studies focused on achieving controlled release or immobilization of payloads, 
photodegradation of gels, or modulation of gel stiffness.220–222 Therefore, it was deemed suitable 
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for use in fabricating novel photoresponsive gels. Our second focus to enable facile incorporation 
of the photocleavable crosslinker and hence easy fabrication of the photoresponsive gels. While 
there was one report to date that utilized a o-NB based crosslinker for the fabrication of 
photoresponsive polyacrylamide hydrogels, the reported methodology required a multistep 
functionalization process to incorporate the crosslinker into the gel network.218 For a more simpler 
one-step incorporation of the o-NB crosslinker during the gelation step, two acrylate moieties that 
are para-position to one another were conjugated to the o-Nb core. The size of the final compound 
was designed to be similar to bis-acrylamide to minimize the physical perturbation of the gel 
network once it is incorporated. On that note, o-NBbA was synthesized in seven steps from p-ethyl 
aniline (Fig. S4.2A). Due to its design, the o-NBbA crosslinker copolymerized with acrylamide and 
bis-acrylamide to produce a photoresponsive polyacrylamide hydrogel in a single step, and 
photolysis of o-NBbA did not release any byproducts to the gel environment (Fig. S4.2B). It should 
be noted that after the publication of our work, a paper that utilized an o-NB-based crosslinker very 
similar to our molecule was published.223 While the molecule allowed a one-step incorporation of 
the o-NB molecule into the gel similar to our work, the molecule experienced a high degree of 
hydrophobicity due to the excessive carbons in the molecule, which eventually led to certain 
limitations. Their gels also required additional steps to functionalize the gel surface with reactive 
moieties to anchor ECM-proteins. The facile ECM-coating method that was used in our 
photoresponsive gels is covered in later sections. 
 
Preparation, characterization, and optimization of the o-NBbA incorporated 
photoresponsive hydrogels 
 The o-NBbA incorporated gel was prepared based on a previously reported method.224 
Briefly, a prepolymer mixture based on a 20 kPa polyacrylamide gel was prepared by replacing half 
(50 mol%) of the bis-acrylamide content with o-NBbA, aiming to create a gel that exhibits an initial 
stiffness of 20 kPa that is reduced to 10 kPa, or half of the initial stiffness, once completely 
photolyzed. Polyacrylamide was chosen over other types of other gels such as collagen, hyaluronic 
acid, or polyethylene glycol-based gels, as it is known to be inert to interactions with cell surface 
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receptors, which is a particularly important factor to consider in durotaxis studies. The gels were 
prepared on glass-bottom dishes were activated by silanized to promote covalent adhesion of the 
gel to the glass surface. 
 Once prepared, the stiffness or Young’s modulus of the gel was characterized using bead 
indentation (Fig. S4.3b-d).225 Softening of the gel was conducted via photolysis while measuring 
the stiffness, which resulted in a stiffness versus time plot that displayed an exponential decay (Fig. 
S4.3d). However, the initial (15 kPa) and final (8 kPa) stiffness values were shown lower than 
expected (20 and 10 kPa, respectively). The discrepancy was larger for gels that had replaced a 
larger portion of the bis-acrylamide (80 mol%) with o-NBbA. Instead of resulting in 20 kPa gels that 
become 4 kPa after complete photocleavage of the o-NBbA, the gels exhibited an initial stiffness 
of 4 kPa that reduces to 1 kPa. In addition, substantial amounts of creases were observed on the 
surface of the gels, which intensified even further after photoirradiation. Interestingly, while both 
gels displayed lower stiffness values than expected, the percent reduction was in accordance with 
the aimed values. In other words, gels that replaced 50% or 80% of the bis-acrylamide with o-NBbA 
resulted in gels that exhibit a 50% or 80% reduction in stiffness, respectively, after photoirradiation. 
 Previous studies have indicated that gels soften with increasing bis-acrylamide content, 
which is due to the clustering and phase separation of the crosslinking molecules, which in turn 
results in the reduction of the elastically effective crosslinkers.226 As o-NBbA is even less water-
soluble than bis-acrylamide, we hypothesized that the reduction of absolute stiffness values occurs 
due to similar reasons. Visual observation revealed that the turbidity of the prepolymer solution 
increases with increasing o-NBbA content, demonstrating that phase separation was occurring due 
to the hydrophobic crosslinker. We believe this indicates that indeed the crosslinker concentration 
is decreasing with increasing o-NBbA content which is therefore causing the issues with creasing.  
The 10% (v/v) methanol that was added to the prepolymer mixture, originally intended to 
facilitate the solubilization of the hydrophobic o-NBbA with the rest of the prepolymer components, 
was another factor that was suspected to aggravate the issue of crease formation and low stiffness 
values. Among various organic solvents, methanol was chosen due to its high solubility parameter 
(δ) which would allow it to form a homogenous solution with water. However, once the polymerized 
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gels were washed and immersed in PBS solution, the gels were anticipated to swell due to the 
osmotic pressure difference with the surrounding medium, which in turn could cause creasing and 
reduction in stiffness. Experiments confirmed this was indeed the case. It was shown that when the 
gel is immersed in high concentration PBS (x10), the extent of creases reduces, which eventually 
disappears once the buffer solution is exchanged to 10% (v/v) methanol in PBS (Fig. S4.11). These 
results indicated that different solvent compositions of the gel and surrounding medium could result 
in structural instability of the gel. 
 Since durotaxis studies require an even surface where stiffness gradients are the only 
factor that affects cell migration, obtaining a crease-free gel was particularly important. It was also 
beneficial to obtain a gel that can exhibit a wide range of stiffness values to diversify the durotactic 
environment. Therefore, optimization of the gel preparation condition was required before moving 
onto cell-based studies. First, the components of the prepolymer mixture were adjusted. Increasing 
the acrylamide content while decreasing the crosslinker content, which was aimed to retain a 
certain level of stiffness while reducing the amount hydrophobic molecules and hence reduce the 
tendency of the gels to crease, did not yield improvements.226 However, removing the methanol 
from the prepolymer mixture was found to produce gels that are more stable against creases 
without affecting the stiffness. Therefore, the recipe was modified to exclude methanol from this 
point forward.  
 Next, the effect of the cover-glass bottom of the culture dishes on gel-creasing was 
investigated. Prior to casting the gels on cover dishes, the glass bottoms of the dishes were 
activated according to a procedure known as silanization.227 The purpose of the process was to 
promote covalent anchoring of the gel to the glass substrate. However, previous reports showed 
that a thin layer of gel fixed to a rigid substrate could experience anisotropic swelling. This change 
in gel volume was shown to introduce equibiaxial compressive strain on the gel surface and hence 
result in surface creases.228 Based on this study, gels were prepared on non-silanized culture 
dishes to confirm whether relieving the stress applied to the gel surface could help preventing 
creases. The adjustment was found ineffective, and the surface tension between the gel and the 
glass itself, even without covalent interactions, seemed sufficient to produce enough strain to 
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promote the buckling of the gel surface. The thickness of the gel was found to be one of the most 
important factors in preventing creases. Maintaining a minimal thickness (> 600 µm) of the gel led 
to crease-free gels, which was in accordance with previous reports that demonstrated the inverse 
correlation between the thickness of the gel and the onset point of creasing.228,229  
 Despite optimizations that led to improvements, we note that the main source of the issue, 
which is the hydrophobicity of o-NBbA, was not resolved in this study. We believe functionalizing 
o-NBbA with water-soluble moieties such as charged carboxylic acids or PEG would be most 
effective in masking the hydrophobicity of the crosslinker, which would allow a wider applicability of 
o-NBbA in durotaxis studies. However, as the focus this study was to mimic the brain environment 
that mostly exhibits stiffness values within 25 kPa, this task was held off for future studies. Therefore, 
the final product that was obtained was a crease-free gel with an initial stiffness value of 15 kPa 
which reduces to 8 kPa upon full-photolysis. It is also important to note that despite not having more 
water-soluble pendant groups, the reported o-NBbA was able to maintain enough hydrophilicity that 
allowed its dissolution in the prepolymer mixture which was due to its molecular design. The o-
NBbA molecule contained only a minimum number of carbons required for its photoactivity and 
crosslinking capabilities. This was later found to be extremely important, as a similar molecule that 
was reported following our publication which had only a few more carbons compared to our o-NBbA 
was shown to require surfactants and a series of heating and vortexing procedures for the 
solubilization of the molecule. Those interested in a more detailed analysis of the correlation 
between the gel composition that includes this o-NB based photocleavable crosslinker and the 
mechanical properties or photodegradation kinetics of the resulting gel are directed to this report.223 
It is important to note that our gel product still holds concerns of creasing, especially when the 
whole gel is exposed to light that leads to a higher degree of swelling. However, as our studies did 
not require photolysis of the whole gel but rather irradiation of specific regions, for instance, spot- 
or line-irradiation for the fabrication of stiffness patterns, the swelling of the photo-exposed regions 
could be buffered by the surrounding non-irradiated regions of the gel, which could minimize the 
degree of swelling and hence crease formation.  
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Fabrication of fibronectin and stiffness patterns onto photoresponsive hydrogels 
 To promote the adhesion of cells on the gel surface, a coated layer of extracellular matrix 
(ECM) protein was required. The most commonly used ECM-coating method involves the use of 
sulfo-SANPAH which is a heterobifunctional photoactivatable crosslinker. One end of the 
crosslinker contains a phenyl azide that binds to the gel upon UV irradiation, and the other end 
which consists of an activated N-hydroxysuccinimide (NHS) ester binds to the primary amines of 
the protein, forming a linkage between the two components. However, this method was not 
applicable for our studies due to the light-sensitive nature of our gel. Therefore, a microcontact 
printing method was utilized to transfer 1-D patterned ECM to the gel surface (Fig. S4.3a). Briefly, 
a PDMS stamp containing topographical patterns created by photolithography was used in creating 
ECM patterns on a coverslip, which was then placed on top of the prepolymer solution facedown 
during its gelation. The NHS-ester acrylic acid that was included in the prepolymer solution as a 
tethering agent allowed the covalent-transfer of the ECM from the coverslip to the surface of the 
gel without additional activation steps. The remaining activated-esters after ECM-printing was 
passivated with BSA solution. The ECM protein of choice was fibronectin which was printed as line 
patterns to restrict the cellular movement to 1-dimension as it would allow easier quantification. 
Theses line patterns later also allowed easier reproduction of the cellular environment in 
computational simulation studies. 
The next step was to introduce stiffness patterns to the gels. Conventional methods that 
utilize photomasks require additional steps to design masks via photolithography and suffer from 
low-resolution and low spatiotemporal control due to irradiation that is restricted to predesignated 
locations according to the design of the photomask. Therefore, we aimed to create stiffness 
patterns differently by using an LED from a SpectraX light engine instrument installed on the Nikon 
TiE microscope, which was originally purposed for epifluorescence imaging. The wavelength of the 
light was set at 395 nm using the DAPI filter. Using a light source attached to the microscope 
resulted in multiple advantages. Precise spatial control of the area of irradiation could be achieved 
due to the ease of switching between phase-contrast imaging and LED irradiation. This advantage 
also allowed temporal control, which could be exploited for photoirradiation at various time points 
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during live cell culture. While temporally controlled photolysis was not heavily focused in this study, 
we expect this capability could be exploited in future studies, for instance, in observing cellular 
responses that result immediately after introducing a stiffness gradient. The dimensions of light 
could be easily and precisely controlled by adjusting the field diaphragm and objective of the 
microscope. The diameter of the LED-irradiated region could be set as low as 59 µm using a 40x 
objective, which could potentially go lower with a higher objective. High resolution stiffness patterns 
could be created using the microscope software to create dots, lines, or even planes of light-
exposed regions. Taking advantage of these features, alternating 8 and 15 kPa regions were 
created orthogonal to the fibronectin lines (Fig. S4.3a). Although atomic force microscopy (AFM) 
measurements were omitted, the stiffness gradients created by this method is presumed to be very 
steep since the only factor that can cause gradients would be the diffraction that occurs at the air-
gel interface.  
 In durotactic studies, it is preferred that the only factor stimulating cellular migration is the 
stiffness gradient. Therefore, to confirm that photoirradiation solely alters the stiffness, control 
experiments were performed. The sustained uniformity of the fabricated fibronectin patterns after 
UV irradiation was demonstrated by immunofluorescence imaging, in which the irradiated and non-
irradiated regions of the gel were shown to display no difference in fibronectin density (Fig. S4.12). 
The topography was investigated by comparing the z-dimension or thickness of the irradiated and 
non-irradiated regions of the gel. It was shown that the thickness at the 8 kPa region is only 3% or 
20 µm higher than the 15 kPa regions, which is well below the cellular dimensions of U-251MG 
cells. These results demonstrated that the methodology used in creating stiffness patterns would 
result in minimal side effects that affect the cellular behavior in any other way.  
 
Observation of U-251MG cells on the fabricated gels 
 Once transferred to the gel, U-251MG cells were found to attach selectively to the 
fibronectin printed regions and to migrate along the printed lines. Time-lapse movies were taken 
for 45-60 hours, and the directional bias for cells migrating at the interface between soft and stiff 
region were tracked. The expectation was that cells would migrate towards the stiffer 15 kPa 
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regions, since durotaxis has been widely accepted as a biased movement towards the stiffer parts 
of the substrate for decades since its initial discovery.211 However, contrary results were observed. 
U-251MG cells were shown to preferentially congregate towards the softer 8 kPa regions over the 
15 kPa regions (Fig. 4.1e). As supported by experiments in previous sections, this contradicting 
behavior of U-251MG cells was not an artifact since fibronectin density, topography, and gel 
composition were shown consistent regardless of substrate stiffness. 5 days after transferring the 
cells to the gel surface, U-251MG cell were shown to have proliferated overtime and therefore was 
fully occupying the fibronectin printed regions of the gel. Interestingly, the preference towards the 
softened regions was so great that the cells had started to realign its orientation to maximize the 
packing density in these softened regions. In other words, instead of fully adhering along a single 
line of fibronectin, some cells were found latching onto two lines, perpendicular to the direction of 
the fibronectin lines, to maximize the amount of cellular localization in the 8 kPa region (Fig. S4.12). 
These observations were sufficient to confirm the discovery of negative durotaxis, a biased 
migration of cells towards the softened regions of a substrate, which developed into a highly 
collaborative project across three continents. Research groups that each possess expertise in 
computational modeling and microbiology were added to the mix to gain a deeper understanding 
of the mechanism behind this peculiar behavior of U-251MG cells. 
 
4.1.4 Conclusion 
 In summary, a novel photocleavable crosslinker was developed and employed in 
fabricating a photoresponsive hydrogel. The gel required an optimization process to form a flat and 
even surface, a requirement for it to be utilized as a suitable platform for durotaxis studies. Followed 
by introduction of stiffness patterns, gels were used as a platform to observe the migration behavior 
of U-251MG cells. Contrary to our expectations, directional bias towards softer regions of the gel 
was observed. The discovery of negative durotaxis stimulated a collaboration with multiple 
institutions to define the mechanism behind the capability of the cell to sense and adjust their 
movement upon its local environment. While the details of the studies are displayed in Chapter 4.2, 
the following ending paragraph describes the key points without figure assignments. 
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There was a previous study that reported that the relationship between traction force and 
substrate stiffness is biphasic, and that cells generate maximal traction force at the intermediate 
stiffness range.230 This ‘optimal stiffness’ could be predicted in this study by using a mathematical 
model called the motor-clutch model, where two given molecular components dictate cell migration, 
ATP-dependent myosin 2 (motor), and mechanical adhesions (clutches) typically caused by 
integrins. Based on this study, it was hypothesized that cells including U-251MG can potentially 
exhibit negative durotaxis if their optimal stiffness lies more closely towards the softer region over 
the stiffer region, and hence if more traction is generated at the softer region over the stiffer region. 
For validation at the molecular level, protein expression levels of U-251MG cells at various Young’s 
moduli was investigated, which was also compared to that of MDA-MB-231 breast cancer cells 
which are known to exhibit positive durotaxis. Unlike MDA-MB-231 cells, U-251MG cells did not 
show any correlation between the substrate stiffness and the key mediators of 
mechanotransduction such as myosin 2 light chain and focal adhesion kinase. Correlation with 
mechanosensitive adhesion proteins such as talin or vinculin was not observed as well. However, 
high activity of integrin was observed, which is a component that is involved in the cell’s interaction 
with the fibronectin-coated substrate. Simulation studies were carried out to see whether the in vitro 
results could be reproduced. Indeed, when the optimal stiffness was set at softer regions, negative 
durotaxis could be replicated. This directional movement could be reversed to positive durotaxis 
when the traction force was set to increase with increasing stiffness. Based on these results, 
knockdown of talin was performed on MDA-MB-231 cells, which is a factor known to be involved in 
adhesion reinforcement which in turn leads to the monophasic behavior between traction force and 
substrate stiffness. It was confirmed that talin downregulated MDA-MB-231 cells behave like U-
251MG cells, exhibiting negative durotaxis and clustering to the intermediate regions on a 0.5-22 
kPa gel, demonstrating the effect of cellular adhesion forces on durotaxis. Overall, the presence of 
a single mechanism in sensing the local environment which in turn causes durotaxis was observed 
across two different cell types, which could be explained by the dynamics of traction force based 
on the motor-clutch model. 
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4.2 Negative durotaxis: cell movement toward softer environments 
 
Reproduced with permission from Aleksi Isomursu, Keun-Young Park, Jay Hou, Bo Cheng, 
Ghaidan Shamsan, Benjamin Fuller, Jesse Kasim, M. Mohsen Mahmoodi, Tian Jian Lu, Guy M. 
Genin, Feng Xu, Min Lin, Mark Distefano, Johanna Ivaska, and David J. Odde. Negative durotaxis: 
cell movement toward softer environments.  
 
 
How cells sense tissue stiffness to guide cell migration is a fundamental question in 
development, fibrosis and cancer. Although durotaxis – traditionally defined as cell migration toward 
increasing stiffness – is well established, it remains unknown whether individual cells can migrate 
toward softer environments. Using microfabricated stiffness gradients, we observed directed glioma 
cell migration toward lower stiffness. This ‘negative durotaxis’ did not coincide with changes in 
canonical mechanosensitive signaling or actomyosin contractility. Instead, motor-clutch-based 
modeling predicted migration toward cell-intrinsic ‘optimal stiffness’, where cells generate maximal 
traction. As predicted by the model, positive durotaxis was switched to negative experimentally by 
lowering the optimal stiffness via downregulation of a key clutch component, talin. Our results 
identify the molecular mechanism driving context-dependent positive or negative durotaxis, 
determined by a cell’s contractile and adhesive machinery. 
 
The capacity of living cells to undergo controlled migration is critical for tissue homeostasis 
and development, and underlies pathological conditions like cancer metastasis231,232. Cells migrate 
in response to chemical and physical cues including the elasticity, or stiffness, of the surrounding 
extracellular matrix (ECM). The well-known tendency for many cells to migrate toward stiffer 
substrates, known as durotaxis211,212,233–236, has implications for both developmental 
morphogenesis237,238 and cancer cell invasion236,239. 
Despite progress in empirically identifying environmental conditions and molecular 
components that enable or promote durotaxis212,233,240–242, our understanding of its fundamental 
 120
mechanisms in different cell types is lacking. A long-standing mathematical model for cell migration 
is based on the motor-clutch mechanism225,243–245, in which F-actin filaments polymerize against 
the plasma membrane to push the cell edge forward, while being simultaneously pulled away from 
the cell edge by ATP-dependent myosin II (‘molecular motors’) and pushed by force from the ATP-
dependent polymerization itself. Retrograde F-actin flow can be mitigated by mechanical 
connections or ‘clutches’, typically integrin-mediated adhesions, between the F-actin and ECM to 
generate traction and bias cell movement toward more adhesive environments246,247. Similarly, 
fibroblasts on stiffness gradients exhibit asymmetric traction, which has been postulated to 
contribute to their polarization and durotaxis234,248. Interactions between actomyosin machinery and 
integrin-mediated adhesions have also been implicated in neuronal growth and pathfinding; 
however, the unifying principles underlying these behaviors across cell types have not been 
established249–251. 
Recently, cellular traction forces were shown to be maximal on substrates of an ‘optimal 
stiffness’ that can be predicted by the motor-clutch model225,230,245,252–255. However, the biological 
relevance of this on cell behavior remains to be fully elucidated. Due to the key role of traction in 
driving mesenchymal cell migration, we predicted that any cell whose adhesion dynamics are 
governed by the motor-clutch model could potentially migrate toward softer environments, if such 
environments were closer to the cell’s optimal stiffness for maximal traction generation. We call this 
behavior ‘negative durotaxis’. 
To test our hypothesis, we seeded U-251MG human glioblastoma cells, previously shown 
to exhibit maximal traction at an optimal stiffness of 5‒10 kPa (Fig. 4.1a)230, on fibronectin-
functionalized polyacrylamide hydrogels having a continuous stiffness gradient of approximately 
0.5‒22 kPa (Fig. 4.1b)256 – a range representative of healthy and malignant brain tissue257. We 
observed a strong tendency for these cells to undergo negative durotaxis, migrating from the stiffest 
regions to regions of intermediate stiffness over time (Fig. 4.1b‒c). Fewer cells were observed in 
the softest regions, implying that cells below the optimal stiffness underwent conventional positive 
durotaxis. To exclude cell proliferation as a cause of these differences, we quantified the rate of 
EdU incorporation in cells cultured on homogeneous 0.5, 9.6 and 60 kPa substrates. Proliferation 
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was equal on 9.6 kPa and 60 kPa hydrogels and only slightly lower on 0.5 kPa substrates (Fig. 
S4.1a‒b), suggesting that the absence of cells in the stiffer regions of the gradient was indeed due 
to biased migration. 
To verify this, we cultured cells on photoresponsive hydrogels with alternating 8 and 15 
kPa regions, connected by steep stiffness gradients (hereafter ‘stepwise gradients’) (Figs. S4.2, 
S4.3; Supplementary Text 1). 20 µm wide fibronectin lines were printed across the gradients to 
facilitate cell motility. Live imaging revealed that cells migrated along the fibronectin lines and 
clustered preferentially in the softer 8 kPa regions (Figs. 4.1d‒e, g; S4.1c‒d; Movie S1). Moreover, 
tracking of individual U-251MGs confirmed that any cells making contact with a stiffness gradient 
migrated preferentially to the 8 kPa side (Fig. 4.1f, h; Movie S2). Taken together, these data 
demonstrate that U-251MGs are capable of negative durotaxis from stiff to soft environments, 
consistent with their stiffness optimum for maximal traction. 
To gain insight into the molecular basis of negative durotaxis, we investigated key 
mediators of mechanotransduction, whereby biomechanical cues are translated into changes in 
cell signaling and behavior258. We speculated that a biphasic response in any of these could, in 
part, modulate the negative durotaxis of U-251MGs. However, no changes were observed in 
myosin II light chain (MLC2), focal adhesion kinase (FAK) or extracellular signal-regulated kinase 
(ERK) phosphorylation in U-251MGs cultured on substrates with moduli of 0.5, 8 or 50 kPa (Fig. 
4.2a‒b). These results were surprising because, in most adherent cell types, increasing substrate 
stiffness supports integrin clustering and focal adhesion (FA) growth, promoting the activation of 
mechanosensitive downstream signaling pathways245,259,260. 
This prompted us to compare focal adhesions in U-251MGs, capable of negative durotaxis, 
and MDA-MB-231 breast adenocarcinoma cells, which reportedly undergo positive durotaxis236. As 
expected, MDA-MB-231s displayed stiffness-induced growth of paxillin-positive FAs (Fig. S4.4a) 
whereas U-251MGs displayed very few FAs even on 60 kPa substrates, as confirmed by 
immunostaining of paxillin (Fig. 4.2c) and additional FA markers, vinculin and phosphorylated FAK 
(Fig. S4.4b). This was not due to low expression of mechanosensitive adhesion proteins talin-1, 
talin-2 or vinculin, or due to low myosin II activity (p-MLC2), as these were expressed at comparable 
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levels in U-251MG, MDA-MB-231, and human osteosarcoma U-2 OS, another FA-forming261 cell 
line (Fig. S4.4c‒d). Nevertheless, U-251MGs displayed high β1-integrin activity and their spreading 
on fibronectin was sensitive to β1-integrin inhibition with a function-blocking antibody (Mab13) (Fig. 
S4.4e‒g), suggesting that they interact with their substrate primarily through integrins. 
Hippo-family proteins yes-associated protein 1 (YAP) and transcriptional co-activator with 
PDZ-binding motif (TAZ) are transcriptional co-regulators that integrate cues from different 
mechanical and biochemical sources to direct cell behavior. Nuclear localization and activation of 
YAP/TAZ on stiff substrates are linked to increased F-actin assembly and FA formation; conversely, 
YAP/TAZ can promote adhesion turnover and cell migration262 and baseline YAP activity may even 
be necessary for conventional durotaxis241. We stained endogenous YAP from MDA-MB-231s and 
observed robust stiffness-induced nuclear translocation (Fig. 4.2d‒e). In contrast, U-251MGs 
displayed much lower nuclear YAP on both soft and stiff substrates, with a slight increase but no 
visible peak between 0.5 and 60 kPa (Fig. 4.2d‒e). Thus, mechanosensitive signaling responses 
of U-251MGs are minimal and not specific to the 5‒10 kPa range, and cannot explain negative 
durotaxis. 
The optimal stiffness for U-251MG traction and the increasing overall motility of these cells 
(random motility coefficient, RMC) with stiffness up to 100 kPa can be explained by motor-clutch 
dynamics230. Without talin unfolding and vinculin-mediated ‘clutch reinforcement’ and FA growth, 
the motor-clutch model naturally predicts a biphasic dependence of traction forces on substrate 
stiffness245. After confirming that U-251MGs migrated preferentially toward their known traction 
optimum in all of our experimental conditions (Fig. 4.1a‒h), we investigated whether stochastic 
computational simulation of cell-level motor-clutch dynamics would be sufficient to reproduce 
negative durotaxis (Fig. 4.3a, Supplementary Text 2). We simulated the migration of individual U-
251MGs on mechanically homogeneous substrates for one hour to allow the system to reach a 
dynamic steady state, then placed each cell on a continuous substrate consisting of alternating 60 
µm wide regions of low and high stiffness, joined together by smooth 30 µm wide stiffness gradients 
(Figs. 4.3b, S4.5a‒b). 
On 10‒100 pN nm-1 gradients, corresponding to ~10‒100 kPa for typical adhesion sizes263, 
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and where the cells’ optimal stiffness overlaps with the softer regions (Fig. 4.3c‒d), we found that 
the majority of cells translocated away from stiffer areas in the first 12 hours of the simulation (Fig. 
4.3e‒f). This occurred despite the cells being less motile (i.e. having lower RMC) on the softer 
substrate (Fig. 4.3d). On stiffness gradients, cellular protrusions (modules) displayed higher 
average traction on soft than on stiff regions (Fig. 4.3g‒i). The cells also migrated preferentially 
toward the softer side, recapitulating the behavior observed in U-251MGs in vitro (Fig. 4.3j). By 
altering the range of the gradient, such that the side associated with higher predicted traction was 
the stiffer one, durotaxis could be reversed and cells clustered primarily in the stiff regions (Fig. 
S4.6a‒d). 
We verified the generality of these principles by applying them to model axonal pathfinding 
in neuronal development and regeneration (Figs. S4.7, S4.8; Supplementary Text 3). Indeed, the 
tendency for Xenopus retinal ganglion cells to grow toward softer tissue is closely analogous to 
negative durotaxis250. Neurite elongation and pathfinding via the actin-rich neuronal growth cone 
(GC) at the distal end of the axon involves contractile filopodia of variable length and orientation 
(Fig. S4.7a). Applying our model to individual filopodia (Fig. S4.7b) and to GCs with multiple 
filopodia (Fig. S4.8a), we found that the protrusions elongated faster and generated more traction 
on soft substrates (0.01‒0.1 pN nm-1) (Fig. S4.7c‒h). This was consistent both with earlier 
predictions of relatively low optimal stiffness for neurons225,264,265, and with our hypothesis that 
positive and negative durotaxis are governed by motor-clutch dynamics in concert with optimal 
stiffness. The results also suggested that gradient strength may further increase propensity for 
negative durotaxis: GCs steered to more compliant regions on substrates with stronger gradients 
(reaching a maximum at ~10 pN nm-1/20 μm), but did not change direction on mild gradients (~0.1 
pN nm-1/20 μm) or on substrates that were overall stiff compared to the optimum (>1 pN nm-1) (Fig. 
S4.8c‒e). 
While U-251MGs and neurons exhibit biphasic traction forces in the physiological stiffness 
range, many adherent cell types do not239,245,266,267. Rather, their traction increases as a function of 
substrate stiffness unless talin- and vinculin-mediated FA formation is disrupted, e.g. by depletion 
of both talin isoforms245 (Fig. 4.4a). Therefore, we hypothesized that targeting adhesion 
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reinforcement can generate an intermediate optimal stiffness and enable negative durotaxis in cell 
types that normally undergo only positive durotaxis. To test this, we used siRNAs to reduce talin-1 
and talin-2 expression in MDA-MB-231 cells that exert increasing traction with increasing substrate 
stiffness267 and undergo positive durotaxis in the 2‒18 kPa range236. Talin knockdown (Fig. 4.4b) 
resulted in significantly fewer and smaller FAs (Fig. 4.4c‒e) and reduced traction on ~20 kPa 
substrates, where adhesion reinforcement is expected to counteract clutch dissociation by rapidly 
accumulating forces (Figs. 4.4f‒h, S9a). EdU incorporation increased from 0.5 to 9.6 kPa and 
plateaued thereafter, with and without talin silencing (Fig. S4.9b‒c). While control MDA-MB-231s 
seeded on 0.5‒22 kPa stiffness gradients migrated toward the stiffest regions available, talin-low 
MDA-MB-231s phenocopied the negative durotaxis seen in U-251MGs and clustered 
predominantly in regions of intermediate stiffness (Fig. 4.4i‒j). Thus, the familiar positive durotactic 
behavior can be converted to negative durotaxis by manipulating the adhesive and contractile 
machinery of a cell to change its optimal stiffness. 
The concept of cells moving toward environments where they can exert more traction is 
intuitive, but has been previously understood in the context of denser, stiffer ECM providing cells 
with more stable anchorage235. Our results demonstrate the additional capacity of individual cells 
to migrate toward softer environments, i.e. negative durotaxis, which can be explained by a motor-
clutch-based model. Cells that lack robust adhesion reinforcement, such as U-251MG glioma cells 
or talin-low MDA-MB-231 breast cancer cells, tend to exert maximal traction on substrates of 
intermediate stiffness, and migrate along gradients to reach this optimum by positive or negative 
durotaxis (Fig. S4.10). The same mechanism is likely to contribute to the recently described neurite 
growth toward soft matrix250. 
Besides directly reinforcing connections to stiff matrix, mechanosensitive FA formation 
may promote positive durotaxis by additional mechanisms. Preferential trafficking of adhesion 
components toward existing FAs268, local activation of mechanically gated ion channels269 or other 
biochemical signaling pathways initiated at the FAs260 may all contribute to further polarization of 
cell-matrix adhesion and, consequently, of cellular traction forces. How these factors influence 
stiffness optima on different substrates, and in different biological conditions, will be an interesting 
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topic for future research. Taken together, our results point to a single, conserved mechanism for 
stiffness sensing and durotaxis across a broad range of cell types, with motor-clutch dynamics 





Figure 4.1 U-251MG glioblastoma cells undergo negative durotaxis. (a) Schematic representation 
of U-251MG traction, maximal on 5‒10 kPa substrates230, and how it relates to the two stiffness 
gradients employed here. (b) (Top) Representative region of a diffusion-based polyacrylamide 
stiffness gradient (Young’s modulus ~0.5‒22 kPa), at the outset of the experiment and 48 hours 
later. U-251MG cells are indicated by nuclear staining. Scale bar, 500 µm. (Bottom) Quantification 
of cells across the gradient. (c) Cell density in different parts of the stiffness gradient. Bins denote 
pooled regions of interest in the bottom, middle and top third of the gradient, respectively. Mean ± 
SEM of n = 14‒42 ROIs, analyzed by Kruskal-Wallis one-way ANOVA and Dunn’s post hoc test. (d) 
Schematic representation of photoresponsive hydrogels with stepwise stiffness gradients. (e‒h) U-
251MG migration on stepwise gradient hydrogels. A representative example (e) and quantification 
(g) of the change in cell density across the gradients over time. Blue overlay denotes softer, UV-
exposed regions. Vertical and horizontal gray lines in (e) are out-of-focus markings in the underlying 
glass, used as a reference. Scale bar, 200 µm. Mean ± 95% CI from n = 24 fields of view, from two 
independent experiments. (f) End points (left) and 24-hour tracks (right) depicting the migration of 
individual cells in the region denoted by a white rectangle in (e). Scale bar, 100 µm. (h) Violin plots 
of accumulated distance migrated by individual cells along the x-axis over 12 hours, starting from 
a gradient (top) or from the middle of a compliant region (bottom). Vertical lines denote medians, n 





Figure 4.2 U-251MG cells display limited mechanosensitive signaling and adhesion maturation. 
(a‒b) Representative western blot (a) and quantification (b) depicting protein phosphorylation in U-
251MGs on 0.5‒50 kPa substrates. Mean ± SD of 2‒5 independent experiments. (c) 
Immunofluorescence images of paxillin and F-actin in U-251MGs on 0.5‒60 kPa substrates. The 
bottom panels show individual focal planes from confocal stacks, corresponding to the basal side 
of each cell. Scale bar, 20 µm. (d‒e) Immunofluorescence images (d) and quantification (e) 
showing the intracellular localization of YAP as a function of substrate stiffness in U-251MG and 
MDA-MB-231 cells. Insets depict representative nuclei. Scale bar, 20 µm. Each box displays upper 
and lower quartiles and a median, the whiskers denote minimum and maximum values. n = 57‒
135 cells, ***p < 0.001, *p = 0.018, n.s. = not significant, analyzed by Kruskal-Wallis one-way 






Figure 4.3 Motor-clutch simulations recapitulate negative durotaxis. (a) Schematic representation 
of the cell migration simulator . Individual modules and a central cell body are attached to the elastic 
substrate by sets of clutch molecules (Supplementary Text 2). (b) Experimental setup used here 
and in (Fig. S4.6). Simulated cells in a dynamic steady state were placed on a substrate with 
repeating stiff and soft regions and tracked over time. An equal number of cells were placed on 
both stiffnesses (red area). (c‒d) Module-wise traction forces (c) and RMC (d) of the simulated cells 
as a function of substrate stiffness. Red overlay highlights the range of the 10‒100 pN nm-1 gradient 
in (e‒j). Mean ± SEM of n = 10 cells. (e‒f) Evolution of cell density on mechanically heterogeneous 
substrates over time. (e) Coordinates of individual cells 0, 4 and 16 hours into the simulation. Stiff 
(≥55 pN nm-1) and compliant (<55 pN nm-1) regions are indicated by gray and blue, respectively. (f) 
Fraction of cells residing in the stiff and soft regions over the course of the simulation. ±95% CI, n 
= 882 cells. (g) When individual cells were on top of a stiffness gradient, their traction forces were 
recorded. (h‒i) Forces exerted by clutch modules on stiff, intermediate and soft substrate, while the 
cell is on top of a stiffness gradient. (h) Bar graphs depicting mean ± SEM of n = 292‒1380 modules. 
***p < 0.001, n.s. = not significant, Kruskal-Wallis one-way ANOVA and Dunn’s post hoc test. (i) 
Histograms overlaid with probability density functions, dashed lines indicate medians. n = 292‒365 
modules, analyzed by Kolmogorov-Smirnov test. (j) Violin plots of accumulated distance migrated 
by individual cells along the orientation of the gradient and over 12 hours, starting from a gradient 







Figure 4.4 Lowering traction optimum by blocking adhesion reinforcement shifts cells from positive 
to negative durotaxis. (a) Schematic representation of the relationship between traction forces, 
substrate stiffness and talin/vinculin-mediated ‘clutch reinforcement’. Depletion of these clutch 
components forces some cell types back into a biphasic traction regime245. (b) Representative 
western blot depicting talin-1 and talin-2 double knockdown in MDA-MB-231 cells. (c‒d) 
Immunofluorescence images (c) and quantification (d) of focal adhesions in MDA-MB-231s on 60 
kPa substrate, without and after talin knockdown. Scale bar, 20 µm. Mean ± SD of n = 32‒35 cells, 
analyzed by Mann-Whitney test. (e) Distribution of focal adhesion sizes in control and talin-low cells. 
Histograms overlaid with probability density functions, dashed lines indicate medians. n = 524‒
1844 adhesions from 32‒35 cells, analyzed by Kolmogorov-Smirnov test. Representative of two 
independent experiments. (f‒h) Traction force analysis of control and talin-low MDA-MB-231s. (f) 
Total force exerted by the cells as a function of substrate stiffness. Background, BG. Mean ± SEM 
of n = 18‒55 cells from three independent experiments, *p = 0.029. (g) Representative traction 
maps from cells on 22 kPa substrate. Cell outlines are indicated by white dashed lines. Scale bar, 
20 µm. (h) Histograms of the 22 kPa data overlaid with probability density functions, dashed lines 
indicate medians. n = 37‒55 cells from three independent experiments, analyzed by Kolmogorov-
Smirnov test. (i) (Left) Representative regions of two 0.5‒22 kPa polyacrylamide stiffness gradients, 
72 hours after being seeded with MDA-MB-231 cells (indicated by nuclear staining). Scale bar, 500 
µm. (Right) Quantification of cells across the gradients. (j) Relative cell densities in different parts 
of the gradients, overlaid with binned data. Mean ± SEM of n = 13‒141 ROIs per bin, from one 
(siCTRL) or two (siTLN1+2) gradient gels, representative of three independent experiments. 
Analyzed by Mann-Whitney test. 
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Materials and Methods 
Cell culture and transfections 
U-251MG human glioblastoma cells were obtained from Dr. G. Yancey Gillespie (U. Alabama-
Birmingham), authenticated using a short tandem repeat assay (University of Arizona Genetics 
Core) and cultured in Dulbecco’s modified Eagle’s medium (DMEM)/F-12 (Gibco, 11320-074) 
supplemented with 8% fetal bovine serum (Sigma, F7524). MDA-MB-231 human breast 
adenocarcinoma cells were purchased from American Type Culture Collection and authenticated 
using a short tandem repeat assay (Leibniz Institute DSMZ ‒ German Collection of Microorganisms 
and Cell Cultures, Braunschweig, Germany). U-2 OS human osteosarcoma cells were acquired 
from DSMZ. Both MDA-MB-231 and U-2 OS were cultured in high-glucose DMEM (Sigma, D5796-
500ML) supplemented with 10% fetal bovine serum (Sigma, F7524), 2 mM L-glutamine (Sigma, 
G7513-100ML) and 1x non-essential amino acids (Sigma, M7145-100ML). The cells were tested 
for mycoplasma contamination and cultured at +37 °C, 5% CO2 in a humidified incubator. 
For transient downregulation of target proteins, the cells were transfected with corresponding 
siRNAs at a 50 nM concentration per oligo. The transfections were conducted using Opti-MEM 
Reduced Serum Medium (Thermo Fisher Scientific, 31985-047) and Lipofectamine RNAiMAX 
reagent (Thermo Fisher Scientific, 56532) according to the manufacturer’s instructions. The 
siRNAs used were Hs_TLN1_3 FlexiTube siRNA (Qiagen, SI00086975), Hs_TLN2_3 FlexiTube 
siRNA (Qiagen, SI00109277) and AllStars Negative Control siRNA (Qiagen, 1027281). Silenced 




The following antibodies were used at the indicated dilutions: ms anti-paxillin (BD Biosciences, 
612405, 1:200 for IF), rbt anti-paxillin (Santa Cruz Biotechnology, sc-5574, 1:200 for IF), ms anti-
vinculin (Sigma, V9131, 1:200 for IF, 1:1000 for WB), ms anti-talin-1 (Novus, NBP2-50320, 1:1000 
for WB), ms anti-talin-2 (Novus, NBP2-50322, 1:1000 for WB), ms anti-FAK (BD Biosciences, 
610088, 1:1000 for WB), rbt anti-p-FAK (Y397) (Cell Signaling Technology, 8556, 1:100 for IF, 
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1:1000 for WB), rbt anti-MLC2 (Cell Signaling Technology, 3672, 1:1000 for WB), rbt anti-p-MLC2 
(T18/S19) (Cell Signaling Technology, 3674, 1:1000 for WB), rbt anti-ERK1/2 (Cell Signaling 
Technology, 9102, 1:1000 for WB), rbt anti-p-ERK1/2 (T202/Y204) (Cell Signaling Technology, 4370, 
1:1000 for WB), ms anti-YAP (Santa Cruz Biotechnology, sc-101199, 1:200 for IF), rbt anti-vimentin 
(Cell Signaling Technology, 5741, 1:1000 for WB), ms anti-GAPDH (HyTest, MAb 6C5, 1:5000 for 
WB), ms anti-active β1-integrin (clone 12G10, in-house production, 5 µg/ml for IF), rat anti-inactive 
β1-integrin (clone Mab13, in-house production, 10 µg/ml for cell culture), and normal rat IgG2a 
kappa isotype control (eBioscience, 14-4321-85, 10 µg/ml for cell culture). 
Additionally, the following secondary antibodies were used for immunofluorescence and 
immunoblots at the indicated dilutions: Alexa Fluor 488/568-conjugated secondary antibodies 
raised against mouse (Invitrogen, A21202 and A10037, 1:400 for IF) and rabbit (Invitrogen, A21206 
and A10042, 1:400 for IF), IRDye 800CW Donkey anti-Mouse IgG (LI-COR Biosciences, 926-
32212, 1:5000 for WB), IRDye 800CW Donkey anti-Rabbit IgG (LI-COR Biosciences, 926-32213, 
1:5000 for WB), and IRDye 680LT Donkey anti-Mouse IgG (LI-COR Biosciences, 926-68022, 
1:5000 for WB). 
 
EdU incorporation assay 
To measure the rate of EdU (5-ethynyl-2′-deoxyuridine) incorporation into DNA, cells were grown 
on hydrogels for 24 hours, after which they were prepared into fluorescence microscopy samples 
using an EdU Proliferation Assay Kit (Abcam, ab222421), according to the manufacturer’s 
instructions. Briefly, the cells were supplemented with 20 µM EdU for 2 hours, fixed, permeabilized, 
and the EdU was stained with iFluor 647 azide via a copper-catalyzed click reaction. Nuclei were 
counterstained before imaging (see below). 
 
Blocking β1-integrin function with antibodies 
U-251MG cells were grown on 0.5 kPa and 60 kPa hydrogels for 24 hours, after which they were 
treated with 10 µg/ml of anti-inactive β1-integrin (i.e. function-blocking) clone Mab13 or normal rat 
isotype control for 2 hours (see the list of antibodies for details). The cells were fixed and processed 
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for immunofluorescence imaging. 
 
Cell migration on stiffness gradient substrates 
For analysis of cell migration on continuous 2D stiffness gradients, 15,000 (MDA-MB-231)‒20,000 
(U-251MG) cells were seeded on a fibronectin-functionalized stiffness gradient hydrogel. Even 
distribution of cells in the beginning of the experiment was confirmed visually (via brightfield 
microscopy) and by recording the positions of individual nuclei along the gradient using SiR-DNA. 
The plate was returned to the incubator for 48 (U-251MG) or 72 hours (MDA-MB-231), after which 
the cells were fixed and nuclei were re-visualized with DAPI. 
For live imaging of U-251MG migration on stepwise gradient hydrogels, 10,000 cells were seeded 
per dish and allowed to settle in the incubator for 30 min prior to imaging. Time-lapse movies were 
acquired at 20 or 30 min intervals for 45 to 60 hours. The number of cells in the soft and stiff regions 
of the gel, in the beginning and end of the experiment, was quantified. Additionally, the movies were 
analyzed for cells directly on top of a stiffness gradient. Such cells were tracked over time to 
investigate their bias for migrating toward either stiffness. Mitotic, dying or crowded cells were 
excluded from the analysis. 
 
Western blotting 
Cells on hydrogels were placed on ice, rinsed twice with ice-cold PBS and scraped into lysis buffer 
[50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% SDS, 0.5% Triton X-100, 5% glycerol, supplemented 
with protease (Roche, 05056489001) and phosphatase (Roche, 04906837001) inhibitors]. The 
lysates were vortexed, placed on a heat block (+90 °C) for 10 min and sonicated before separation 
by SDS-PAGE (4-20% Mini-PROTEAN TGX Gels, Bio-Rad, 456-1096). Next, the proteins were 
transferred to nitrocellulose membranes and visualized using 1% Ponceau S staining solution. The 
membranes were blocked with 5% skimmed milk in TBST and incubated with the indicated primary 
antibodies overnight at +4°C, followed by fluorophore-conjugated secondary antibodies for 1 to 2 
hours at room temperature. All the antibodies were diluted in StartingBlock blocking buffer (Thermo 
Fisher Scientific, 37538). Finally, the membranes were scanned using an Odyssey infrared imaging 
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system (LI-COR Biosciences). 
 
Conventional polyacrylamide hydrogels 
Glass-bottom dishes (Cellvis, D35-14-1-N) were treated for 20 min at room temperature with 100 
μl of Bind-Silane solution – a mixture of 3-(trimethoxysilyl)propylmethacrylate (7.15% by volume, 
Sigma-Aldrich, M6514) and acetic acid (7.15% by volume) in absolute ethanol – to promote gel 
attachment to the glass surface. After the Bind-Silane was aspirated, the glass was washed twice 
with ethanol and left to dry completely. For homogeneous (constant Young’s modulus) hydrogels, 
pre-defined ratios of 40% (w/v) acrylamide (Sigma-Aldrich, A4058) and 2% (w/v) N,N-methyl-bis-
acrylamide (Sigma-Aldrich, M1533) were mixed in PBS on ice and vortexed carefully. The final 
concentrations were adjusted to yield a desired Young’s modulus (Table S1). Gels that were 
indicated for traction force microscopy were supplemented with additional 0.2 µm yellow-green 
fluorescent (505/515) microspheres (~1.5 x 1010/ml final concentration, Invitrogen, F8811), which 
were sonicated for 3 min prior to use. Polymerization was initiated by addition of 10% ammonium 
persulfate (APS, final 0.1% by volume, Bio-Rad) and N,N,N′,N′-tetramethylethylenediamine 
(TEMED, final 0.2% by volume, Sigma-Aldrich, T-9281) to the solution. Immediately afterwards, 13 
μl of the solution was pipetted onto the glass bottom dish and a 13 mm circular coverslip was ‐
placed on top of the droplet. After polymerization for ~1 hour at room temperature, the gel was 
immersed in PBS for 5 min, the top coverslip was gently removed, and the gel was washed twice 
with PBS to remove any excess acrylamide. Hydrogels with continuous 2D stiffness gradients were 
fabricated as described previously256. Briefly, 0.5 kPa and 22 kPa acrylamide prepolymer solutions 
were prepared and 0.1 µm fluorescent (505/515) microspheres (~1.2 x 1011/ml final concentration, 
Invitrogen, F8803) were added to the 22 kPa solution. After polymerization was initiated, the two 
solutions were allowed to diffuse together on a glass-bottom dish, under a glass coverslip, to yield 
a gradient wherein microsphere density correlates linearly with the Young’s modulus of the 
substrate. 
Prior to use, the hydrogels were activated by a combination of 0.2 mg/ml Sulfo-SANPAH (Thermo 
Fisher Scientific, 22589) and 2 mg/ml N-(3-dimethylaminopropyl)-N′-
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ethylcarbodiimidehydrochloride (EDC, Sigma-Aldrich, 03450) in 50 mM 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES). 500 μl of the solution was added on top 
of the hydrogel and incubated for 30 min at room temperature, protected from light and subjected 
to gentle agitation. The gel and solution were then UV-irradiated for 10 min (28-32 mW/cm2) to 
activate the Sulfo-SANPAH, and the plate was washed with PBS three times to remove any residual 
compounds. Finally, each hydrogel was functionalized by incubation in 10 μg/ml fibronectin solution 
overnight at +4°C. 
Cells that were collected for protein lysates were cultured on commercial hydrogel-coated 6-well 
plates (Matrigen, SW6-EC-0.5/SW6-EC-8/SW6-EC-50). These gels were similarly coated with 10 
µg/ml of fibronectin before use. 
 
Synthesis of o-NBbA 
2-nitro-4-ethyl aniline (S2) 
p-Ethyl aniline (5 g, 41.3 mmol) was added dropwise to a cold solution of concentrated H2SO4 (30 
ml) and stirred for 5 min. In a separate flask, 5.3 ml of 70% HNO3 (82.6 mmol) was mixed with an 
equal volume of H2SO4, and added dropwise to the reaction vessel, followed by 15 min stirring at 
0 °C. Thin layer chromatography (TLC) analysis (Hex:EtOAc, 2:1, v/v) indicated complete 
conversion to the product. The reaction was quenched by pouring the mixture into 200 ml ice water. 
The resulting precipitate was filtered and washed with H2O to yield compound S2 (6.2 g, 90%). 
1H NMR (500 MHz, CDCl3)  ppm 1.099 (t, J = 7.5 Hz, 3H), 2.612 (q, J = 7.0 Hz, 2H), 5.558 (s, 2H), 
6.804 (dd, J = 8.0, 2.5 Hz, 1H), 7.041 (d, J = 2.5 Hz, 1H), 7.095 (d, J = 8.5 Hz, 1 H) 
13C NMR (400 MHz, DMSO-d6) 149.3411, 147.8646, 131.6051, 124.0586, 118.8417, 107.9194, 
24.4890, 15.3093 
HRMS (m/z): [M]+ calcd for [C8H10N2O2]+ 166.0737, found 166.0737. 
 
4-ethyl-3-nitrophenol (S3) 
Compound S2 (6.2 g, 37.3 mmol) was suspended in a mixture of H2SO4 and H2O (1:3, v/v, 25-50 
ml) by sonication (if sonification did not yield a homogenous suspension, a few ml of THF was used 
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to dissolve the solid S2, which was then added to the mixture of aqueous H2SO4). NaNO2 (3.86 g, 
56.0 mmol) dissolved in H2O (2.5 ml) was added slowly to the reaction flask and stirred at room 
temperature for 1.5 h. In a separate flask H2SO4:H2O (4:3, v/v, 75 ml) was added and heated to 
reflux. To the refluxing mixture, the S2 solution was added dropwise and stirred for 30 min. The 
mixture was quenched with ice water and extracted with EtOAc (3 x 75 ml). After drying the organic 
layer with Mg2SO4, the solvent was removed in vacuo and the crude product was purified by silica 
gel flash chromatography (Hex:EtOAc, 2:1) to give S3 (3.11 g, 50%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.249 (t, J = 7.5 Hz, 3H), 2.842 (q, J = 8.5 Hz, 2H), 7.030 (dd, J 
= 8.5, 2.5 Hz, 1H), 7.230 (d, J = 8.5 Hz, 1H), 7.383 (d, J = 2.5 Hz, 1H) 
13C NMR (400 MHz, CDCl3) 154.2470, 149.5150, 132.3914, 131.3014, 120.7326, 111.4436, 
25.6617, 15.1987 
HRMS (m/z): [M - H]- calcd for [C8H8NO3]- 166.0510, found 166.0524. 
 
tert-butyl 2-(4-ethyl-3-nitrophenoxy)acetate (S4) 
Compound S3 (3.11 g, 18.6 mmol) and tert-butyl 2-bromoacetate (4.35 g, 22.3 mmol) were 
dissolved in DMF (25 ml). Solid K2CO3 (5.14 g, 37.2 mmol) was added to the reaction flask and left 
to stir at +70 °C for 1.5 h until TLC analysis (2:1 Hex:EtOAc, v/v) indicated complete conversion to 
the product. The solvent was removed in vacuo and redissolved in 100 ml EtOAc. The organic layer 
was washed with saturated NH4Cl (50 ml) and brine, then dried over Na2SO4. Solvent removal in 
vacuo afforded S4 (4.97 g, 95%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.253 (t, J = 7.5 Hz, 3H), 1.5 (s, 9H), 2.857 (q, J = 7.5 Hz, 2H), 
4.554 (s, 2H), 7.116 (dd, J = 8.5, 2.5 Hz, 1H), 7.277 (d, J = 8.5 Hz, 1H), 7.391 (d, J = 3 Hz, 1H) 
13C NMR (400 MHz, CDCl3) 167.3932, 156.3652, 149.4567, 132.3149, 132.2128, 120.6270, 
110.0036, 83.0951, 66.0518, 28.1809, 25.7638, 15.1222 
HRMS (m/z): [M + Na]+ calcd for [C14H19NO5Na]+ 304.1155, found 304.1160. 
 
tert-butyl 2-(4-(1-bromoethyl)-3-nitrophenoxy)acetate (S5) 
Compound S4 (4.97 g, 17.7 mmol), N-bromosuccinimide (3.8 g, 19.5 mmol) and benzoylperoxide 
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(0.2 g, 1 mmol) were dissolved in CCl4 (100 ml) and refluxed for 4 h. The reaction mixture was 
cooled to room temperature and washed with 0.1% NaHCO3 (aq) and brine, then dried over Na2SO4. 
The solvent was removed in vacuo and the crude product was purified by silica gel flash column 
chromatography (3:1 Hex:EtOAc, v/v) to afford S4 (5.7 g, 90%) as a yellow oil.  
1H NMR (500 MHz, CDCl3)  ppm 1.498 (s, 9H), 2.054 (d, J = 7 Hz, 3H), 4.571 (s, 2H), 5.787 (q, J 
= 7 Hz, 1H), 7.184 (dd, J = 8.5, 3 Hz, 1H), 7.299 (d, J = 2.5 Hz, 1H), 7.784 (d, J = 9 Hz, 1H) 
13C NMR (400 MHz, CDCl3) 167.0028, 157.7588, 148.0010, 131.1486, 130.8123, 120.7031, 
109.7326, 83.3722, 66.0153, 42.0634, 28.1845, 27.3715 
HRMS (m/z): [M - Br]+ calcd for [C14H18NO5]+ 280.1179, found 280.1163. 
 
2-(4-(1-bromoethyl)-3-nitrophenoxy)ethan-1-ol (S6) 
Compound S5 (5.7 g, 15.9 mmol) was dissolved in 100 ml THF and cooled down to -78 °C. DIBAL-
H (39.8 mmol) was added to the reaction flask and stirred at -78 °C for 20 min, and then left to stir 
for an additional 2 h at 0 °C. TLC analysis (3:1 Hex:EtOAc, v/v) indicated essentially complete 
conversion to the product. The reaction was quenched by slowly adding 30 ml H2O to the mixture, 
followed by the addition of 5% HCl (aq) solution until the aqueous solution became acidic (pH = ~4, 
as judged by pH paper). After vigorously mixing the biphasic mixture in a separatory funnel, the 
separated organic layer was washed with brine, then dried over Na2SO4. The solvent was removed 
in vacuo and the crude product was purified by silica gel flash column chromatography to yield S6 
(3.23 g, 60%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 2.056 (d, J = 5 Hz, 3H), 4.006 (dd, J = 4.5, 4.5 Hz, 2H), 4.142 
(dd, J = 4, 4 Hz, 2H), 5.785 (q, J = 7 Hz, 1H), 7.201 (dd, J = 8.5, 2.5 Hz, 1H), 7.356 (d, J = 2.5 Hz, 
1H), 7.783 (d, J = 8.5 Hz, 1H) 
13C NMR (400 MHz, CDCl3) 158.5634, 148.1515, 131.0462, 130.2806, 120.5139, 109.6535, 
70.1749, 61.2504, 42.1290, 27.3423 





S6 (3.23 g, 11.1 mmol) was dissolved in 250 ml H2O and refluxed for 1 h. TLC analysis (1:1 
Hex:EtOAc, v/v) indicated essentially complete conversion to the product. The product was 
extracted with EtOAc (3 x 50 ml). The organic layer was washed with brine and then dried over 
Na2SO4. The solvent was evaporated in vacuo and S7 (2.0 g, 80%) was used for the next step 
without further purification. 
1H NMR (500 MHz, CDCl3)  ppm 1.540 (d, J = 6.4 Hz, 3H), 3.997 (dd, J = 4.6, 4.6 Hz, 2H), 4.120 
(dd, J = 7.1, 7.1 Hz, 2H), 5.341 (q, J = 6.2 Hz, 1H), 7.201 (dd, J = 8.8, 2.8 Hz, 1H), 7.410 (d, J = 
2.7 Hz, 1H), 7.734 (d, J = 8.8 Hz, 1H) 
 
1-(4-(2-(acryloyloxy)ethoxy)-2-nitrophenyl)ethyl acrylate (o-NBbA, S8) 
To a solution of S7 (2.0 g, 8.88 mmol) and acryloyl chloride (26.6 mmol) in CH2Cl2 (75 ml), TEA 
(3.5 eq) was added and the mixture was stirred at room temperature for 24 h. The mixture was 
washed with H2O and brine and then dried over Na2SO4. The solvent was evaporated in vacuo and 
the crude material was purified by silica gel flash column chromatography (2.5:1 Hex:EtOAc, v/v) 
to yield S8 (1.79 g, 60%) as a yellow oil. 
1H NMR (500 MHz, CDCl3)  ppm 1.653 (d, J = 6.5 Hz, 3H), 4.253-4.272 (m, 2H), 4.517-4.536 (m, 
2H), 5.849 (dd, J = 16.5, 1.5 Hz, 1H), 5.87 (dd, J = 16.5, 1.5 Hz, 1H), 6.135 (dd, J = 33, 10.5 Hz, 
1H), 6.135 (dd, J = 10.5, 1.5 Hz, 1H), 6.333 (dd, J = 6.5, 6.5 Hz, 1H), 6.425 (dd, J = 38.5, 1.5 Hz, 
1H), 6.425 (dd, J = 4, 1 Hz, 1H), 7.181 (dd, J = 8.5, 2.5 Hz, 1H), 7.471 (d, J = 2.5 Hz, 1H), 7.547 
(d, J = 8.5 Hz, 1H) 
13C NMR (400 MHz, DMSO-d6) 165.3601, 164.6091, 157.8246, 148.5720, 132.2687, 132.0463, 
128.7689, 128.2840, 127.9741, 127.9522, 120.6063, 109.4215, 67.2670, 66.6545, 62.5167, 
21.2189 
HRMS (m/z): [M + Na]+ calcd for [C16H17NO7Na]+ 358.0897, found 358.0888. 
 
Fabrication of photoresponsive polyacrylamide hydrogels 
Photoresponsive polyacrylamide gel substrates were prepared based on a previously reported 
method270. Briefly, Grid-500 high glass-bottom dishes (Fischer, 50-305-810) were activated for gel 
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attachment by sequential treatment with 0.1 M NaOH, 97% (3-aminoproyl)trimethoxysilane (Sigma 
Aldrich, 281778) and 0.5% glutaraldehyde (Polysciences, 01909). A prepolymer mixture of 40% 
(w/v) acrylamide solution (25% by volume, Fisher, BP1402), 2% (w/v) bis-acrylamide solution (2.5% 
by volume, Fisher, BP1404), 50 mM o-nitrobenzyl bis-acrylate (in DMSO, 3.25% by volume), 1M 
HEPES (pH 7.0, 1% by volume, Sigma Aldrich, H6147) solution, 71.7 mM acrylic acid N-
hydroxysuccinimide ester (in DMSO, 4% by volume, Sigma Aldrich, A8060), and H2O (63.25% by 
volume) was prepared. After degassing for 30 min, polymerization was initiated by adding 10% 
(w/v) APS (0.6% by volume, Bio-Rad, 161-0700) solution and TEMED (0.4% by volume, Fisher, 
BP150). Immediately after initiation, 200 µL of gel solution was pipetted onto the activated glass 
culture dish and covered with a fibronectin-patterned glass coverslip face down (fabricated as 
described below). After 30 min of polymerization, PBS was added on the dish and the coverslip 
was removed. Finally, the gel was washed with PBS. 
 
Preparation of 1D fibronectin micropatterns 
1D lines of fibronectin were created on the photoresponsive hydrogels following a microcontact 
printing method widely applied in the field of surface protein fabrication271. Briefly, PDMS stamps 
fabricated by photolithography and containing topographical patterns (21 µm width, 40 µm spacing) 
were obtained from the M. Piel laboratory (Inst. Curie) and used as received272. The patterned side 
of the stamp was inked with 100 µg/ml fibronectin (Sigma Aldrich, F1141) for 1 h. After drying the 
stamp using a stream of air, the fibronectin-coated stamp was stamped onto a 12 mm no. 1.5 
circular coverslip (Fisher, 12-545-80), rinsed with ethanol and treated with plasma (Harrick Plasma) 
for 60 sec, and a 20 g weight was placed on top of the stamp. The fibronectin pattern was finally 
transferred to the gel surface by placing the coverslip face down on the prepolymer solution as 
described above, immediately upon the initiation of polymerization. 
 
Fabrication of stepwise stiffness gradients by controlled UV exposure 
Stiffness patterns were fabricated on photoresponsive hydrogels using a Nikon Eclipse Ti-E 
epifluorescence microscope and Plan Fluor 10x/0.30NA objective (Nikon), controlled by NIS-
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Elements software (Nikon). The fibronectin-patterned photoresponsive gel was placed on the stage 
and, using phase-contrast imaging, two regions were selected such that they were ‘A’ mm (A > 2) 
apart. A hypothetical line connecting the two regions ran across the fibronectin patterns 
perpendicularly (Fig. S4.3). The field diaphragm lever was then adjusted so that the diameter of 
the illuminated area on the substrate was 500 µm. Fluorescence imaging using a 395/25 nm LED 
(315 mW) and DAPI filter set with LED fluorescence illumination from a SpectraX light Engine 
(Lumencor) was initiated, and a time lapse movie of the two regions was captured at 0 s intervals 
for ‘15 x A’ min, leaving the active shutter open during stage movement. This led to a 500 µm x ‘A’ 
mm region being photoirradiated to the extent that all the photolabile crosslinkers in the exposed 
region were cleaved. The process was repeated in regions parallel to and 500 µm apart from the 
first irradiated area, resulting in a gel that had alternating, 500 µm wide stiff (~15 kPa) and soft (~8 
kPa) regions. 
 
Stiffness characterization by bead indentation 
The irradiation time-dependent change in the Young’s modulus of the photoresponsive 
polyacrylamide gel was measured using a bead indentation method225 based on Hertzian 
indentation theory. A thick (>1 mm) hydrogel was created by pipetting 300 µl of prepolymer solution 
onto an activated glass culture dish and covering it with a 25 mm no. 1.5 circular coverslip (Fisher, 
12-545-102). After polymerization, the coverslip was removed in PBS and the gel was washed with 
additional PBS. A silica bead (Polysciences, 1 mm diameter) was placed on the gel after 200 nm 
crimson fluorospheres were first gravity-settled on the gel surface to function as markers for 
measuring bead contact area with epifluorescence microscopy. At each irradiation time point, the 
bead indentation depth (δ) was calculated from the bead radius (R) and the contact radius (r) 
according to equation (1): 
 =  −  −  (1) 
From this indentation depth, the Young’s modulus (E) was calculated using the Poisson ratio of the 






4     (2) 
For polyacrylamide gels, ν = 0.3‒0.5 (here, ν = 0.3 was used). The glass bead density was 
measured to be ~2600 kg/m3. 
 
Immunofluorescence staining 
Samples were fixed for 10 min with warm 4% PFA, followed by permeabilization and blocking for 
20 min with 0.3% Triton X-100 in 10% horse serum (Gibco, 16050-122). Primary antibodies were 
diluted in 10% horse serum and samples were incubated with the antibody overnight at +4 °C. 
Secondary antibodies were diluted in PBS and samples were incubated with the antibody for one 
to two hours at room temperature. Where indicated, the nuclei were counterstained using 5 µg/ml 
DAPI (4',6-diamidino-2-phenylindole) or 500 nM SiR-DNA (Spirochrome, SC007; for live cells) and 
filamentous actin using 200 nM SiR-actin (Spirochrome, SC001). 
 
Fluorescence and brightfield microscopy 
Most fluorescent specimens were imaged using a Marianas spinning disk confocal microscope with 
a Yokogawa CSU-W1 scanning unit, controlled by SlideBook 6 software (Intelligent Imaging 
Innovations). The objectives used were a 20x/0.8 Plan-Apochromat (Zeiss) and 40x/1.1 W LD C-
Apochromat (Zeiss), and images were acquired using an Orca Flash4 sCMOS camera 
(Hamamatsu Photonics). The 2D gradient hydrogels with cells were imaged using Nikon Eclipse 
Ti2-E widefield microscope, controlled by NIS-Elements AR 5.11 software (Nikon). The objective 
used was a 10x/0.3 CFI Plan-Fluor objective (Nikon), and images were acquired using an Orca 
Flash4 sCMOS camera (Hamamatsu Photonics) and 2x2 binning. 
Live phase contrast imaging of U-251MG cells on photoresponsive hydrogels was done using a 
Nikon Eclipse Ti-E microscope and an Andor Zyla 5.5 sCMOS camera (Andor Technology). The 
objective was a Plan Fluor 10x/0.30NA objective (Nikon) and samples were maintained in a Bold 




Traction force microscopy 
To measure the tractions exerted by MDA-MB-231 cells on their substrate, polyacrylamide 
hydrogels of varying stiffness (fibronectin-functionalized and supplemented with fluorescent 
microbeads) were manufactured on glass-bottom dishes as described above. Cells were seeded 
on the gels (5,000 cells/plate) approximately 24 hours after transfection with the indicated siRNAs, 
and grown for another 48 hours before the experiment was conducted. For imaging the cells and 
beads, a Marianas spinning disk confocal microscope with a stage top incubator unit (+37 °C/5% 
CO2) was used. Brightfield images of single cells and fluorescence z-stacks of the beads embedded 
in the hydrogel were captured before and after cell detachment by addition of 2% sodium dodecyl 
sulfate. 
The resulting data were analyzed using a previously described implementation of Fourier transform 
traction cytometry . First, displacement fields were calculated using high-resolution subsampling 
and assuming no outward deformation of the substrate. Optimal L2-regularization was performed 
on sets of images acquired from soft and stiff gels to determine the final regularization parameter 
λ = 5 x 10-6, which was then used for calculating all the subsequent traction fields. The background, 
or noise, of the measurements was estimated by analyzing five empty (i.e. no cells) fields of view 
per substrate stiffness. 
Finite element analysis 
To estimate the effective spring constant around the interface of a stepwise stiffness gradient, a 
finite element model using COMSOL Multiphysics (COMSOL, Inc., Burlington, MA) multibody 
dynamics module was utilized. Two three-dimensional blocks (120 µm x 60 µm x 20 µm) were 
created and interfaced at (x = 0). Linear elastic material properties were prescribed to both blocks 
with Poisson's ratio = 0.4, density = 1000 kg/m3 and Young’s modulus = 1 kPa and 10 kPa. A lateral 
0.5 nN force was applied on a circular (1 µm radius) surface contact (Figure S4.5a). Fixed boundary 
conditions were applied to all surfaces except the top surface. The displacement field due to applied 
loads was computed on a model created using built-in automatic meshing routines (extra-fine 
mechanics-based mesh). These data were used to calculate effective spring constant at the contact 
zone (  = applied force/average displacement under the circular contact area). The location of 
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the circular contact and direction of the force were varied, and effective spring constants were 
calculated accordingly (Figure S4.5b). 
 
Computational modeling of single-cell migration and growth cone steering on stiffness 
gradients 
A previously described263 C++ version of the stochastic cell migration simulator (CMS) was modified 
to account for spatial variations in substrate stiffness. The detailed algorithms and equations 
governing the base CMS have been described in full in230. Briefly, the CMS uses the Gillespie 
Stochastic Simulation Algorithm274 to simulate an entire cell by connecting several motor-clutch 
modules to a central cell body and then balancing forces at the center (Fig. 4.3a). Here, the cells 
were simulated for 60 min to allow them to reach a dynamic steady state, after which each cell was 
displaced randomly to a 180 µm x 180 µm region on a substrate with repeating soft and stiff areas 
and connecting stiffness gradients (Fig. 4.3b). Cell positions and traction forces were recorded 
every second and used to calculate RMC and mean traction force per module. Custom Matlab code 
was used to quantify module forces on soft and stiff substrates, and to track the displacement of 
individual cells, from gradients or soft regions, over time. All the CMS simulations were conducted 
at the Minnesota Supercomputing Institute (MSI). For additional details on the cellular level model 
and its implementation, see Supplementary Text 2. 
The CMS was further modified to investigate filopodial and GC dynamics on substrate stiffness 
gradients. The filopodia were represented by individual CMS modules that were arranged around 
an initially semicircular GC. Each filopodia was allocated a set number of molecular clutches – the 
corresponding substrate clutches were distributed randomly and their spring constants varied 
linearly with position along the gradient. The details of the GC model and corresponding simulations 
are presented in Supplementary Text 3. 
 
Image analysis 
Images were analyzed using ImageJ (National Institutes of Health) and CellProfiler v2.2.0 (Broad 
Institute) software. For analysis of YAP nuclear localization, a custom CellProfiler pipeline was used 
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to segment the cells into nuclei (corresponding to the nuclear counterstain) and cytoplasm (a region 
of max. 4 µm around the nucleus, excluding parts outside the cell). The mean gray value in the 
nucleus was divided by the corresponding value in the cytoplasm. For analysis of vinculin-positive 
adhesions in MDA-MB-231s, a semi-automatic ImageJ script was used: an individual confocal 
plane from the basal side of the cell was subjected to background removal (rolling ball) and 
thresholding to exclude cytoplasmic signal and peripheral ruffles. The number and sizes of the 
remaining adhesions were recorded. 
 
Statistical analysis 
Statistical analyses and plotting were performed using GraphPad Prism v6.05 (GraphPad) and R 
v3.5.1 (R Core Team). Confidence intervals for means were calculated using bias-corrected and 
accelerated (BCa) bootstrap intervals from 10,000 resamples. Confidence intervals for binomial 
data were calculated using Wilson score interval. Whenever data were deemed to follow a non-
normal distribution (according to Shapiro-Wilk normality test), analyses were conducted using non-
parametric methods. The names and/or numbers of individual statistical tests, samples and data 
points are indicated in figure legends. Unless otherwise noted, all results are representative of three 







Figure S4.1 Mechanosensitivity of U-251MG proliferation and clustering on stepwise stiffness 
gradients. (a‒b) Fluorescence images (a) and quantification (b) depicting EdU incorporation by U-
251MG cells on 0.5‒60 kPa substrates. Scale bar, 20 µm. Mean values from three independent 
experiments. Analyzed by one-way ANOVA and Sidak’s post hoc test. (c‒d) Total number of cells 
in the different gradient regions in (Fig. 4.1e and g). (c) Bar graph, n = 952‒3,167 cells per time 




Figure S4.2 Synthesis and photochemistry of o-nitrobenzyl bis-acrylate. (a) Schematic of the 
synthesis of o-NBbA. (b) Copolymerization of o-NBbA with acrylamide and bis-acrylamide yields 
hydrogels composed of strands of polyacrylamide crosslinked by either o-NBbA or bis-acrylamide. 
UV irradiation cleaves the photolabile o-NBbA, resulting in gels with lower crosslinking density and 




Figure S4.3 Preparation and characterization of photoresponsive hydrogels. (a) Schematic 
representation of stiffness gradient preparation for migration experiments. The photocleavable 
carbon-oxygen bond in o-NBbA is indicated by red color. (b‒d) Stiffness characterization by bead 
indentation. A schematic representation of the technique (b), representative fluorescence images 
(c) and quantified results (d) from the experiment, depicting hydrogel elasticity as a function of UV 





Figure S4.4 Focal adhesion maturation and adhesion components in U-251MG and other cancer 
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cells. (a) Immunofluorescence images of paxillin and F-actin in MDA-MB-231 cells on 0.5‒60 kPa 
substrates. The bottom panels show individual focal planes from confocal stacks, corresponding to 
the basal side of each cell. Scale bar, 20 µm. (b) Immunofluorescence images of vinculin (top), p-
FAK (bottom) and F-actin in U-251MG cells on 0.5 and 60 kPa substrates. The bottom panels show 
individual focal planes from confocal stacks, corresponding to the basal side of each cell. (c‒d) 
Representative western blots (c) and quantification (d) depicting talin-1/2, vinculin and p-MLC2 
levels across three different cell lines. Densitometric measurements were normalized to vimentin, 
mean ± SD of 2‒3 independent experiments. (e‒f) Immunofluorescence images (e) and 
quantification (f) showing active β1-integrin (clone 12G10) in U-251MGs on 0.5 and 60 kPa 
substrates. The cells were treated with a control antibody (normal rat IgG) or β1 function-blocking 
Mab13 for two hours before fixation. Mean ± SD of n = 27‒45 cells, analyzed by Kruskal-Wallis 
one-way ANOVA and Dunn’s post hoc test. Representative of two independent experiments. (g) 
Spreading of U-251MGs on 0.5 and 60 kPa substrates, without or after β1-integrin blocking by 
Mab13. Mean ± SD of n = 27‒45 cells, analyzed by Kruskal-Wallis one-way ANOVA and Dunn’s 




Figure S4.5 Finite element analysis of polyacrylamide displacement next to a stepwise elastic 
gradient. (a) COMSOL Multiphysics® model setup (b) The effect of steep elastic gradients on the 
effective spring constant of polyacrylamide. A lateral 0.5 nN force was exerted on the substrate 
through a circular adhesion zone ( = 1 µm) as shown in (a). The position of the adhesion zone 
was adjusted repeatedly at 2 µm steps. The direction of the force was varied by 180° but was 
always parallel to the gradient. In both cases, normal cumulative distribution function was a good 




Figure S4.6 Modifying the range of the gradient can reverse durotaxis in silico. (a‒b) Module 
traction forces (a) and RMC (b) of the simulated cells as a function of substrate stiffness, as in (Fig. 
4.3c-d). Red overlays highlight the ranges of the 0.3‒3 pN nm-1 and 100‒300 pN nm-1 gradients in 
(c‒d). Mean ± SEM of n = 10 cells. (c‒d) Evolution of cell density on mechanically heterogeneous 
substrates over time. (c) Coordinates of individual cells on the 0.3‒3 pN nm-1 gradient 0, 4 and 16 
hours into the simulation (left) and the fraction of cells residing in the stiffer and softer areas over 
the course of the simulation (right). ±95% CI, n = 588 cells. (d) As above, but for the 100‒300 pN 






Figure S4.7 Motor-clutch model of filopodial dynamics. (a) Schematic representation of a neuronal 
GC. Filopodia, surrounded by a less polarized actin network, reside in the peripheral domain. They 
are separated from the axon by a thin transitional domain, and a central domain (light blue) that is 
primarily composed of microtubules. (b) The filopodia in GCs are modeled as individual motor-
clutch modules, with adhesion springs (homogeneous stiffness), substrate springs (heterogeneous 
stiffness) and inward actin flow resulting from active myosin motors. Actin monomers are added 
into the filaments at a constant rate. (c) Setup used in the single-filopodium simulations. The 
filopodium interacts with the substrate in a set orientation relative to the linear stiffness gradient. (d) 
(Left) Traction force exerted by the filopodium increases when the protrusion is pointing down the 
gradient, toward softer substrate. (Right) Perpendicular to the gradient, traction increases with 
filopodia length mainly due to more clutches being available to bind with the substrate. Data shown 
are from n = 10 independent simulations. (e) Average traction exerted by a single filopodium on 
different substrate stiffness gradients. Data represent means of n = 10 simulations. (f) Filopodia 
length is affected by both actin flow,  , and the polymerization rate,  . Depending on the 
orientation of the filopodium, the actin may flow toward soft (filopodium pointing up the gradient) or 
stiff (filopodium pointing down the gradient) substrate. (g) Evolution of filopodia length on stiffness 
gradients upon different actin polymerization rates. The different combinations of  and filopodia 
orientation are color-coded, while each line represents the temporal variation in the length of a 
single filopodium. (h) Effect of actin polymerization and orientation relative to a stiffness gradient 






Figure S4.8 Motor-clutch model predicts growth cone steering toward soft matrix. (a) Schematic 
representation of the GC model. (Left) Dimensions of a newly initialized GC. (Right) Each GC 
consists of multiple filopodia, distributed between –π/2 and π/2 relative to the axon. On stiffness 
gradients (, = 0.01 pN nm-1, , = 100 pN nm-1), filopodia on the more compliant side of the 
substrate rapidly outgrow the others, leading to effective turning of the GC. (b) Filopodia length (top) 
and traction (bottom) based on their orientation around the GC central domain. On stiffness 
gradients, filopodia pointing toward the softer substrate elongate faster and generate more traction. 
Data shown are from n = 10 independent simulations. (c) Examples of GC behavior on different 
stiffness gradients. Green denotes filopodia that are retracting during the course of the simulation, 
red denotes filopodia that are elongating. Depending on the gradient, individual GCs may retract 
or enlarge isotropically, or steer toward the softer substrate. Displayed are means of n = 10 
simulations. (d) Phase diagram of GC turning to left, , on different mechanically graded substrates. 
(e) Phase diagram depicting the strength of the stiffness gradient for varying ,  and , . 
Gradient strength alone cannot explain the magnitude of , if the whole substrate is stiffer than the 




Figure S4.9 Mechanosensitive traction and proliferation of MDA-MB-231 cells. (a) Representative 
traction maps from MDA-MB-231 cells on 0.5‒22 kPa substrates, corresponding to the data in (Fig. 
4.4f). Cell outlines are indicated by white dashed lines. Scale bar, 20 µm.  (b‒c) Fluorescence 
images (a) and quantification (b) depicting EdU incorporation by control and talin-low MDA-MB-231 
cells on 0.5‒60 kPa substrates. Scale bar, 50 µm. Mean values from one to three independent 




Figure S4.10 Schematic representation of the regulation of positive and negative durotaxis by 
motor-clutch dynamics. Cell-intrinsic molecular machinery dictates the cell’s capacity to exert force 
on mechanically heterogeneous substrates, driving positive or negative durotaxis. Without clutch 
reinforcement (mechanosensitive FA formation, D), the motor-clutch model predicts a biphasic 
relationship between traction force and substrate stiffness (A‒C)17,18,25–29. This fundamental 
relationship, and the physical reinforcement of cell-matrix adhesion by FAs, are likely to be further 
influenced by biochemical signaling pathways and feedback loops that modulate the expression, 





Figure S4.11 Creasing of the photoresponsive gel surface in various solvent conditions. The 
degree of creasing of the gel immersed in 1x PBS reduces when the solvent is exchanged to 10x 











Figure S4.13 Density of the microprinted fibronectin in the UV-irradiated and non-irradiated regions 
of the photoresponsive gel. Immunofluorescence detection of the fibronectin density by 
fluorescence microscopy indicated that photocleavage of the gel does not result in changes in 




Supplementary Text 1: Chemistry of o-NBbA and photoresponsive polyacrylamide 
hydrogels 
Polyacrylamide was selected as the base material for the stiffness gradients used in this study, as 
it is the most widely employed model system for investigating the role of substrate stiffness in 
directing cell behavior. This is partly due to the ease of obtaining elastic moduli in a wide, 
physiologically relevant range49,50. While other types of gels (e.g. collagen or hyaluronic acid) are 
known to interact directly with cell surface receptors, including integrins, polyacrylamide gels are 
inert to such interactions. This allows more control over the types and densities of ligands that will 
be presented to the cells, making the material ideal for mechanobiological studies. Various methods 
have been developed to fabricate stiffness gradients in gels to study the durotactic behavior of cells. 
Some examples exploit the diffusion of two prepolymer solutions12,30, tilted-superposition of two 
hydrogels51, freeze-thaw-induced crosslinking of polyvinyl alcohol52, or toehold-mediated strand 
displacement of DNA53. Aiming for high-resolution spatiotemporal control over the mechanical 
properties of the gel, we chose light as the external stimulus54–58. Therefore, we aimed to design 
and synthesize a new, minimalistic and photocleavable crosslinker that contains acrylate moieties. 
Among various photolabile functionalities that are available, o-nitrobenzyl (o-NB) was chosen due 
to its high one-photon photolysis efficiency and high deprotection yields59,60. o-NB based 
compounds have been used widely in hydrogel-based studies to achieve controlled release or 
immobilization of payloads61–65, photodegradation of gels66–68, or modulation of gel stiffness56,69. 
However, many of these studies have focused on polyethylene glycol-based gels rather than 
polyacrylamide, or complete degradation of the gel rather than controlling the Young’s modulus. To 
our knowledge, there has been only one report to date where o-NB-based crosslinkers have been 
used to fabricate photoresponsive polyacrylamide hydrogels70. While the study demonstrates the 
feasibility of o-NB based crosslinking, the method itself requires multiple steps to crosslink chains 
of polyacrylamide through the o-NB moiety, which made its application here unwieldy. 
In this study, a simple one-step synthesis of photoresponsive polyacrylamide gels was enabled by 
the functionalization of an o-NB group with two acrylate moieties to yield a crosslinker that would 
cleave upon photolysis. The photocleavable crosslinker, o-nitrobenzyl bis-acrylate (o-NBbA), was 
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synthesized in seven steps from p-ethyl aniline (Fig. S4.2a) and designed so that its cleavage would 
not release any byproducts in the medium (Fig. S4.2b). Based on a previously reported 
polyacrylamide recipe44, a photoresponsive gel with an initial stiffness of 20 kPa that can be 
reduced down to 10 kPa was designed by replacing 50 mol % of bis-acrylamide with o-NBbA. The 
resulting gel exhibited a Young’s modulus of ~15 kPa that was reduced down to ~8 kPa after 
complete cleavage of the o-NBbA crosslinker by exposure to 395 nm light for 5 min (Fig. S4.3b‒d). 
The slight discrepancy between the expected and measured substrate stiffness could be due to 
the relatively low water solubility and partial phase separation of o-NBbA in the prepolymer solution, 
which would result in softening of the hydrogel post-polymerization71. 
The light source used for the photocleavage was an LED from a SpectraX light engine instrument 
installed in a Nikon TiE microscope, originally intended for epifluorescence imaging. This method 
had several advantages: spatial control can be achieved easily, as the location of the substrate can 
be precisely chosen via phase-contrast imaging and the area of irradiation can be controlled with 
the field diaphragm and objectives. For instance, the diameter of the LED-irradiated area could be 
adjusted to as low as 59 µm using a 40x objective with a nearly closed field diaphragm, or as high 
as 978 µm under a 10x objective with a fully opened field diaphragm. Stiffness patterns could also 
be created using the ‘time lapse movie’ function of the NIS-Elements software (Nikon). Here, 
alternating stiffness gradients were created by initiating a time-lapse movie between two regions of 
the gel, a method that could be modified to yield more complex 1D patterns or even 2D shapes. 
Although not explored here, temporal control would be equally possible: for example, stiffness 
gradients could be introduced in gels at various time points during live cell culture, while 
simultaneously observing cellular behavior and responses. 
To conjugate fibronectin to the surface of the gel via covalent interaction, acrylic acid N-
hydroxysuccinimide (NHS) ester was used as the tethering agent. While two methods, addition of 
acrylic acid NHS ester in the pregel solution followed by stamping of fibronectin, or stamping of the 
pregel solution with fibronectin preincubated with acrylic acid NHS ester, both produced fibronectin-
patterned hydrogels, the former was chosen since it yielded more consistent results. Once the gel 
had been fabricated, any remaining NHS ester moieties in the gel were passivated with bovine 
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serum albumin (BSA) in PBS to prevent any non-specific interactions between the gel and cells. 
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Supplementary Text 2: Implementation of the cell migration simulator using mechanically 
heterogeneous substrates 
To establish whether our observations of negative (and positive) durotaxis could be explained 
through a single set of principles, namely the motor-clutch dynamics of cell-matrix adhesions, we 
developed a modified version of the cell migration simulator (CMS) that can be used for modeling 
cell migration on mechanically heterogeneous substrates. The detailed governing equations and 
algorithms of the original CMS were described previously28. Briefly, the CMS comprises multiple 
motor-clutch models (i.e. modules) that mimic cellular protrusions, and determines cell motion by 
a force balance between the modules and a central cell body (Fig. 4.3a). In the CMS, new modules 
are nucleated stochastically, module length increases over time via actin polymerization that is 
simultaneously counteracted by myosin-induced retraction of actin fibers, and modules are 
removed when they become too short. In addition, total actin and numbers of clutches and motors 
are kept constant in accordance with the conservation of mass. 
In each motor-clutch system, adhesion clutches bind to elastic substrate springs with a constant 
rate of . Connected clutches form a direct mechanical link from the intracellular cytoskeleton to 
the extracellular substrate – forces are borne from active myosin motors and transmitted by the 
resulting inward actin flow. The unbinding rate of a connected clutch , ,, varies with force  
according to the Bell model72: 
, = ∗ !"#
/% 
 = &" 
(S1) 
where ∗  is the clutch unbinding rate in the absence of loading, % is the characteristic clutch 
rupture force, and " is the elongation of the spring representing the '( connected clutch with a 
spring constant &. The actin filaments are pulled by ) myosin motors, each capable of exerting 
a force , and balanced by the traction force , resulting in inward actin flow with the effective 
actin flow rate () based on 
 = ∗ *1 − '+,,- (S2) 
where ∗  is the unloaded rate, '+,, = ) is the stall force of the ensemble of myosin motors, 
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and the traction force  transmitted by all the connected clutches is given by: 




in which )&, is the number of connected clutch bonds. Actin monomers are added to the barbed 
ends of actin filaments in the cellular protrusions (modules) at a polymerization rate , constrained 
by the total actin length 3'' in the cell according to the relation: 
 = ∗435/3''6 (S4) 
where 35  is the amount of available G-actin and ∗  is the maximum polymerization rate. 
Module elongation and retraction both result from this actin polymerization and the actin flow rate 
(). New modules are nucleated at a nucleation rate 7, also constrained by actin availability: 
7 = 7∗ 435/3''6 (S5) 
where 7∗  is the maximum module nucleation rate. Actin filaments are depolymerized into actin 
monomers when they pass through the position of the myosin motors. Filaments can also be 
capped and polymerization arrested by actin capping proteins at a capping rate &+ . Actin 
filaments, and the corresponding modules, are removed from the simulation when their length falls 
below 9. 
Monte Carlo simulations were conducted using a direct Gillespie Stochastic Simulation Algorithm48, 
with each time step determined based on total event rates, including , ,, 7, and &+, 
and the event execution determined based on accumulated event rates. The CMS C++ version, 
described in37, was modified to account for variations in substrate stiffness (described below), and 
simulations were conducted in Mesabi computer cluster at the Minnesota Supercomputing Institute 
(MSI).  
After the simulated cells had reached a dynamic steady state (60 min), they were displaced 
randomly to a 180 µm x 180 µm region (Fig. 4.3b), and the substrate stiffnesses () experienced 
by the cell body and each protrusion were determined based on their respective y-coordinates (:). 
The substrate could be either soft (soft ), stiff (stiff ), or between the two extremes [gradients 
following a normal cumulative distribution function, described by the following error functions (erf)]: 
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s = soft 105 < :mod180 ≤ 165  (S6) 
s = soft + 12 41 + erf
:mod180/70716
stiff − soft −15 < :mod180 ≤ 15  (S7) 
s = stiff 15 < :mod180 ≤ 75 (S8) 
s = stiff + 12 C1 + erf4
:mod180 − 90/70716E 
soft − stiff 75 < :mod180 ≤ 105 (S9) 
where :mod180 = 
: mod 180/:F with 
: mod 180 representing the remainder of : divided by 
180 µm (ranging from -15 to 165) and  :F = 1 µm. This way, the number of cells in both soft and 
stiff regions was initially the same. In addition, by repeating the same stiffness pattern ad infinitum, 
the finite amount of cells placed in the finite rectangular region was representative of infinite cells 
placed on an infinite substrate with the same initial distribution of cells between soft and stiff areas. 
A normal cumulative distribution function was selected due to a finite element model of 
polyacrylamide, which demonstrated that the effective spring constant around a stepwise gradient 
of elastic modulus follows a similar distribution (Fig. S4.5). This was true regardless of the 
orientation of the applied traction (soft-to-stiff vs. stiff-to-soft). 
Here, we adopted the high-motor-clutch parameter values used previously28 to describe U-251MG 
migration on mechanically distinct but isotropic substrates (Table S2). Clutch stiffness was further 
adjusted to 8 pN nm-1 to better recapitulate the stiffness-dependence of U-251MG speed in vitro28. 
During the CMS simulations, cell positions and traction forces were recorded every second. The 
data collected during the first 60 min were analyzed to ensure that the simulated cells had indeed 
reached a dynamic steady state. Random motility coefficients (RMC) were calculated as described 
previously28. Briefly, the mean squared displacement, 〈〉, was calculated with overlapping time 
periods ∆J = 10 min, 20 min, ..., and plotted as a function of ∆J. The first half of the plotted curve 
was fitted with a straight line (slope = 〈〉/∆J), and RMC was given by RMC = 〈〉/4∆J. Module 
forces were recorded every 10 min and averaged throughout the simulation to yield the average 
traction force per module. Custom Matlab scripts were employed to analyze the change in cell 
numbers in soft and stiff regions over time, to compare module forces in the soft and stiff parts of 




On 10‒100 pN nm-1 gradients, we found that the majority of cells translocated away from stiffer 
regions and toward soft areas (Fig. 4.3e‒f), which were associated with higher traction forces per 
module and lower overall migration speed, RMC (Fig. 4.3c‒d). We also tested whether altering the 
range of the gradient would affect the durotaxis. On 0.3‒3 pN nm-1 gradients, the stiffer side was 
associated with higher traction forces and higher RMC (Fig. S4.6a‒b). On these substrates, 
simulated cells displayed rapid accumulation in the stiffer regions (Fig. S4.6c). Finally, when the 
gradient was chosen such that there would be no appreciable difference in mean traction forces 
(100‒300 pN nm-1), cells clustered primarily in stiffer regions with lower RMC (Fig. S4.6a‒b,d). 
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Supplementary Text 3: Modeling axonal pathfinding and mechanosensitive steering of 
growth cones 
Axonal growth cones (GCs) (Fig. S4.7a) can turn or contract in response to substrate stiffness 
gradients23,73 by controlling the dynamics of adhesions, filopodial remodeling, and active 
contraction38. To establish whether motor-clutch dynamics could explain the mechanosensitive 
turning of neuronal GCs23, akin to the negative durotaxis exhibited by the U-251MG glioblastoma 
cells, we modified the CMS to model an individual GC on a functionally graded substrate. A group 
of  filopodia, each modeled as a single molecular clutch module (Fig. 4.7b), were attached to a 
GC central domain. Each module was allocated ) molecular clutches (linear springs of stiffness 
&) and ) corresponding substrate clutches (linear springs of stiffness ,). Substrate clutches 
were distributed randomly, and had values , ≤ , ≤ , that varied linearly with position along 
the gradient. 
Monte Carlo simulations were conducted to evaluate filopodial and GC dynamics over time. We 
modeled a GC as having 21 potential growth sites for filopodia, chosen from a uniform orientation 
distribution between –π/2 and π/2, relative to the direction of the ‘axon’. New protrusions with an 
initial length 9 and width 9K7, dictating the effective clutch-ligand binding area, were added into 
the simulation at a rate 7 and assigned ) myosin motors; note that we used an actin filament 
in the schematic diagram (Fig. S4.8a) to represent the filament bundle in the filopodium. The 
adhesion and substrate clutches under each filament then evolved according to the clutch binding 
and unbinding dynamics described above. Unlike the cellular level CMS, our modified model 
assumes a relatively stable pool of actin monomer in the GC. Thus, the actin polymerization rate 
  remained constant during each simulation. See Table S3 for parameter details. 
First, we investigated whether the dozens of filopodia within a GC might enable mechanically 
directed growth by evaluating the response of an individual 8 µm filopodium to a linear stiffness 
gradient of 0.01 to 100 pN nm-1 (Fig. S4.7b). The filopodium was placed on a 10 µm x 10 µm square 
substrate and oriented at an angle 0 ≤ θ ≤ π/2 relative to the gradient (Fig. S4.7c). When the 
filopodium length was fixed, simply increasing the orientation between the filopodium and the 
gradient was sufficient to significantly increase traction force generation (Fig. S4.7d). Conversely, 
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when the orientation was fixed at π/2, i.e. perpendicular to the gradient, we found that both traction 
force and the number of engaged clutches increased linearly with filopodium length (Fig. S4.7d). 
Next, we investigated the impact of different stiffness gradients for traction force generation using 
a fixed filopodium length (8 μm) and orientation (0). Maximal traction forces resulted from the 
filopodium sensing a soft region, in the range of 0.01 to 0.1 pN nm-1. The higher end of the stiffness 
gradient proved significantly less important for the overall traction (Fig. S4.7e). This result 
demonstrates that a filopodium can generate comparatively high forces even if only a part of it is 
located on softer substrate. Thus, high traction force generation by individual filopodia is favored at 
a low optimal stiffness and forces drastically drop on stiffer matrices. 
Higher traction forces are often accompanied by a decrease in actin retrograde flow, as myosin-
borne forces are transmitted to the ECM instead of freely displacing actin. Regardless of filopodia 
orientation, actin in GCs flows toward the structure’s center, and much like traction forces, actin 
flow rates can also differ for different types of neurons39. We therefore investigated how both the 
speed and direction of actin flow relative to the stiffness gradient affect the dynamics of single 
filopodia. By studying filopodia oriented at their growing end with either the stiffer or more compliant 
end of a stiffness gradient (Fig. S4.7f), we found that orientation toward the compliant end of the 
substrate (and hence actin retrograde flow toward the stiff end of the substrate) led to increased 
extension rates and decreased retraction rates (Fig. S4.7g). In all cases, the overall growth rate of 
filopodia was a trade-off between growth at the constant actin polymerization rate  , and 
shortening at the actin flow rate  , which varied almost linearly with substrate stiffness (Fig. 
S4.7h). For an intermediate polymerization rate of  = 120 nm s-1, orientation affected filopodia 
growth rate by a factor of two (Fig. S4.7h). Together, these results provide a mechanism by which 
individual filopodia can exert more traction and elongate faster on softer substrates. 
We then investigated whether these changes in filopodial dynamics could contribute to GC steering 
on stiffness gradients. First, we evaluated the degree of GC turning on one type of stiffness gradient 
(,  = 0.01 pN nm-1 and ,  = 100 pN nm-1) by studying an initially semicircular GC with 21 
uniformly distributed filopodia (Fig. S4.8a). Within 15 seconds of simulation, the filopodia pointing 
toward the compliant end of the substrate outgrew the rest, resulting in an effective turning of the 
 
 173
GC (Fig. S4.8a). As expected from the previous results, filopodia in the softer regions of the gradient 
were longer and generated higher traction forces (Fig. S4.8b). 
To investigate the effect of different stiffness gradients on GC turning in detail, we repeated our 
simulations over a broad range of possible substrate stiffnesses, with ,,' and ,5L(' varying 
from 0.01 to 100 pN nm-1. To quantify the degree of turning, we defined a parameter  = 9,̅'/95̅L(', 
which represents the degree to which the GC has turned left. Here, 9,̅' and 95̅L(' are the average 
lengths of filopodia in the left-hand and right-hand sides of the GC after 100 seconds of simulation, 
respectively. In addition to developing polarity through turning, the GC could enlarge, with all 
filopodia elongating as compared to their initial length, or retract (Fig. S4.8c). Enlarged GCs 
appeared on very compliant substrates (red section, ,,' and ,5L(' on the order of 0.01 to 0.1 
pN nm-1) with a negligible stiffness gradient, and retractile GCs appeared on higher stiffnesses, 
independent of the actual strength of the gradient (green section, ,,' and ,5L(' on the order 
of 1 to 100 pN nm-1). Finally, polarized GCs appeared on compliant substrates with a moderate or 
high stiffness gradient (,,' on the order of 0.01 to 0.1 pN nm-1, >1 pN/nm/20 μm). A phase 
diagram for GC turning illustrates how the structure can either remain straight or turn to the more 
compliant side (Fig. S4.8d), and reveals that a stronger gradient may also promote GC turning, 
unless the range of the gradient as a whole is significantly stiffer than the optimal stiffness range 
for individual filopodia (Fig. S4.8e). Thus, the motor-clutch model can recapitulate 
mechanosensitive GC steering toward softer matrix in silico.  
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Table S4.1 Relative acrylamide and bis-acrylamide concentrations and corresponding Young’s 














5.4 0.04 63 10 397 0.5 
5.7 0.08 63 17.5 365 2 
7.5 0.2 94 50 356 9.6 
12 0.2 150 50 300 22 
18 0.4 225 100 175 60 
*Values obtained using atomic force microscopy, see reference30. 
 
Table S4.2 Parameters for the cellular level CMS 
Parameter Symbol Value Ref. 
Total number of myosin motors N 10,000 28 
Total number of clutches N& 7,500 28 
Maximum total actin length 3'' 100 µm 28 
Maximum actin polymerization rate ∗ 200 nm/s 28 
Maximum module nucleation rate 7∗  1 s–1 28 
Module capping rate &+ 0.001 s–1 28 
Initial module length 9 5 µm 28 
Minimum module length 9 0.1 µm 28 
Cell spring constant &,, 10,000 pN/nm 28 
Number of cell body clutches )&,&,, 10 28 
Substrate spring constant  0.3‒300 pN/nm Adjusted 
Maximum number of module motors )∗  1,000 28 
Myosin motor stall force  2 pN 28 
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Unloaded actin flow rate ∗  120 nm/s 28 
Maximum number of module clutches )&∗ 750 28 
Clutch on-rate  1 s–1 28 
Unloaded clutch off-rate ∗  0.1 s–1 28 
Clutch spring constant & 8 pN/nm Adjusted 
Characteristic clutch rupture force % 2 pN 28 
 
Table S4.3 Parameters for the filopodia/GC model 
Parameter Symbol Value Ref. 
Actin polymerization rate  90‒130 nm/s 74, adjusted 
Module nucleation rate 7 1 s–1 28 
Initial filopodium length 9 3 μm Adapted from 28 
Minimum filopodium length  9 0.1 μm Adapted from 28 
Filopodium width for ligand binding 9K7  0.2 μm 75 
Substrate spring constant (soft region)  , 10-2‒102 pN/nm Adjusted 
Substrate spring constant (stiff region) , 10-2‒102 pN/nm Adjusted 
Initial number of module motors ) 50 26 
Myosin motor stall force  2 pN 26 
Unloaded actin flow rate ∗  120 nm/s 26 
Initial number of module clutches )& 50 26 
Clutch on-rate  0.3 s–1 26 
Unloaded clutch off-rate ∗  0.1 s–1 26 
Clutch spring constant & 1 pN/nm 26 
Characteristic clutch rupture force % 2 pN 26 
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Captions for Movies S1‒S2 
Movie S1. Evolution of U-251MG glioblastoma cell distribution on stiffness gradient 
hydrogels over time. Blue overlay in the middle denotes a softer, UV-irradiated region. Vertical 
and horizontal lines are out-of-focus markings in the underlying glass. Scale bar, 200 µm.  
Movie S2. Migration of individual U-251MG cells on stiffness gradient hydrogels. (Top) 
Phase-contrast data showing migrating cells over the span of 24 hours. Scale bar, 100 µm. 
(Bottom) Tracks corresponding to the cells in the top panel. Softer, UV-irradiated hydrogel is 






(1)  Hentschel, A.; Zahedi, R. P.; Ahrends, R. Protein Lipid Modifications—More than Just a 
Greasy Ballast. PROTEOMICS 2016, 16 (5), 759–782. 
https://doi.org/10.1002/pmic.201500353. 
(2)  Wang, M.; Casey, P. J. Protein Prenylation: Unique Fats Make Their Mark on Biology. Nat. 
Rev. Mol. Cell Biol. 2016, 17 (2), 110–122. https://doi.org/10.1038/nrm.2015.11. 
(3)  Jiang, H.; Zhang, X.; Chen, X.; Aramsangtienchai, P.; Tong, Z.; Lin, H. Protein Lipidation: 
Occurrence, Mechanisms, Biological Functions, and Enabling Technologies. Chem. Rev. 
2018, 118 (3), 919–988. https://doi.org/10.1021/acs.chemrev.6b00750. 
(4)  Resh, M. D. Fatty Acylation of Proteins: The Long and the Short of It. Prog. Lipid Res. 2016, 
63, 120–131. https://doi.org/10.1016/j.plipres.2016.05.002. 
(5)  Ciepla, P.; Magee, A. I.; Tate, E. W. Cholesterylation: A Tail of Hedgehog. Biochem. Soc. 
Trans. 2015, 43 (2), 262–267. https://doi.org/10.1042/BST20150032. 
(6)  Running, M. The Role of Lipid Post–Translational Modification in Plant Developmental 
Processes. Front. Plant Sci. 2014, 5, 50. https://doi.org/10.3389/fpls.2014.00050. 
(7)  Resh, M. D. Covalent Lipid Modifications of Proteins. Curr. Biol. CB 2013, 23 (10), R431–
R435. https://doi.org/10.1016/j.cub.2013.04.024. 
(8)  Chen, B.; Sun, Y.; Niu, J.; Jarugumilli, G. K.; Wu, X. Protein Lipidation in Cell Signaling and 
Diseases: Function, Regulation, and Therapeutic Opportunities. Cell Chem. Biol. 2018, 
25 (7), 817–831. https://doi.org/10.1016/j.chembiol.2018.05.003. 
(9)  Ganesan, L.; Levental, I. Pharmacological Inhibition of Protein Lipidation. J. Membr. Biol. 
2015, 248 (6), 929–941. https://doi.org/10.1007/s00232-015-9835-4. 
(10)  Fraser, N. J.; Howie, J.; Wypijewski, K. J.; Fuller, W. Therapeutic Targeting of Protein S-
Acylation for the Treatment of Disease. Biochem. Soc. Trans. 2019, 48 (1), 281–290. 
https://doi.org/10.1042/BST20190707. 
(11)  Palsuledesai, C. C.; Distefano, M. D. Protein Prenylation: Enzymes, Therapeutics, and 
Biotechnology Applications. ACS Chem. Biol. 2015, 10 (1), 51–62. 
https://doi.org/10.1021/cb500791f. 
(12)  Rashidian, M.; Dozier, J. K.; Distefano, M. D. Enzymatic Labeling of Proteins: Techniques 
and Approaches. Bioconjug. Chem. 2013, 24 (8), 1277–1294. 
https://doi.org/10.1021/bc400102w. 
(13)  Zhang, Y.; Park, K.-Y.; Suazo, K. F.; Distefano, M. D. Recent Progress in Enzymatic Protein 
Labelling Techniques and Their Applications. Chem. Soc. Rev. 2018, 47 (24), 9106–
9136. https://doi.org/10.1039/C8CS00537K. 
(14)  Tate, E. W.; Kalesh, K. A.; Lanyon-Hogg, T.; Storck, E. M.; Thinon, E. Global Profiling of 
Protein Lipidation Using Chemical Proteomic Technologies. Curr. Opin. Chem. Biol. 
2015, 24, 48–57. 
(15)  Gao, X.; Hannoush, R. N. A Decade of Click Chemistry in Protein Palmitoylation: Impact on 
Discovery and New Biology. Cell Chem. Biol. 2018, 25 (3), 236–246. 
https://doi.org/10.1016/j.chembiol.2017.12.002. 
(16)  Wang, Y.-C.; Distefano, M. D. Synthetic Isoprenoid Analogues for the Study of Prenylated 
Proteins: Fluorescent Imaging and Proteomic Applications. Bioorganic Chem. 2016, 64 
(Supplement C), 59–65. https://doi.org/10.1016/j.bioorg.2015.12.003. 
(17)  Peng, T.; Thinon, E.; Hang, H. C. Proteomic Analysis of Fatty-Acylated Proteins. Curr. Opin. 
Chem. Biol. 2016, 30, 77–86. https://doi.org/10.1016/j.cbpa.2015.11.008. 
(18)  Suazo, K. F.; Schey, G.; Schaber, C.; Odom John, A. R.; Distefano, M. D. Proteomic 
Analysis of Protein–Lipid Modifications: Significance and Application. Mass 
Spectrometry Based Chemical Proteomics‐ . August 13, 2019, pp 317–347. 
(19)  Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click Chemistry: Diverse Chemical Function from 




(20)  Sletten, E. M.; Bertozzi, C. R. Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of 
Functionality. Angew. Chem. Int. Ed. 2009, 48 (38), 6974–6998. 
https://doi.org/doi:10.1002/anie.200900942. 
(21)  Sletten, E. M.; Bertozzi, C. R. From Mechanism to Mouse: A Tale of Two Bioorthogonal 
Reactions. Acc. Chem. Res. 2011, 44 (9), 666–676. https://doi.org/10.1021/ar200148z. 
(22)  McKay, C. S.; Finn, M. G. Click Chemistry in Complex Mixtures: Bioorthogonal 
Bioconjugation. Chem. Biol. 2014, 21 (9), 1075–1101. 
https://doi.org/10.1016/j.chembiol.2014.09.002. 
(23)  Oliveira, B. L.; Guo, Z.; Bernardes, G. J. L. Inverse Electron Demand Diels–Alder Reactions 
in Chemical Biology. Chem. Soc. Rev. 2017, 46 (16), 4895–4950. 
https://doi.org/10.1039/C7CS00184C. 
(24)  Kölmel, D. K.; Kool, E. T. Oximes and Hydrazones in Bioconjugation: Mechanism and 
Catalysis. Chem. Rev. 2017, 117 (15), 10358–10376. 
https://doi.org/10.1021/acs.chemrev.7b00090. 
(25)  Kim, E.; Koo, H. Biomedical Applications of Copper-Free Click Chemistry: In Vitro, in Vivo, 
and Ex Vivo. Chem. Sci. 2019, 10 (34), 7835–7851. 
https://doi.org/10.1039/C9SC03368H. 
(26)  Saxon, E.; Bertozzi, C. R. Cell Surface Engineering by a Modified Staudinger Reaction. 
Science 2000, 287 (5460), 2007–2010. https://doi.org/10.1126/science.287.5460.2007. 
(27)  Bednarek, C.; Wehl, I.; Jung, N.; Schepers, U.; Bräse, S. The Staudinger Ligation. Chem. 
Rev. 2020, 120 (10), 4301–4354. https://doi.org/10.1021/acs.chemrev.9b00665. 
(28)  Lin, F. L.; Hoyt, H. M.; van Halbeek, H.; Bergman, R. G.; Bertozzi, C. R. Mechanistic 
Investigation of the Staudinger Ligation. J. Am. Chem. Soc. 2005, 127 (8), 2686–2695. 
https://doi.org/10.1021/ja044461m. 
(29)  Tornøe, C. W.; Christensen, C.; Meldal, M. Peptidotriazoles on Solid Phase:  [1,2,3]-
Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal 
Alkynes to Azides. J. Org. Chem. 2002, 67 (9), 3057–3064. 
https://doi.org/10.1021/jo011148j. 
(30)  Rostovtsev, V. V; Green, L. G.; Fokin, V. V; Sharpless, K. B. A Stepwise Huisgen 
Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and 
Terminal Alkynes. Angew. Chem. Int. Ed. 2002, 41 (14), 2596–2599. 
https://doi.org/10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4. 
(31)  Meldal, M.; Tornøe, C. W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem. Rev. 2008, 
108 (8), 2952–3015. https://doi.org/10.1021/cr0783479. 
(32)  Neumann, S.; Biewend, M.; Rana, S.; Binder, W. H. The CuAAC: Principles, Homogeneous 
and Heterogeneous Catalysts, and Novel Developments and Applications. Macromol. 
Rapid Commun. 2020, 41 (1), 1900359. https://doi.org/10.1002/marc.201900359. 
(33)  Chan, T. R.; Hilgraf, R.; Sharpless, K. B.; Fokin, V. V. Polytriazoles as Copper(I)-Stabilizing 
Ligands in Catalysis. Org. Lett. 2004, 6 (17), 2853–2855. 
https://doi.org/10.1021/ol0493094. 
(34)  Hong, V.; Presolski, S. I.; Ma, C.; Finn, M. G. Analysis and Optimization of Copper-
Catalyzed Azide–Alkyne Cycloaddition for Bioconjugation. Angew. Chem. Int. Ed. 2009, 
48 (52), 9879–9883. https://doi.org/10.1002/anie.200905087. 
(35)  Presolski, S. I.; Hong, V.; Cho, S.-H.; Finn, M. G. Tailored Ligand Acceleration of the Cu-
Catalyzed Azide−Alkyne Cycloaddition Reaction: Practical and Mechanistic Implications. 
J. Am. Chem. Soc. 2010, 132 (41), 14570–14576. https://doi.org/10.1021/ja105743g. 
(36)  Soriano del Amo, D.; Wang, W.; Jiang, H.; Besanceney, C.; Yan, A. C.; Levy, M.; Liu, Y.; 
Marlow, F. L.; Wu, P. Biocompatible Copper(I) Catalysts for in Vivo Imaging of Glycans. 
J. Am. Chem. Soc. 2010, 132 (47), 16893–16899. https://doi.org/10.1021/ja106553e. 
(37)  Das, D.; Tnimov, Z.; Nguyen, U. T. T.; Thimmaiah, G.; Lo, H.; Abankwa, D.; Wu, Y.; Goody, 
R. S.; Waldmann, H.; Kirill, A. Flexible and General Synthesis of Functionalized 
Phosphoisoprenoids for the Study of Prenylation in Vivo and in Vitro. ChemBioChem 
2012, 13 (5), 674–683. https://doi.org/10.1002/cbic.201100733. 
(38)  Uttamapinant, C.; Tangpeerachaikul, A.; Grecian, S.; Clarke, S.; Singh, U.; Slade, P.; Gee, 
K. R.; Ting, A. Y. Fast, Cell-Compatible Click Chemistry with Copper-Chelating Azides for 
 
 179
Biomolecular Labeling. Angew. Chem. Int. Ed. 2012, 51 (24), 5852–5856. 
https://doi.org/10.1002/anie.201108181. 
(39)  Jiang, H.; Zheng, T.; Lopez-Aguilar, A.; Feng, L.; Kopp, F.; Marlow, F. L.; Wu, P. Monitoring 
Dynamic Glycosylation in Vivo Using Supersensitive Click Chemistry. Bioconjug. Chem. 
2014, 25 (4), 698–706. https://doi.org/10.1021/bc400502d. 
(40)  Bevilacqua, V.; King, M.; Chaumontet, M.; Nothisen, M.; Gabillet, S.; Buisson, D.; Puente, 
C.; Wagner, A.; Taran, F. Copper-Chelating Azides for Efficient Click Conjugation 
Reactions in Complex Media. Angew. Chem. Int. Ed. 2014, 53 (23), 5872–5876. 
https://doi.org/10.1002/anie.201310671. 
(41)  Kennedy, D. C.; McKay, C. S.; Legault, M. C. B.; Danielson, D. C.; Blake, J. A.; Pegoraro, 
A. F.; Stolow, A.; Mester, Z.; Pezacki, J. P. Cellular Consequences of Copper Complexes 
Used To Catalyze Bioorthogonal Click Reactions. J. Am. Chem. Soc. 2011, 133 (44), 
17993–18001. https://doi.org/10.1021/ja2083027. 
(42)  Agard, N. J.; Prescher, J. A.; Bertozzi, C. R. A Strain-Promoted [3 + 2] Azide−Alkyne 
Cycloaddition for Covalent Modification of Biomolecules in Living Systems. J. Am. Chem. 
Soc. 2004, 126 (46), 15046–15047. https://doi.org/10.1021/ja044996f. 
(43)  Dommerholt, J.; Rutjes, F. P. J. T.; van Delft, F. L. Strain-Promoted 1,3-Dipolar 
Cycloaddition of Cycloalkynes and Organic Azides. Top. Curr. Chem. 2016, 374 (2), 16. 
https://doi.org/10.1007/s41061-016-0016-4. 
(44)  Agard, N. J.; Baskin, J. M.; Prescher, J. A.; Lo, A.; Bertozzi, C. R. A Comparative Study of 
Bioorthogonal Reactions with Azides. ACS Chem. Biol. 2006, 1 (10), 644–648. 
https://doi.org/10.1021/cb6003228. 
(45)  Mbua, N. E.; Guo, J.; Wolfert, M. A.; Steet, R.; Boons, G.-J. Strain-Promoted Alkyne–Azide 
Cycloadditions (SPAAC) Reveal New Features of Glycoconjugate Biosynthesis. 
ChemBioChem 2011, 12 (12), 1912–1921. https://doi.org/10.1002/cbic.201100117. 
(46)  Sletten, E. M.; Bertozzi, C. R. A Hydrophilic Azacyclooctyne for Cu-Free Click Chemistry. 
Org. Lett. 2008, 10 (14), 3097–3099. https://doi.org/10.1021/ol801141k. 
(47)  Ning, X.; Guo, J.; Wolfert, M. A.; Boons, G.-J. Visualizing Metabolically Labeled 
Glycoconjugates of Living Cells by Copper-Free and Fast Huisgen Cycloadditions. 
Angew. Chem. Int. Ed. 2008, 47 (12), 2253–2255. 
https://doi.org/10.1002/anie.200705456. 
(48)  Chang, P. V; Prescher, J. A.; Sletten, E. M.; Baskin, J. M.; Miller, I. A.; Agard, N. J.; Lo, A.; 
Bertozzi, C. R. Copper-Free Click Chemistry in Living Animals. Proc. Natl. Acad. Sci. 
2010, 107 (5), 1821 LP – 1826. https://doi.org/10.1073/pnas.0911116107. 
(49)  van Geel, R.; Pruijn, G. J. M.; van Delft, F. L.; Boelens, W. C. Preventing Thiol-Yne Addition 
Improves the Specificity of Strain-Promoted Azide–Alkyne Cycloaddition. Bioconjug. 
Chem. 2012, 23 (3), 392–398. https://doi.org/10.1021/bc200365k. 
(50)  Karver, M. R.; Weissleder, R.; Hilderbrand, S. A. Bioorthogonal Reaction Pairs Enable 
Simultaneous, Selective, Multi-Target Imaging. Angew. Chem. Int. Ed. 2012, 51 (4), 920–
922. https://doi.org/10.1002/anie.201104389. 
(51)  Nikić, I.; Plass, T.; Schraidt, O.; Szymański, J.; Briggs, J. A. G.; Schultz, C.; Lemke, E. A. 
Minimal Tags for Rapid Dual-Color Live-Cell Labeling and Super-Resolution Microscopy. 
Angew. Chem. Int. Ed. 2014, 53 (8), 2245–2249. https://doi.org/10.1002/anie.201309847. 
(52)  Rashidian, M.; Keliher, E. J.; Bilate, A. M.; Duarte, J. N.; Wojtkiewicz, G. R.; Jacobsen, J. 
T.; Cragnolini, J.; Swee, L. K.; Victora, G. D.; Weissleder, R.; Ploegh, H. L. Noninvasive 
Imaging of Immune Responses. Proc. Natl. Acad. Sci. 2015, 112 (19), 6146–6151. 
(53)  Yang, J.; Šečkutė, J.; Cole, C. M.; Devaraj, N. K. Live-Cell Imaging of Cyclopropene Tags 
with Fluorogenic Tetrazine Cycloadditions. Angew. Chem. Int. Ed. 2012, 51 (30), 7476–
7479. https://doi.org/10.1002/anie.201202122. 
(54)  Yang, J.; Liang, Y.; Šečkutė, J.; Houk, K. N.; Devaraj, N. K. Synthesis and Reactivity 
Comparisons of 1-Methyl-3-Substituted Cyclopropene Mini-Tags for Tetrazine 
Bioorthogonal Reactions. Chem. – Eur. J. 2014, 20 (12), 3365–3375. 
https://doi.org/10.1002/chem.201304225. 
(55)  Engelsma, S. B.; Willems, L. I.; van Paaschen, C. E.; van Kasteren, S. I.; van der Marel, G. 
A.; Overkleeft, H. S.; Filippov, D. V. Acylazetine as a Dienophile in Bioorthogonal Inverse 
 
 180
Electron-Demand Diels–Alder Ligation. Org. Lett. 2014, 16 (10), 2744–2747. 
https://doi.org/10.1021/ol501049c. 
(56)  Cohen, J. D.; Zou, P.; Ting, A. Y. Site-Specific Protein Modification Using Lipoic Acid Ligase 
and Bis-Aryl Hydrazone Formation. Chembiochem Eur. J. Chem. Biol. 2012, 13 (6), 888–
894. https://doi.org/10.1002/cbic.201100764. 
(57)  Dirksen, A.; Dirksen, S.; Hackeng, T. M.; Dawson, P. E. Nucleophilic Catalysis of 
Hydrazone Formation and Transimination:  Implications for Dynamic Covalent Chemistry. 
J. Am. Chem. Soc. 2006, 128 (49), 15602–15603. https://doi.org/10.1021/ja067189k. 
(58)  Dirksen, A.; Hackeng, T. M.; Dawson, P. E. Nucleophilic Catalysis of Oxime Ligation. 
Angew. Chem. Int. Ed. 2006, 45 (45), 7581–7584. 
https://doi.org/10.1002/anie.200602877. 
(59)  Dirksen, A.; Dawson, P. E. Rapid Oxime and Hydrazone Ligations with Aromatic Aldehydes 
for Biomolecular Labeling. Bioconjug. Chem. 2008, 19 (12), 2543–2548. 
https://doi.org/10.1021/bc800310p. 
(60)  Rashidian, M.; Mahmoodi, M. M.; Shah, R.; Dozier, J. K.; Wagner, C. R.; Distefano, M. D. A 
Highly Efficient Catalyst for Oxime Ligation and Hydrazone–Oxime Exchange Suitable for 
Bioconjugation. Bioconjug. Chem. 2013, 24 (3), 333–342. 
https://doi.org/10.1021/bc3004167. 
(61)  Kalia, J.; Raines, R. T. Hydrolytic Stability of Hydrazones and Oximes. Angew. Chem. Int. 
Ed Engl. 2008, 47 (39), 7523–7526. https://doi.org/10.1002/anie.200802651. 
(62)  Rashidian, M.; Song, J. M.; Pricer, R. E.; Distefano, M. D. Chemoenzymatic Reversible 
Immobilization and Labeling of Proteins without Prior Purification. J. Am. Chem. Soc. 
2012, 134 (20), 8455–8467. https://doi.org/10.1021/ja211308s. 
(63)  Bandyopadhyay, A.; Gao, J. Iminoboronate Formation Leads to Fast and Reversible 
Conjugation Chemistry of α-Nucleophiles at Neutral PH. Chem. – Eur. J. 2015, 21 (42), 
14748–14752. https://doi.org/10.1002/chem.201502077. 
(64)  Nisal, R.; P. Jose, G.; Shanbhag, C.; Kalia, J. Rapid and Reversible Hydrazone 
Bioconjugation in Cells without the Use of Extraneous Catalysts. Org. Biomol. Chem. 
2018, 16 (23), 4304–4310. https://doi.org/10.1039/C8OB00946E. 
(65)  Agarwal, P.; van der Weijden, J.; Sletten, E. M.; Rabuka, D.; Bertozzi, C. R. A Pictet-
Spengler Ligation for Protein Chemical Modification. Proc. Natl. Acad. Sci. 2013, 110 (1), 
46 LP – 51. https://doi.org/10.1073/pnas.1213186110. 
(66)  Drake, P. M.; Albers, A. E.; Baker, J.; Banas, S.; Barfield, R. M.; Bhat, A. S.; de Hart, G. W.; 
Garofalo, A. W.; Holder, P.; Jones, L. C.; Kudirka, R.; McFarland, J.; Zmolek, W.; 
Rabuka, D. Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of 
ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo 
Efficacy and PK Outcomes. Bioconjug. Chem. 2014, 25 (7), 1331–1341. 
https://doi.org/10.1021/bc500189z. 
(67)  Kudirka, R.; Barfield, R. M.; McFarland, J.; Albers, A. E.; de Hart, G. W.; Drake, P. M.; 
Holder, P. G.; Banas, S.; Jones, L. C.; Garofalo, A. W.; Rabuka, D. Generating Site-
Specifically Modified Proteins via a Versatile and Stable Nucleophilic Carbon Ligation. 
Chem. Biol. 2015, 22 (2), 293–298. https://doi.org/10.1016/j.chembiol.2014.11.019. 
(68)  Zeng, Y.; Ramya, T. N. C.; Dirksen, A.; Dawson, P. E.; Paulson, J. C. High-Efficiency 
Labeling of Sialylated Glycoproteins on Living Cells. Nat. Methods 2009, 6 (3), 207–209. 
https://doi.org/10.1038/nmeth.1305. 
(69)  Spears, R. J.; Fascione, M. A. Site-Selective Incorporation and Ligation of Protein 
Aldehydes. Org. Biomol. Chem. 2016, 14 (32), 7622–7638. 
https://doi.org/10.1039/C6OB00778C. 
(70)  Hoyle, C. E.; Bowman, C. N. Thiol–Ene Click Chemistry. Angew. Chem. Int. Ed. 2010, 49 
(9), 1540–1573. https://doi.org/10.1002/anie.200903924. 
(71)  Lowe, A. B. Thiol–Ene “Click” Reactions and Recent Applications in Polymer and Materials 
Synthesis: A First Update. Polym. Chem. 2014, 5 (17), 4820–4870. 
https://doi.org/10.1039/C4PY00339J. 
(72)  Koo, S. P. S.; Stamenović, M. M.; Prasath, R. A.; Inglis, A. J.; Du Prez, F. E.; Barner-
Kowollik, C.; Van Camp, W.; Junkers, T. Limitations of Radical Thiol-Ene Reactions for 
 
 181
Polymer–Polymer Conjugation. J. Polym. Sci. Part Polym. Chem. 2010, 48 (8), 1699–
1713. https://doi.org/10.1002/pola.23933. 
(73)  Derboven, P.; D’hooge, D. R.; Stamenovic, M. M.; Espeel, P.; Marin, G. B.; Du Prez, F. E.; 
Reyniers, M.-F. Kinetic Modeling of Radical Thiol–Ene Chemistry for Macromolecular 
Design: Importance of Side Reactions and Diffusional Limitations. Macromolecules 2013, 
46 (5), 1732–1742. https://doi.org/10.1021/ma302619k. 
(74)  Teders, M.; Henkel, C.; Anhäuser, L.; Strieth-Kalthoff, F.; Gómez-Suárez, A.; Kleinmans, 
R.; Kahnt, A.; Rentmeister, A.; Guldi, D.; Glorius, F. The Energy-Transfer-Enabled 
Biocompatible Disulfide–Ene Reaction. Nat. Chem. 2018, 10 (9), 981–988. 
https://doi.org/10.1038/s41557-018-0102-z. 
(75)  Nolan, M. D.; Scanlan, E. M. Applications of Thiol-Ene Chemistry for Peptide Science   . 
Frontiers in Chemistry  . 2020, p 1060. 
(76)  Grim, J. C.; Marozas, I. A.; Anseth, K. S. Thiol-Ene and Photo-Cleavage Chemistry for 
Controlled Presentation of Biomolecules in Hydrogels. J. Control. Release Off. J. Control. 
Release Soc. 2015, 219, 95–106. https://doi.org/10.1016/j.jconrel.2015.08.040. 
(77)  Spicer, C. D.; Davis, B. G. Selective Chemical Protein Modification. Nat. Commun. 2014, 5, 
4740. 
(78)  Roque, A. C. A.; Lowe, C. R.; Taipa, M. Â. Antibodies and Genetically Engineered Related 
Molecules: Production and Purification. Biotechnol. Prog. 2004, 20 (3), 639–654. 
https://doi.org/10.1021/bp030070k. 
(79)  Young, T. S.; Schultz, P. G. Beyond the Canonical 20 Amino Acids: Expanding the Genetic 
Lexicon. J. Biol. Chem. 2010, 285 (15), 11039–11044. 
https://doi.org/10.1074/jbc.R109.091306. 
(80)  Mann, R. K.; Beachy, P. A. Novel Lipid Modifications of Secreted Protein Signals. Annu. 
Rev. Biochem. 2004, 73 (1), 891–923. 
https://doi.org/10.1146/annurev.biochem.73.011303.073933. 
(81)  Subramanian, T.; Pais, J. E.; Liu, S.; Troutman, J. M.; Suzuki, Y.; Leela Subramanian, K.; 
Fierke, C. A.; Andres, D. A.; Spielmann, H. P. Farnesyl Diphosphate Analogues with Aryl 
Moieties Are Efficient Alternate Substrates for Protein Farnesyltransferase. Biochemistry 
2012, 51 (41), 8307–8319. https://doi.org/10.1021/bi3011362. 
(82)  Nguyen, U. T. T.; Guo, Z.; Delon, C.; Wu, Y.; Deraeve, C.; Fränzel, B.; Bon, R. S.; 
Blankenfeldt, W.; Goody, R. S.; Waldmann, H.; Wolters, D.; Alexandrov, K. Analysis of 
the Eukaryotic Prenylome by Isoprenoid Affinity Tagging. Nat. Chem. Biol. 2009, 5 (4), 
227–235. https://doi.org/10.1038/nchembio.149. 
(83)  Dozier, J. K.; Khatwani, S. L.; Wollack, J. W.; Wang, Y.-C.; Schmidt-Dannert, C.; Distefano, 
M. D. Engineering Protein Farnesyltransferase for Enzymatic Protein Labeling 
Applications. Bioconjug. Chem. 2014, 25 (7), 1203–1212. 
(84)  Zahn, T. J.; Whitney, J.; Weinbaum, C.; Gibbs, R. A. Synthesis and Evaluation of GGPP 
Geometric Isomers: Divergent Substrate Specificities of FTase and GGTase I. Bioorg. 
Med. Chem. Lett. 2001, 11 (12), 1605–1608. https://doi.org/10.1016/S0960-
894X(01)00292-X. 
(85)  Rose, M. W.; Xu, J.; Kale, T. A.; O’Doherty, G.; Barany, G.; Distefano, M. D. Enzymatic 
Incorporation of Orthogonally Reactive Prenylazide Groups into Peptides Using 
Geranylazide Diphosphate via Protein Farnesyltransferase: Implications for Selective 
Protein Labeling. Pept. Sci. 2005, 80 (2–3), 164–171. https://doi.org/10.1002/bip.20239. 
(86)  Restituyo, J. A.; Comstock, L. R.; Petersen, S. G.; Stringfellow, T.; Rajski, S. R. Conversion 
of Aryl Azides to O-Alkyl Imidates via Modified Staudinger Ligation. Org. Lett. 2003, 5 
(23), 4357–4360. https://doi.org/10.1021/ol035635s. 
(87)  Rose, M. W.; Rose, N. D.; Boggs, J.; Lenevich, S.; Xu, J.; Barany, G.; Distefano, M. D. 
Evaluation of Geranylazide and Farnesylazide Diphosphate for Incorporation of 
Prenylazides into a CAAX Box-Containing Peptide Using Protein Farnesyltransferase. J. 
Pept. Res. 2005, 65 (6), 529–537. https://doi.org/10.1111/j.1399-3011.2005.00261.x. 
(88)  Xu, J.; DeGraw, A. J.; Duckworth, B. P.; Lenevich, S.; Tann, C.-M.; Jenson, E. C.; Gruber, 
S. J.; Barany, G.; Distefano, M. D. Synthesis and Reactivity of 6,7-Dihydrogeranylazides: 
Reagents for Primary Azide Incorporation into Peptides and Subsequent Staudinger 
 
 182
Ligation. Chem. Biol. Drug Des. 2006, 68 (2), 85–96. https://doi.org/10.1111/j.1747-
0285.2006.00420.x. 
(89)  Duckworth, B. P.; Xu, J.; Taton, T. A.; Guo, A.; Distefano, M. D. Site-Specific, Covalent 
Attachment of Proteins to a Solid Surface. Bioconjug. Chem. 2006, 17 (4), 967–974. 
https://doi.org/10.1021/bc060125e. 
(90)  Speers, A. E.; Cravatt, B. F. Profiling Enzyme Activities In Vivo Using Click Chemistry 
Methods. Chem. Biol. 2004, 11 (4), 535–546. 
https://doi.org/10.1016/j.chembiol.2004.03.012. 
(91)  Gauchet, C.; Labadie, G. R.; Poulter, C. D. Regio- and Chemoselective Covalent 
Immobilization of Proteins through Unnatural Amino Acids. J. Am. Chem. Soc. 2006, 128 
(29), 9274–9275. https://doi.org/10.1021/ja061131o. 
(92)  Labadie, G. R.; Viswanathan, R.; Poulter, C. D. Farnesyl Diphosphate Analogues with ω-
Bioorthogonal Azide and Alkyne Functional Groups for Protein Farnesyl Transferase-
Catalyzed Ligation Reactions. J. Org. Chem. 2007, 72 (24), 9291–9297. 
https://doi.org/10.1021/jo7017747. 
(93)  Duckworth, B. P.; Zhang, Z.; Hosokawa, A.; Distefano, M. D. Selective Labeling of Proteins 
by Using Protein Farnesyltransferase. ChemBioChem 2007, 8 (1), 98–105. 
https://doi.org/10.1002/cbic.200600340. 
(94)  Duckworth, B. P.; Chen, Y.; Wollack, J. W.; Sham, Y.; Mueller, J. D.; Taton, T. A.; 
Distefano, M. D. A Universal Method for the Preparation of Covalent Protein–DNA 
Conjugates for Use in Creating Protein Nanostructures. Angew. Chem. Int. Ed. 2007, 46 
(46), 8819–8822. https://doi.org/10.1002/anie.200701942. 
(95)  Nguyen, U. T. T.; Cramer, J.; Gomis, J.; Reents, R.; Gutierrez Rodriguez, M.; Goody, R. ‐
S.; Alexandrov, K.; Waldmann, H. Exploiting the Substrate Tolerance of 
Farnesyltransferase for Site Selective Protein Derivatization. ‐ ChemBioChem 2007, 8 
(4), 408–423. https://doi.org/doi:10.1002/cbic.200600440. 
(96)  Wollack, J. W.; Silverman, J. M.; Petzold, C. J.; Mougous, J. D.; Distefano, M. D. A 
Minimalist Substrate for Enzymatic Peptide and Protein Conjugation. Chembiochem Eur. 
J. Chem. Biol. 2009, 10 (18), 2934–2943. https://doi.org/10.1002/cbic.200900566. 
(97)  Rashidian, M.; Dozier, J. K.; Lenevich, S.; Distefano, M. D. Selective Labeling of 
Polypeptides Using Protein Farnesyltransferase via Rapid Oxime Ligation. Chem. 
Commun. 2010, 46 (47), 8998–9000. https://doi.org/10.1039/C0CC03305G. 
(98)  Berry, A. F. H.; Heal, W. P.; Tarafder, A. K.; Tolmachova, T.; Baron, R. A.; Seabra, M. C.; 
Tate, E. W. Rapid Multilabel Detection of Geranylgeranylated Proteins by Using 
Bioorthogonal Ligation Chemistry. ChemBioChem 2010, 11 (6), 771–773. 
https://doi.org/10.1002/cbic.201000087. 
(99)  Weinrich, D.; Lin, P.; Jonkheijm, P.; Nguyen, U. T. T.; Schröder, H.; Niemeyer, C. M.; 
Alexandrov, K.; Goody, R.; Waldmann, H. Oriented Immobilization of Farnesylated 
Proteins by the Thiol Ene Reaction. ‐ Angew. Chem. Int. Ed. 2010, 49 (7), 1252–1257. 
https://doi.org/doi:10.1002/anie.200906190. 
(100)  Wang, Y.; Kilic, O.; Csizmar, C. M.; Ashok, S.; Hougland, J. L.; Distefano, M. D.; Wagner, 
C. R. Engineering Reversible Cell–Cell Interactions Using Enzymatically Lipidated 
Chemically Self-Assembled Nanorings. Chem. Sci. 2021, 12 (1), 331–340. 
https://doi.org/10.1039/D0SC03194A. 
(101)  Khatwani, S. L.; Kang, J. S.; Mullen, D. G.; Hast, M. A.; Beese, L. S.; Distefano, M. D.; 
Taton, T. A. Covalent Protein-Oligonucleotide Conjugates by Copper-Free Click 
Reaction. Bioorg. Med. Chem. 2012, 20 (14), 4532–4539. 
https://doi.org/10.1016/j.bmc.2012.05.017. 
(102)  Rashidian, M.; Kumarapperuma, S. C.; Gabrielse, K.; Fegan, A.; Wagner, C. R.; 
Distefano, M. D. Simultaneous Dual Protein Labeling Using a Triorthogonal Reagent. J. 
Am. Chem. Soc. 2013, 135 (44), 16388–16396. https://doi.org/10.1021/ja403813b. 
(103)  Mahmoodi, M. M.; Rashidian, M.; Zhang, Y.; Distefano, M. D. Application of Meta- and 
Para-Phenylenediamine as Enhanced Oxime Ligation Catalysts for Protein Labeling, 




(104)  Tolstyka, Z. P.; Richardson, W.; Bat, E.; Stevens, C. J.; Parra, D. P.; Dozier, J. K.; 
Distefano, M. D.; Dunn, B.; Maynard, H. D. Chemoselective Immobilization of Proteins by 
Microcontact Printing and Bioorthogonal Click Reactions. Chembiochem 2013, 14 (18), 
2464–2471. https://doi.org/10.1002/cbic.201300478. 
(105)  Seo, J.; Lee, S.; Poulter, C. D. Regioselective Covalent Immobilization of Recombinant 
Antibody-Binding Proteins A, G, and L for Construction of Antibody Arrays. J. Am. Chem. 
Soc. 2013, 135 (24), 8973–8980. https://doi.org/10.1021/ja402447g. 
(106)  Seo, J.; Poulter, C. D. Sandwich Antibody Arrays Using Recombinant Antibody-Binding 
Protein L. Langmuir 2014, 30 (22), 6629–6635. https://doi.org/10.1021/la500822w. 
(107)  Choi, S.; Seo, J.; Bohaty, R. F. H.; Poulter, C. D. Regio- and Chemoselective 
Immobilization of Proteins on Gold Surfaces. Bioconjug. Chem. 2014, 25 (2), 269–275. 
https://doi.org/10.1021/bc400413d. 
(108)  Wollack, J. W.; Monson, B. J.; Dozier, J. K.; Dalluge, J. J.; Poss, K.; Hilderbrand, S. A.; 
Distefano, M. D. Site-Specific Labeling of Proteins and Peptides with Trans-Cyclooctene 
Containing Handles Capable of Tetrazine Ligation. Chem. Biol. Drug Des. 2014, 84 (2), 
140–147. https://doi.org/10.1111/cbdd.12303. 
(109)  Zhang, Y.; Blanden, M. J.; Sudheer, Ch.; Gangopadhyay, S. A.; Rashidian, M.; 
Hougland, J. L.; Distefano, M. D. Simultaneous Site-Specific Dual Protein Labeling Using 
Protein Prenyltransferases. Bioconjug. Chem. 2015, 26 (12), 2542–2553. 
https://doi.org/10.1021/acs.bioconjchem.5b00553. 
(110)  Yeo, J. E.; Wickramaratne, S.; Khatwani, S.; Wang, Y.-C.; Vervacke, J.; Distefano, M. D.; 
Tretyakova, N. Y. Synthesis of Site-Specific DNA–Protein Conjugates and Their Effects 
on DNA Replication. ACS Chem. Biol. 2014, 9 (8), 1860–1868. 
https://doi.org/10.1021/cb5001795. 
(111)  Lee, J.; Choi, H.; Yun, M.; Kang, Y.; Jung, J.; Ryu, Y.; Kim, T. Y.; Cha, Y.; Cho, H.; Min, 
J.; Chung, C.; Kim, H. Enzymatic Prenylation and Oxime Ligation for the Synthesis of 
Stable and Homogeneous Protein–Drug Conjugates for Targeted Therapy. Angew. 
Chem. Int. Ed. 2015, 54 (41), 12020–12024. https://doi.org/doi:10.1002/anie.201505964. 
(112)  Lee, B. I.; Park, M.-H.; Byeon, J.-J.; Shin, S.-H.; Choi, J.; Park, Y.; Park, Y.-H.; Chae, J.; 
Shin, Y. G. Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity 
Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific 
Antibody-Drug Conjugate. Mol. Basel Switz. 2020, 25 (7), 1515. 
https://doi.org/10.3390/molecules25071515. 
(113)  Zhang, Y.; Auger, S.; Schaefer, J. V; Plückthun, A.; Distefano, M. D. Site-Selective 
Enzymatic Labeling of Designed Ankyrin Repeat Proteins Using Protein 
Farnesyltransferase BT  - Bioconjugation: Methods and Protocols; Massa, S., Devoogdt, 
N., Eds.; Springer New York: New York, NY, 2019; pp 207–219. 
https://doi.org/10.1007/978-1-4939-9654-4_14. 
(114)  Ho, S. H.; Tirrell, D. A. Chemoenzymatic Labeling of Proteins for Imaging in Bacterial 
Cells. J. Am. Chem. Soc. 2016, 138 (46), 15098–15101. 
https://doi.org/10.1021/jacs.6b07067. 
(115)  Ho, S. H.; Tirrell, D. A. N-Myristoyl Transferase (NMT)-Catalyzed Labeling of Bacterial 
Proteins for Imaging in Fixed and Live Cells BT  - Enzyme-Mediated Ligation Methods; 
Nuijens, T., Schmidt, M., Eds.; Springer New York: New York, NY, 2019; pp 315–326. 
https://doi.org/10.1007/978-1-4939-9546-2_16. 
(116)  Kulkarni, C.; Lo, M.; Fraseur, J. G.; Tirrell, D. A.; Kinzer-Ursem, T. L. Bioorthogonal 
Chemoenzymatic Functionalization of Calmodulin for Bioconjugation Applications. 
Bioconjug. Chem. 2015, 26 (10), 2153–2160. 
https://doi.org/10.1021/acs.bioconjchem.5b00449. 
(117)  Fraseur, J. G.; Kinzer-Ursem, T. L. Next Generation Calmodulin Affinity Purification: 
Clickable Calmodulin Facilitates Improved Protein Purification. PloS One 2018, 13 (6), 
e0197120–e0197120. https://doi.org/10.1371/journal.pone.0197120. 
(118)  Heal, W. P.; Wickramasinghe, S. R.; Bowyer, P. W.; Holder, A. A.; Smith, D. F.; 
Leatherbarrow, R. J.; Tate, E. W. Site-Specific N-Terminal Labelling of Proteinsin Vitro 
and in Vivo Using N-Myristoyl Transferase and Bioorthogonal Ligation Chemistry. Chem. 
Commun. 2008, No. 4, 480–482. https://doi.org/10.1039/B716115H. 
 
 184
(119)  Heal, W. P.; Wickramasinghe, S. R.; Leatherbarrow, R. J.; Tate, E. W. N-Myristoyl 
Transferase-Mediated Protein Labelling in Vivo. Org. Biomol. Chem. 2008, 6 (13), 2308–
2315. https://doi.org/10.1039/B803258K. 
(120)  Heal, W. P.; Wright, M. H.; Thinon, E.; Tate, E. W. Multifunctional Protein Labeling via 
Enzymatic N-Terminal Tagging and Elaboration by Click Chemistry. Nat Protoc. 2012, 7 
(1), 105–117. 
(121)  Kulkarni, C.; Kinzer Ursem, T. L.; Tirrell, D. A. Selective Functionalization of the Protein ‐
N Terminus with N M‐ yristoyl Transferase for Bioconjugation in Cell Lysate. 
ChemBioChem 2013, 14 (15), 1958–1962. https://doi.org/10.1002/cbic.201300453. 
(122)  Gao, H.; Sun, W.; Song, Z.; Yu, Y.; Wang, L.; Chen, X.; Zhang, Q. A Method to Generate 
and Analyze Modified Myristoylated Proteins. Chembiochem Eur. J. Chem. Biol. 2017, 18 
(3), 324–330. https://doi.org/10.1002/cbic.201600608. 
(123)  Ejendal, K. F. K.; Fraseur, J. G.; Kinzer-Ursem, T. L. Protein Labeling and Bioconjugation 
Using N-Myristoyltransferase BT  - Bioconjugation: Methods and Protocols; Massa, S., 
Devoogdt, N., Eds.; Springer New York: New York, NY, 2019; pp 149–165. 
https://doi.org/10.1007/978-1-4939-9654-4_11. 
(124)  Ho, S. H.; Tirrell, D. A. Enzymatic Labeling of Bacterial Proteins for Super-Resolution 
Imaging in Live Cells. ACS Cent. Sci. 2019, 5 (12), 1911–1919. 
https://doi.org/10.1021/acscentsci.9b00617. 
(125)  Kudirka, R. A.; Barfield, R. M.; McFarland, J. M.; Drake, P. M.; Carlson, A.; Bañas, S.; 
Zmolek, W.; Garofalo, A. W.; Rabuka, D. Site-Specific Tandem Knoevenagel 
Condensation–Michael Addition To Generate Antibody–Drug Conjugates. ACS Med. 
Chem. Lett. 2016, 7 (11), 994–998. https://doi.org/10.1021/acsmedchemlett.6b00253. 
(126)  Urquhart, L. Top Companies and Drugs by Sales in 2019. Nat. Rev. Drug Discov. 2020, 
19 (4), 228. 
(127)  Vogel, C.; Cobleigh, M. A.; Tripathy, D.; Gutheil, J. C.; Harris, L. N.; Fehrenbacher, L.; 
Slamon, D. J.; Murphy, M.; Novotny, W. F.; Burchmore, M.; Shak, S.; Stewart, S. J. First-
Line, Single-Agent Herceptin® (Trastuzumab) in Metastatic Breast Cancer: A Preliminary 
Report. Eur. J. Cancer 2001, 37, 25–29. https://doi.org/10.1016/S0959-8049(00)00405-6. 
(128)  Swierczewska, M.; Lee, K. C.; Lee, S. What Is the Future of PEGylated Therapies? 
Expert Opin. Emerg. Drugs 2015, 20 (4), 531–536. 
https://doi.org/10.1517/14728214.2015.1113254. 
(129)  Qi, Y.; Chilkoti, A. Growing Polymers from Peptides and Proteins: A Biomedical 
Perspective. Polym. Chem. 2014, 5 (2), 266–276. https://doi.org/10.1039/C3PY01089A. 
(130)  Lewis, A.; Tang, Y.; Brocchini, S.; Choi, J.; Godwin, A. Poly(2-Methacryloyloxyethyl 
Phosphorylcholine) for Protein Conjugation. Bioconjug. Chem. 2008, 19 (11), 2144–
2155. https://doi.org/10.1021/bc800242t. 
(131)  Nauka, P. C.; Lee, J.; Maynard, H. D. Enhancing the Conjugation Yield of Brush 
Polymer–Protein Conjugates by Increasing the Linker Length at the Polymer End-Group. 
Polym. Chem. 2016, 7 (13), 2352–2357. https://doi.org/10.1039/C6PY00080K. 
(132)  Bontempo, D.; Maynard, H. D. Streptavidin as a Macroinitiator for Polymerization:  In Situ 
Protein−Polymer Conjugate Formation. J. Am. Chem. Soc. 2005, 127 (18), 6508–6509. 
https://doi.org/10.1021/ja042230+. 
(133)  Lele, B. S.; Murata, H.; Matyjaszewski, K.; Russell, A. J. Synthesis of Uniform 
Protein−Polymer Conjugates. Biomacromolecules 2005, 6 (6), 3380–3387. 
https://doi.org/10.1021/bm050428w. 
(134)  Gao, W.; Liu, W.; Mackay, J. A.; Zalutsky, M. R.; Toone, E. J.; Chilkoti, A. In Situ Growth 
of a Stoichiometric PEG-like Conjugate at a Protein’s N-Terminus with Significantly 
Improved Pharmacokinetics. Proc. Natl. Acad. Sci. 2009, 106 (36), 15231. 
https://doi.org/10.1073/pnas.0904378106. 
(135)  Mansfield, K. M.; Maynard, H. D. Site-Specific Insulin-Trehalose Glycopolymer Conjugate 
by Grafting from Strategy Improves Bioactivity. ACS Macro Lett. 2018, 7 (3), 324–329. 
https://doi.org/10.1021/acsmacrolett.7b00974. 
(136)  Hu, J.; Wang, G.; Zhao, W.; Liu, X.; Zhang, L.; Gao, W. Site-Specific in Situ Growth of an 
Interferon-Polymer Conjugate That Outperforms PEGASYS in Cancer Therapy. 
Biomaterials 2016, 96, 84–92. https://doi.org/10.1016/j.biomaterials.2016.04.035. 
 
 185
(137)  Roberts, M. J.; Bentley, M. D.; Harris, J. M. Chemistry for Peptide and Protein 
PEGylation. MOST CITED Pap. Hist. Adv. DRUG Deliv. Rev. TRIBUTE 25TH Anniv. J. 
2012, 64, 116–127. https://doi.org/10.1016/j.addr.2012.09.025. 
(138)  Johnson, J. A.; Lu, Y. Y.; Van Deventer, J. A.; Tirrell, D. A. Residue-Specific 
Incorporation of Non-Canonical Amino Acids into Proteins: Recent Developments and 
Applications. Model Syst. Synth. Modif. 2010, 14 (6), 774–780. 
https://doi.org/10.1016/j.cbpa.2010.09.013. 
(139)  Suazo, K. F.; Park, K.-Y.; Distefano, M. D. A Not-So-Ancient Grease History: Click 
Chemistry and Protein Lipid Modifications. Chem. Rev. 2021. 
https://doi.org/10.1021/acs.chemrev.0c01108. 
(140)  Liu, X.; Sun, M.; Sun, J.; Hu, J.; Wang, Z.; Guo, J.; Gao, W. Polymerization Induced Self-
Assembly of a Site-Specific Interferon α-Block Copolymer Conjugate into Micelles with 
Remarkably Enhanced Pharmacology. J. Am. Chem. Soc. 2018, 140 (33), 10435–10438. 
https://doi.org/10.1021/jacs.8b06013. 
(141)  Gao, W.; Liu, W.; Christensen, T.; Zalutsky, M. R.; Chilkoti, A. In Situ Growth of a PEG-
like Polymer from the C Terminus of an Intein Fusion Protein Improves Pharmacokinetics 
and Tumor Accumulation. Proc. Natl. Acad. Sci. 2010, 107 (38), 16432. 
https://doi.org/10.1073/pnas.1006044107. 
(142)  Shilova O.N.; Deyev S.M. DARPins: Promising Scaffolds for Theranostics. Acta Naturae 
2019, 11 (4), 42–53. https://doi.org/10.32607/20758251-2019-11-4-42-53. 
(143)  Maetzel, D.; Denzel, S.; Mack, B.; Canis, M.; Went, P.; Benk, M.; Kieu, C.; Papior, P.; 
Baeuerle, P. A.; Munz, M.; Gires, O. Nuclear Signalling by Tumour-Associated Antigen 
EpCAM. Nat. Cell Biol. 2009, 11 (2), 162–171. https://doi.org/10.1038/ncb1824. 
(144)  Simon, M.; Stefan, N.; Borsig, L.; Plückthun, A.; Zangemeister-Wittke, U. Increasing the 
Antitumor Effect of an EpCAM-Targeting Fusion Toxin by Facile Click PEGylation. Mol. 
Cancer Ther. 2014, 13 (2), 375. https://doi.org/10.1158/1535-7163.MCT-13-0523. 
(145)  Martin-Killias, P.; Stefan, N.; Rothschild, S.; Plückthun, A.; Zangemeister-Wittke, U. A 
Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein 
Has Potent Antitumor Activity. Clin Cancer Res 2011, 17 (1), 100–110. 
https://doi.org/10.1158/1078-0432.ccr-10-1303. 
(146)  Stefan, N.; Martin-Killias, P.; Wyss-Stoeckle, S.; Honegger, A.; Zangemeister-Wittke, U.; 
Plückthun, A. DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by 
Phage and Ribosome Display and Engineered for Multivalency. J Mol Biol 2011, 413 (4), 
826–843. https://doi.org/10.1016/j.jmb.2011.09.016. 
(147)  Zhang, L.; Zhao, W.; Liu, X.; Wang, G.; Wang, Y.; Li, D.; Xie, L.; Gao, Y.; Deng, H.; Gao, 
W. Site-Selective in Situ Growth of Fluorescent Polymer-Antibody Conjugates with 
Enhanced Antigen Detection by Signal Amplification. Biomaterials 2015, 64, 2–9. 
https://doi.org/10.1016/j.biomaterials.2015.06.020. 
(148)  Johnson, R. N.; Kopečková, P.; Kopeček, J. Biological Activity of Anti-CD20 Multivalent 
HPMA Copolymer-Fab’ Conjugates. Biomacromolecules 2012, 13 (3), 727–735. 
https://doi.org/10.1021/bm201656k. 
(149)  Yurkovetskiy, A. V.; Yin, M.; Bodyak, N.; Stevenson, C. A.; Thomas, J. D.; Hammond, C. 
E.; Qin, L.; Zhu, B.; Gumerov, D. R.; Ter-Ovanesyan, E.; Uttard, A.; Lowinger, T. B. A 
Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and 
Preclinical Efficacy. Cancer Res. 2015, 75 (16), 3365. https://doi.org/10.1158/0008-
5472.CAN-15-0129. 
(150)  Kovář, M.; Strohalm, J.; Etrych, T.; Ulbrich, K.; Říhová, B. Star Structure of Antibody-
Targeted HPMA Copolymer-Bound Doxorubicin:  A Novel Type of Polymeric Conjugate 
for Targeted Drug Delivery with Potent Antitumor Effect. Bioconjug. Chem. 2002, 13 (2), 
206–215. https://doi.org/10.1021/bc010063m. 
(151)  Etrych, T.; Chytil, P.; Kovář, L.; Říhová, B.; Ulbrich, K. Micellar and Antibody-Targeted 
Polymer Therapeutics. Macromol. Symp. 2010, 295 (1), 1–12. 
https://doi.org/10.1002/masy.200900066. 
(152)  Tappertzhofen, K.; Metz, V. V.; Hubo, M.; Barz, M.; Postina, R.; Jonuleit, H.; Zentel, R. 
Synthesis of Maleimide-Functionalyzed HPMA-Copolymers and in Vitro Characterization 
 
 186
of the ARAGE- and Human Immunoglobulin (HuIgG)–Polymer Conjugates. Macromol. 
Biosci. 2013, 13 (2), 203–214. https://doi.org/10.1002/mabi.201200344. 
(153)  Pauli, J.; Licha, K.; Berkemeyer, J.; Grabolle, M.; Spieles, M.; Wegner, N.; Welker, P.; 
Resch-Genger, U. New Fluorescent Labels with Tunable Hydrophilicity for the Rational 
Design of Bright Optical Probes for Molecular Imaging. Bioconjug. Chem. 2013, 24 (7), 
1174–1185. https://doi.org/10.1021/bc4000349. 
(154)  Pauli, J.; Grabolle, M.; Brehm, R.; Spieles, M.; Hamann, F. M.; Wenzel, M.; Hilger, I.; 
Resch-Genger, U. Suitable Labels for Molecular Imaging – Influence of Dye Structure 
and Hydrophilicity on the Spectroscopic Properties of IgG Conjugates. Bioconjug. Chem. 
2011, 22 (7), 1298–1308. https://doi.org/10.1021/bc1004763. 
(155)  Hamblett, K. J.; Senter, P. D.; Chace, D. F.; Sun, M. M. C.; Lenox, J.; Cerveny, C. G.; 
Kissler, K. M.; Bernhardt, S. X.; Kopcha, A. K.; Zabinski, R. F.; Meyer, D. L.; Francisco, J. 
A. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug 
Conjugate. Clin. Cancer Res. 2004, 10 (20), 7063. https://doi.org/10.1158/1078-
0432.CCR-04-0789. 
(156)  Nagy, A.; Plonowski, A.; Schally, A. V. Stability of Cytotoxic Luteinizing Hormone-
Releasing Hormone Conjugate (AN-152) Containing Doxorubicin 14-<em>O</Em>-
Hemiglutarate in Mouse and Human Serum <em>in Vitro:</Em> Implications for the 
Design of Preclinical Studies. Proc. Natl. Acad. Sci. 2000, 97 (2), 829. 
https://doi.org/10.1073/pnas.97.2.829. 
(157)  Zhang, Y. APPLICATIONS OF ENZYMATIC PROTEIN LABELING BY 
FARNESYLTRANSFERASE TOWARDS DUAL-PROTEIN MODIFICATION AND 
CONSTRUCTION OF TARGETED DELIVERY SYSTEMS. Univ. Minn. PhD Diss. 
(158)  Kubetzko, S.; Sarkar, C. A.; Plückthun, A. Protein PEGylation Decreases Observed 
Target Association Rates via a Dual Blocking Mechanism. Mol. Pharmacol. 2005, 68 (5), 
1439. https://doi.org/10.1124/mol.105.014910. 
(159)  Simon, M.; Zangemeister-Wittke, U.; Plückthun, A. Facile Double-Functionalization of 
Designed Ankyrin Repeat Proteins Using Click and Thiol Chemistries. Bioconjug. Chem. 
2012, 23 (2), 279–286. https://doi.org/10.1021/bc200591x. 
(160)  Veronese, F. M. Peptide and Protein PEGylation: A Review of Problems and Solutions. 
Biomaterials 2001, 22 (5), 405–417. https://doi.org/10.1016/S0142-9612(00)00193-9. 
(161)  Wang, Y.-S.; Youngster, S.; Grace, M.; Bausch, J.; Bordens, R.; Wyss, D. F. Structural 
and Biological Characterization of Pegylated Recombinant Interferon Alpha-2b and Its 
Therapeutic Implications. Pept. Protein Pegylation 2002, 54 (4), 547–570. 
https://doi.org/10.1016/S0169-409X(02)00027-3. 
(162)  Veronese, F. M.; Caliceti, P.; Schiavon, O. Branched and Linear Poly(Ethylene Glycol): 
Influence of the Polymer Structure on Enzymological, Pharmacokinetic, and 
Immunological Properties of Protein Conjugates. J. Bioact. Compat. Polym. 1997, 12 (3), 
196–207. https://doi.org/10.1177/088391159701200303. 
(163)  Winkler, J.; Martin-Killias, P.; Plückthun, A.; Zangemeister-Wittke, U. EpCAM-Targeted 
Delivery of Nanocomplexed SiRNA to Tumor Cells with Designed Ankyrin Repeat 
Proteins. Mol. Cancer Ther. 2009, 8 (9), 2674. https://doi.org/10.1158/1535-7163.MCT-
09-0402. 
(164)  Petersburg, J. R.; Shen, J.; Csizmar, C. M.; Murphy, K. A.; Spanier, J.; Gabrielse, K.; 
Griffith, T. S.; Fife, B.; Wagner, C. R. Eradication of Established Tumors by Chemically 
Self-Assembled Nanoring Labeled T Cells. ACS Nano 2018, 12 (7), 6563–6576. 
https://doi.org/10.1021/acsnano.8b01308. 
(165)  Doronina, S. O.; Toki, B. E.; Torgov, M. Y.; Mendelsohn, B. A.; Cerveny, C. G.; Chace, 
D. F.; DeBlanc, R. L.; Gearing, R. P.; Bovee, T. D.; Siegall, C. B.; Francisco, J. A.; Wahl, 
A. F.; Meyer, D. L.; Senter, P. D. Development of Potent Monoclonal Antibody Auristatin 
Conjugates for Cancer Therapy. Nat. Biotechnol. 2003, 21 (7), 778–784. 
https://doi.org/10.1038/nbt832. 
(166)  Lyon, R. P.; Bovee, T. D.; Doronina, S. O.; Burke, P. J.; Hunter, J. H.; Neff-LaFord, H. D.; 
Jonas, M.; Anderson, M. E.; Setter, J. R.; Senter, P. D. Reducing Hydrophobicity of 
Homogeneous Antibody-Drug Conjugates Improves Pharmacokinetics and Therapeutic 
Index. Nat. Biotechnol. 2015, 33 (7), 733–735. https://doi.org/10.1038/nbt.3212. 
 
 187
(167)  Simon, M.; Frey, R.; Zangemeister-Wittke, U.; Plückthun, A. Orthogonal Assembly of a 
Designed Ankyrin Repeat Protein–Cytotoxin Conjugate with a Clickable Serum Albumin 
Module for Half-Life Extension. Bioconjug. Chem. 2013, 24 (11), 1955–1966. 
https://doi.org/10.1021/bc4004102. 
(168)  Mohamed, M. M.; Sloane, B. F. Cysteine Cathepsins: Multifunctional Enzymes in Cancer. 
Nat Rev Cancer 2006, 6 (10), 764–775. https://doi.org/10.1038/nrc1949. 
(169)  Dorywalska, M.; Dushin, R.; Moine, L.; Farias, S. E.; Zhou, D.; Navaratnam, T.; Lui, V.; 
Hasa-Moreno, A.; Casas, M. G.; Tran, T.-T.; Delaria, K.; Liu, S.-H.; Foletti, D.; O’Donnell, 
C. J.; Pons, J.; Shelton, D. L.; Rajpal, A.; Strop, P. Molecular Basis of Valine-Citrulline-
PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. Mol 
Cancer Ther 2016, 15 (5), 958–970. https://doi.org/10.1158/1535-7163.mct-15-1004. 
(170)  Caculitan, N. G.; dela Cruz Chuh, J.; Ma, Y.; Zhang, D.; Kozak, K. R.; Liu, Y.; Pillow, T. 
H.; Sadowsky, J.; Cheung, T. K.; Phung, Q.; Haley, B.; Lee, B.-C.; Akita, R. W.; 
Sliwkowski, M. X.; Polson, A. G. Cathepsin B Is Dispensable for Cellular Processing of 
Cathepsin B-Cleavable Antibody–Drug Conjugates. Cancer Res. 2017, 77 (24), 7027. 
https://doi.org/10.1158/0008-5472.CAN-17-2391. 
(171)  Lam, M.-H.; Lucas, J.; Maderna, A.; Wald, H.; Wojciechowicz, M.; Dushin, R.; Peano, B.; 
Wang, F.; Myers, J.; Tan, X.; Musto, S.; Charati, M.; Gerber, H.-P.; Loganzo, F. Abstract 
4837: Extracellular Proteolytic Cleavage of Peptide-Linked Antibody-Drug Conjugates 
Promotes Bystander Killing of Cancer Cells. Cancer Res. 2014, 74 (19 Supplement), 
4837. https://doi.org/10.1158/1538-7445.AM2014-4837. 
(172)  Dal Corso, A.; Cazzamalli, S.; Gébleux, R.; Mattarella, M.; Neri, D. Protease-Cleavable 
Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates. 
Bioconjug. Chem. 2017, 28 (7), 1826–1833. 
https://doi.org/10.1021/acs.bioconjchem.7b00304. 
(173)  Joubert, N.; Beck, A.; Dumontet, C.; Denevault-Sabourin, C. Antibody–Drug Conjugates: 
The Last Decade. Pharmaceuticals 2020, 13 (9). https://doi.org/10.3390/ph13090245. 
(174)  Rashidian, M.; Ingram, J. R.; Dougan, M.; Dongre, A.; Whang, K. A.; LeGall, C.; 
Cragnolini, J. J.; Bierie, B.; Gostissa, M.; Gorman, J.; Grotenbreg, G. M.; Bhan, A.; 
Weinberg, R. A.; Ploegh, H. L. Predicting the Response to CTLA-4 Blockade by 
Longitudinal Noninvasive Monitoring of CD8 T Cells. J. Exp. Med. 2017, 214 (8), 2243–
2255. https://doi.org/10.1084/jem.20161950. 
(175)  Rabin, N.; Zheng, Y.; Opoku-Temeng, C.; Du, Y.; Bonsu, E.; Sintim, H. O. Biofilm 
Formation Mechanisms and Targets for Developing Antibiofilm Agents. Future Med. 
Chem. 2015, 7 (4), 493–512. https://doi.org/10.4155/fmc.15.6. 
(176)  Khatoon, Z.; McTiernan, C. D.; Suuronen, E. J.; Mah, T.-F.; Alarcon, E. I. Bacterial 
Biofilm Formation on Implantable Devices and Approaches to Its Treatment and 
Prevention. Heliyon 2018, 4 (12), e01067. https://doi.org/10.1016/j.heliyon.2018.e01067. 
(177)  Percival, S. L.; Suleman, L.; Vuotto, C.; Donelli, G. Healthcare-Associated Infections, 
Medical Devices and Biofilms: Risk, Tolerance and Control. Journal of Medical 
Microbiology, 2015, 64, 323–334. https://doi.org/10.1099/jmm.0.000032. 
(178)  Flemming, H.-C. Biofouling in Water Systems – Cases, Causes and Countermeasures. 
Appl. Microbiol. Biotechnol. 2002, 59 (6), 629–640. https://doi.org/10.1007/s00253-002-
1066-9. 
(179)  Wang, H.; Christiansen, D. E.; Mehraeen, S.; Cheng, G. Winning the Fight against 
Biofilms: The First Six-Month Study Showing No Biofilm Formation on Zwitterionic 
Polyurethanes. Chem. Sci. 2020, 11 (18), 4709–4721. 
https://doi.org/10.1039/C9SC06155J. 
(180)  Huang, S.; Bergonzi, C.; Schwab, M.; Elias, M.; Hicks, R. E. Evaluation of Biological and 
Enzymatic Quorum Quencher Coating Additives to Reduce Biocorrosion of Steel. PLOS 
ONE 2019, 14 (5), e0217059. https://doi.org/10.1371/journal.pone.0217059. 
(181)  Lejars, M.; Margaillan, A.; Bressy, C. Fouling Release Coatings: A Nontoxic Alternative to 




(182)  Bridier, A.; Briandet, R.; Thomas, V.; Dubois-Brissonnet, F. Resistance of Bacterial 
Biofilms to Disinfectants: A Review. Biofouling 2011, 27 (9), 1017–1032. 
https://doi.org/10.1080/08927014.2011.626899. 
(183)  Mah, T.-F. C.; O’Toole, G. A. Mechanisms of Biofilm Resistance to Antimicrobial Agents. 
Trends Microbiol. 2001, 9 (1), 34–39. https://doi.org/10.1016/S0966-842X(00)01913-2. 
(184)  Guardiola, F. A.; Cuesta, A.; Meseguer, J.; Esteban, M. A. Risks of Using Antifouling 
Biocides in Aquaculture. Int. J. Mol. Sci. 2012, 13 (2). 
https://doi.org/10.3390/ijms13021541. 
(185)  Chen, M.; Yu, Q.; Sun, H. Novel Strategies for the Prevention and Treatment of Biofilm 
Related Infections. Int. J. Mol. Sci. 2013, 14 (9). https://doi.org/10.3390/ijms140918488. 
(186)  Lowe, S.; O’Brien-Simpson, N. M.; Connal, L. A. Antibiofouling Polymer Interfaces: 
Poly(Ethylene Glycol) and Other Promising Candidates. Polym. Chem. 2015, 6 (2), 198–
212. https://doi.org/10.1039/C4PY01356E. 
(187)  Callow, J. A.; Callow, M. E. Trends in the Development of Environmentally Friendly 
Fouling-Resistant Marine Coatings. Nat. Commun. 2011, 2 (1), 244. 
https://doi.org/10.1038/ncomms1251. 
(188)  Lyon, G. J.; Muir, T. W. Chemical Signaling among Bacteria and Its Inhibition. Chem. 
Biol. 2003, 10 (11), 1007–1021. https://doi.org/10.1016/j.chembiol.2003.11.003. 
(189)  Ng Filomena S. W.; Wright Daniel M.; Seah Stephen Y. K. Characterization of a 
Phosphotriesterase-Like Lactonase from Sulfolobus Solfataricus and Its Immobilization 
for Disruption of Quorum Sensing. Appl. Environ. Microbiol. 2011, 77 (4), 1181–1186. 
https://doi.org/10.1128/AEM.01642-10. 
(190)  Kim, J.-H.; Choi, D.-C.; Yeon, K.-M.; Kim, S.-R.; Lee, C.-H. Enzyme-Immobilized 
Nanofiltration Membrane To Mitigate Biofouling Based on Quorum Quenching. Environ. 
Sci. Technol. 2011, 45 (4), 1601–1607. https://doi.org/10.1021/es103483j. 
(191)  Jiang, W.; Xia, S.; Liang, J.; Zhang, Z.; Hermanowicz, S. W. Effect of Quorum Quenching 
on the Reactor Performance, Biofouling and Biomass Characteristics in Membrane 
Bioreactors. Water Res. 2013, 47 (1), 187–196. 
https://doi.org/10.1016/j.watres.2012.09.050. 
(192)  Lee, B.; Yeon, K.-M.; Shim, J.; Kim, S.-R.; Lee, C.-H.; Lee, J.; Kim, J. Effective 
Antifouling Using Quorum-Quenching Acylase Stabilized in Magnetically-Separable 
Mesoporous Silica. Biomacromolecules 2014, 15 (4), 1153–1159. 
https://doi.org/10.1021/bm401595q. 
(193)  Rémy, B.; Plener, L.; Poirier, L.; Elias, M.; Daudé, D.; Chabrière, E. Harnessing 
Hyperthermostable Lactonase from Sulfolobus Solfataricus for Biotechnological 
Applications. Sci. Rep. 2016, 6 (1), 37780. https://doi.org/10.1038/srep37780. 
(194)  Bzdrenga, J.; Daudé, D.; Rémy, B.; Jacquet, P.; Plener, L.; Elias, M.; Chabrière, E. 
Biotechnological Applications of Quorum Quenching Enzymes. First Int. Conf. CBRN 
Res. Innov. 2017, 267, 104–115. https://doi.org/10.1016/j.cbi.2016.05.028. 
(195)  Hiblot, J.; Gotthard, G.; Elias, M.; Chabriere, E. Differential Active Site Loop 
Conformations Mediate Promiscuous Activities in the Lactonase SsoPox. PLOS ONE 
2013, 8 (9), e75272. https://doi.org/10.1371/journal.pone.0075272. 
(196)  Vervacke, J. S.; Funk, A. L.; Wang, Y.-C.; Strom, M.; Hrycyna, C. A.; Distefano, M. D. 
Diazirine-Containing Photoactivatable Isoprenoid: Synthesis and Application in Studies 
with Isoprenylcysteine Carboxyl Methyltransferase. J. Org. Chem. 2014, 79 (5), 1971–
1978. 
(197)  Bryant, K. L.; Mancias, J. D.; Kimmelman, A. C.; Der, C. J. KRAS: Feeding Pancreatic 
Cancer Proliferation. Trends Biochem. Sci. 2014, 39 (2), 91–100. 
https://doi.org/10.1016/j.tibs.2013.12.004. 
(198)  DeGraw, A. J.; Palsuledesai, C.; Ochocki, J. D.; Dozier, J. K.; Lenevich, S.; Rashidian, 
M.; Distefano, M. D. Evaluation of Alkyne-Modified Isoprenoids as Chemical Reporters of 
Protein Prenylation. Chem. Biol. Drug Des. 2010, 76 (6), 460–471. 
https://doi.org/10.1111/j.1747-0285.2010.01037.x. 
(199)  Del Vecchio, P.; Elias, M.; Merone, L.; Graziano, G.; Dupuy, J.; Mandrich, L.; Carullo, P.; 
Fournier, B.; Rochu, D.; Rossi, M.; Masson, P.; Chabriere, E.; Manco, G. Structural 
Determinants of the High Thermal Stability of SsoPox from the Hyperthermophilic 
 
 189
Archaeon Sulfolobus Solfataricus. Extremophiles 2009, 13 (3), 461–470. 
https://doi.org/10.1007/s00792-009-0231-9. 
(200)  Luo, Q.; Joubert, M. K.; Stevenson, R.; Ketchem, R. R.; Narhi, L. O.; Wypych, J. 
Chemical Modifications in Therapeutic Protein Aggregates Generated under Different 
Stress Conditions. J. Biol. Chem. 2011, 286 (28), 25134–25144. 
https://doi.org/10.1074/jbc.M110.160440. 
(201)  Tanase, M.; Urbanska, A. M.; Zolla, V.; Clement, C. C.; Huang, L.; Morozova, K.; Follo, 
C.; Goldberg, M.; Roda, B.; Reschiglian, P.; Santambrogio, L. Role of Carbonyl 
Modifications on Aging-Associated Protein Aggregation. Sci. Rep. 2016, 6 (1), 19311. 
https://doi.org/10.1038/srep19311. 
(202)  Dubinsky, L.; Krom, B. P.; Meijler, M. M. Diazirine Based Photoaffinity Labeling. Chem. 
Proteomics 2012, 20 (2), 554–570. https://doi.org/10.1016/j.bmc.2011.06.066. 
(203)  Kim, W.-J.; Kim, A.; Huh, C.; Park, C. W.; Ah, C. S.; Kim, B. K.; Yang, J.-H.; Chung, K. 
H.; Choi, Y. H.; Hong, J.; Sung, G. Y. Photo Selective Protein Immobilization Using 
Bovine Serum Albumin. Appl. Surf. Sci. 2012, 261, 880–889. 
https://doi.org/10.1016/j.apsusc.2012.08.111. 
(204)  McCormick, A. M.; Wijekoon, A.; Leipzig, N. D. Specific Immobilization of Biotinylated 
Fusion Proteins NGF and Sema3A Utilizing a Photo-Cross-Linkable Diazirine Compound 
for Controlling Neurite Extension. Bioconjug. Chem. 2013, 24 (9), 1515–1526. 
https://doi.org/10.1021/bc400058n. 
(205)  Isomursu, A.; Park, K.-Y.; Hou, J.; Cheng, B.; Shamsan, G.; Fuller, B.; Kasim, J.; 
Mahmoodi, M. M.; Lu, T. J.; Genin, G. M.; Xu, F.; Lin, M.; Distefano, M.; Ivaska, J.; Odde, 
D. J. Negative Durotaxis: Cell Movement toward Softer Environments. bioRxiv 2020, 
2020.10.27.357178. https://doi.org/10.1101/2020.10.27.357178. 
(206)  Deegan, R. D.; Bakajin, O.; Dupont, T. F.; Huber, G.; Nagel, S. R.; Witten, T. A. Capillary 
Flow as the Cause of Ring Stains from Dried Liquid Drops. Nature 1997, 389 (6653), 
827–829. https://doi.org/10.1038/39827. 
(207)  Cui, L.; Zhang, J.; Zhang, X.; Huang, L.; Wang, Z.; Li, Y.; Gao, H.; Zhu, S.; Wang, T.; 
Yang, B. Suppression of the Coffee Ring Effect by Hydrosoluble Polymer Additives. ACS 
Appl. Mater. Interfaces 2012, 4 (5), 2775–2780. https://doi.org/10.1021/am300423p. 
(208)  Still, T.; Yunker, P. J.; Yodh, A. G. Surfactant-Induced Marangoni Eddies Alter the 
Coffee-Rings of Evaporating Colloidal Drops. Langmuir 2012, 28 (11), 4984–4988. 
https://doi.org/10.1021/la204928m. 
(209)  Ostrom, Q. T.; Gittleman, H.; Fulop, J.; Liu, M.; Blanda, R.; Kromer, C.; Wolinsky, Y.; 
Kruchko, C.; Barnholtz-Sloan, J. S. CBTRUS Statistical Report: Primary Brain and 
Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro-
Oncol. 2015, 17 (suppl_4), iv1–iv62. https://doi.org/10.1093/neuonc/nov189. 
(210)  Giese, A.; Bjerkvig, R.; Berens, M. E.; Westphal, M. Cost of Migration: Invasion of 
Malignant Gliomas and Implications for Treatment. J. Clin. Oncol. 2003, 21 (8), 1624–
1636. https://doi.org/10.1200/JCO.2003.05.063. 
(211)  Lo, C. M.; Wang, H. B.; Dembo, M.; Wang, Y. L. Cell Movement Is Guided by the Rigidity 
of the Substrate. Biophys. J. 2000, 79 (1), 144–152. 
(212)  Isenberg, B. C.; DiMilla, P. A.; Walker, M.; Kim, S.; Wong, J. Y. Vascular Smooth Muscle 
Cell Durotaxis Depends on Substrate Stiffness Gradient Strength. Biophys. J. 2009, 97 
(5), 1313–1322. https://doi.org/10.1016/j.bpj.2009.06.021. 
(213)  Hadden, W. J.; Young, J. L.; Holle, A. W.; McFetridge, M. L.; Kim, D. Y.; Wijesinghe, P.; 
Taylor-Weiner, H.; Wen, J. H.; Lee, A. R.; Bieback, K.; Vo, B.-N.; Sampson, D. D.; 
Kennedy, B. F.; Spatz, J. P.; Engler, A. J.; Choi, Y. S. Stem Cell Migration and 
Mechanotransduction on Linear Stiffness Gradient Hydrogels. Proc. Natl. Acad. Sci. 
2017, 114 (22), 5647–5652. https://doi.org/10.1073/pnas.1618239114. 
(214)  Kim, T. H.; An, D. B.; Oh, S. H.; Kang, M. K.; Song, H. H.; Lee, J. H. Creating Stiffness 
Gradient Polyvinyl Alcohol Hydrogel Using a Simple Gradual Freezing-Thawing Method 




(215)  Jiang, F. X.; Yurke, B.; Schloss, R. S.; Firestein, B. L.; Langrana, N. A. Effect of Dynamic 
Stiffness of the Substrates on Neurite Outgrowth by Using a DNA-Crosslinked Hydrogel. 
Tissue Eng. Part A 2010, 16 (6), 1873–1889. https://doi.org/10.1089/ten.TEA.2009.0574. 
(216)  Bouchonville, N.; Meyer, M.; Gaude, C.; Gay, E.; Ratel, D.; Nicolas, A. AFM Mapping of 
the Elastic Properties of Brain Tissue Reveals KPa Μm−1 Gradients of Rigidity. Soft 
Matter 2016, 12 (29), 6232–6239. https://doi.org/10.1039/C6SM00582A. 
(217)  Kloxin, A. M.; Tibbitt, M. W.; Kasko, A. M.; Fairbairn, J. A.; Anseth, K. S. Tunable 
Hydrogels for External Manipulation of Cellular Microenvironments through Controlled 
Photodegradation. Adv. Mater. 2010, 22 (1), 61–66. 
https://doi.org/10.1002/adma.200900917. 
(218)  Frey, M. T.; Wang, Y.-L. A Photo-Modulatable Material for Probing Cellular Responses to 
Substrate Rigidity. Soft Matter 2009, 5, 1918–1924. https://doi.org/10.1039/b818104g. 
(219)  Wieboldt, R.; Gee, K. R.; Niu, L.; Ramesh, D.; Carpenter, B. K.; Hess, G. P. Photolabile 
Precursors of Glutamate: Synthesis, Photochemical Properties, and Activation of 
Glutamate Receptors on a Microsecond Time Scale. Proc. Natl. Acad. Sci. U. S. A. 1994, 
91 (19), 8752–8756. 
(220)  Kloxin, A. M.; Kasko, A. M.; Salinas, C. N.; Anseth, K. S. Photodegradable Hydrogels for 
Dynamic Tuning of Physical and Chemical Properties. Science 2009, 324 (5923), 59–63. 
https://doi.org/10.1126/science.1169494. 
(221)  Rosales, A. M.; Vega, S. L.; DelRio, F. W.; Burdick, J. A.; Anseth, K. S. Hydrogels with 
Reversible Mechanics to Probe Dynamic Cell Microenvironments. Angew. Chem. Int. Ed 
Engl. 2017, 56 (40), 12132–12136. https://doi.org/10.1002/anie.201705684. 
(222)  Luo, Y.; Shoichet, M. S. A Photolabile Hydrogel for Guided Three-Dimensional Cell 
Growth and Migration. Nat. Mater. 2004, 3 (4), 249–253. 
https://doi.org/10.1038/nmat1092. 
(223)  Norris, S. C. P.; Soto, J.; Kasko, A. M.; Li, S. Photodegradable Polyacrylamide Gels for 
Dynamic Control of Cell Functions. ACS Appl. Mater. Interfaces 2021. 
https://doi.org/10.1021/acsami.0c19627. 
(224)  Wang, Y. L.; Pelham, R. J. Preparation of a Flexible, Porous Polyacrylamide Substrate 
for Mechanical Studies of Cultured Cells. Methods Enzymol. 1998, 298, 489–496. 
https://doi.org/10.1016/s0076-6879(98)98041-7. 
(225)  Chan, C. E.; Odde, D. J. Traction Dynamics of Filopodia on Compliant Substrates. 
Science 2008, 322 (5908), 1687–1691. https://doi.org/10.1126/science.1163595. 
(226)  Denisin, A. K.; Pruitt, B. L. Tuning the Range of Polyacrylamide Gel Stiffness for 
Mechanobiology Applications. ACS Appl. Mater. Interfaces 2016, 8 (34), 21893–21902. 
https://doi.org/10.1021/acsami.5b09344. 
(227)  Radola, B. J. ULTRATHIN-LAYER ISOELECTRIC FOCUSING IN 50-100 Pm 
POLYACRYLAMIDE GELS ON SILANIZED GLASS PLATES OR POLYESTER FILMS; 
Radola, B. J., International Conference on Electrophoresis <2, 1979, München>, Eds.; 
De Gruyter, 2019; pp 79–94. https://doi.org/10.1515/9783111713625-007. 
(228)  Yoon, J.; Kim, J.; Hayward, R. C. Nucleation, Growth, and Hysteresis of Surface Creases 
on Swelled Polymer Gels. Soft Matter 2010, 6 (22), 5807–5816. 
https://doi.org/10.1039/C0SM00372G. 
(229)  Trujillo, V.; Kim, J.; Hayward, R. C. Creasing Instability of Surface-Attached Hydrogels. 
Soft Matter 2008, 4 (3), 564–569. https://doi.org/10.1039/B713263H. 
(230)  Bangasser, B. L.; Shamsan, G. A.; Chan, C. E.; Opoku, K. N.; Tüzel, E.; Schlichtmann, 
B. W.; Kasim, J. A.; Fuller, B. J.; McCullough, B. R.; Rosenfeld, S. S.; Odde, D. J. 
Shifting the Optimal Stiffness for Cell Migration. Nat. Commun. 2017, 8 (1), 1–10. 
https://doi.org/10.1038/ncomms15313. 
(231)  Ladoux, B.; Mège, R.-M.; Trepat, X. Front-Rear Polarization by Mechanical Cues: From 
Single Cells to Tissues. Trends Cell Biol. 2016, 26 (6), 420–433. 
https://doi.org/10.1016/j.tcb.2016.02.002. 
(232)  Hamidi, H.; Ivaska, J. Every Step of the Way: Integrins in Cancer Progression and 




(233)  Plotnikov, S. V.; Pasapera, A. M.; Sabass, B.; Waterman, C. M. Force Fluctuations within 
Focal Adhesions Mediate ECM-Rigidity Sensing to Guide Directed Cell Migration. Cell 
2012, 151 (7), 1513–1527. https://doi.org/10.1016/j.cell.2012.11.034. 
(234)  Breckenridge, M. T.; Desai, R. A.; Yang, M. T.; Fu, J.; Chen, C. S. Substrates with 
Engineered Step Changes in Rigidity Induce Traction Force Polarity and Durotaxis. Cell. 
Mol. Bioeng. 2014, 7 (1), 26–34. https://doi.org/10.1007/s12195-013-0307-6. 
(235)  Sunyer, R.; Conte, V.; Escribano, J.; Elosegui-Artola, A.; Labernadie, A.; Valon, L.; 
Navajas, D.; Garcia-Aznar, J. M.; Munoz, J. J.; Roca-Cusachs, P.; Trepat, X. Collective 
Cell Durotaxis Emerges from Long-Range Intercellular Force Transmission. Science 
2016, 353 (6304), 1157–1161. https://doi.org/10.1126/science.aaf7119. 
(236)  DuChez, B. J.; Doyle, A. D.; Dimitriadis, E. K.; Yamada, K. M. Durotaxis by Human 
Cancer Cells. Biophys. J. 2019, 116 (4), 670–683. 
https://doi.org/10.1016/j.bpj.2019.01.009. 
(237)  Barriga, E. H.; Franze, K.; Charras, G.; Mayor, R. Tissue Stiffening Coordinates 
Morphogenesis by Triggering Collective Cell Migration in Vivo. Nature 2018, 554 (7693), 
523–527. https://doi.org/10.1038/nature25742. 
(238)  Zhu, M.; Tao, H.; Samani, M.; Luo, M.; Wang, X.; Hopyan, S.; Sun, Y. Spatial Mapping of 
Tissue Properties in Vivo Reveals a 3D Stiffness Gradient in the Mouse Limb Bud. Proc. 
Natl. Acad. Sci. 2020, 117 (9), 4781–4791. https://doi.org/10.1073/pnas.1912656117. 
(239)  McKenzie, A. J.; Hicks, S. R.; Svec, K. V.; Naughton, H.; Edmunds, Z. L.; Howe, A. K. 
The Mechanical Microenvironment Regulates Ovarian Cancer Cell Morphology, 
Migration, and Spheroid Disaggregation. Sci. Rep. 2018, 8 (1), 1–20. 
https://doi.org/10.1038/s41598-018-25589-0. 
(240)  Hartman, C. D.; Isenberg, B. C.; Chua, S. G.; Wong, J. Y. Vascular Smooth Muscle Cell 
Durotaxis Depends on Extracellular Matrix Composition. Proc. Natl. Acad. Sci. 2016, 113 
(40), 11190–11195. https://doi.org/10.1073/pnas.1611324113. 
(241)  Lachowski, D.; Cortes, E.; Robinson, B.; Rice, A.; Rombouts, K.; Del Río Hernández, A. 
E. FAK Controls the Mechanical Activation of YAP, a Transcriptional Regulator Required 
for Durotaxis. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2018, 32 (2), 1099–1107. 
https://doi.org/10.1096/fj.201700721R. 
(242)  Puleo, J. I.; Parker, S. S.; Roman, M. R.; Watson, A. W.; Eliato, K. R.; Peng, L.; Saboda, 
K.; Roe, D. J.; Ros, R.; Gertler, F. B.; Mouneimne, G. Mechanosensing during Directed 
Cell Migration Requires Dynamic Actin Polymerization at Focal Adhesions. J. Cell Biol. 
2019, 218 (12), 4215–4235. https://doi.org/10.1083/jcb.201902101. 
(243)  Abercrombie, M. The Croonian Lecture, 1978 - The Crawling Movement of Metazoan 
Cells. Proc. R. Soc. Lond. B Biol. Sci. 1980, 207 (1167), 129–147. 
https://doi.org/10.1098/rspb.1980.0017. 
(244)  Mitchison, T.; Kirschner, M. Cytoskeletal Dynamics and Nerve Growth. Neuron 1988, 1 
(9), 761–772. https://doi.org/10.1016/0896-6273(88)90124-9. 
(245)  Elosegui-Artola, A.; Oria, R.; Chen, Y.; Kosmalska, A.; Pérez-González, C.; Castro, N.; 
Zhu, C.; Trepat, X.; Roca-Cusachs, P. Mechanical Regulation of a Molecular Clutch 
Defines Force Transmission and Transduction in Response to Matrix Rigidity. Nat. Cell 
Biol. 2016, 18 (5), 540–548. https://doi.org/10.1038/ncb3336. 
(246)  DiMilla, P. A.; Barbee, K.; Lauffenburger, D. A. Mathematical Model for the Effects of 
Adhesion and Mechanics on Cell Migration Speed. Biophys. J. 1991, 60 (1), 15–37. 
https://doi.org/10.1016/S0006-3495(91)82027-6. 
(247)  Klank, R. L.; Decker Grunke, S. A.; Bangasser, B. L.; Forster, C. L.; Price, M. A.; Odde, 
T. J.; SantaCruz, K. S.; Rosenfeld, S. S.; Canoll, P.; Turley, E. A.; McCarthy, J. B.; 
Ohlfest, J. R.; Odde, D. J. Biphasic Dependence of Glioma Survival and Cell Migration 
on CD44 Expression Level. Cell Rep. 2017, 18 (1), 23–31. 
https://doi.org/10.1016/j.celrep.2016.12.024. 
(248)  Rens, E. G.; Merks, R. M. H. Cell Shape and Durotaxis Explained from Cell-Extracellular 




(249)  Schmidt, C. E.; Dai, J.; Lauffenburger, D. A.; Sheetz, M. P.; Horwitz, A. F. Integrin-
Cytoskeletal Interactions in Neuronal Growth Cones. J. Neurosci. Off. J. Soc. Neurosci. 
1995, 15 (5 Pt 1), 3400–3407. 
(250)  Koser, D. E.; Thompson, A. J.; Foster, S. K.; Dwivedy, A.; Pillai, E. K.; Sheridan, G. K.; 
Svoboda, H.; Viana, M.; Costa, L. da F.; Guck, J.; Holt, C. E.; Franze, K. 
Mechanosensing Is Critical for Axon Growth in the Developing Brain. Nat. Neurosci. 
2016, 19 (12), 1592–1598. https://doi.org/10.1038/nn.4394. 
(251)  Franze, K. Integrating Chemistry and Mechanics: The Forces Driving Axon Growth. 
Annu. Rev. Cell Dev. Biol. 2020, 36 (1), 61–83. https://doi.org/10.1146/annurev-cellbio-
100818-125157. 
(252)  Bangasser, B. L.; Odde, D. J. Master Equation-Based Analysis of a Motor-Clutch Model 
for Cell Traction Force. Cell. Mol. Bioeng. 2013, 6 (4), 449–459. 
https://doi.org/10.1007/s12195-013-0296-5. 
(253)  Bangasser, B. L.; Rosenfeld, S. S.; Odde, D. J. Determinants of Maximal Force 
Transmission in a Motor-Clutch Model of Cell Traction in a Compliant Microenvironment. 
Biophys. J. 2013, 105 (3), 581–592. https://doi.org/10.1016/j.bpj.2013.06.027. 
(254)  Cheng, B.; Lin, M.; Li, Y.; Huang, G.; Yang, H.; Genin, G. M.; Deshpande, V. S.; Lu, T. J.; 
Xu, F. An Integrated Stochastic Model of Matrix-Stiffness-Dependent Filopodial 
Dynamics. Biophys. J. 2016, 111 (9), 2051–2061. 
https://doi.org/10.1016/j.bpj.2016.09.026. 
(255)  Lerche, M.; Elosegui-Artola, A.; Kechagia, J. Z.; Guzmán, C.; Georgiadou, M.; Andreu, I.; 
Gullberg, D.; Roca-Cusachs, P.; Peuhu, E.; Ivaska, J. Integrin Binding Dynamics 
Modulate Ligand-Specific Mechanosensing in Mammary Gland Fibroblasts. iScience 
2020, 23 (3), 100907. https://doi.org/10.1016/j.isci.2020.100907. 
(256)  Barber-Pérez, N.; Georgiadou, M.; Guzmán, C.; Isomursu, A.; Hamidi, H.; Ivaska, J. 
Mechano-Responsiveness of Fibrillar Adhesions on Stiffness-Gradient Gels. J. Cell Sci. 
2020, 133 (12). https://doi.org/10.1242/jcs.242909. 
(257)  Miroshnikova, Y. A.; Mouw, J. K.; Barnes, J. M.; Pickup, M. W.; Lakins, J. N.; Kim, Y.; 
Lobo, K.; Persson, A. I.; Reis, G. F.; McKnight, T. R.; Holland, E. C.; Phillips, J. J.; 
Weaver, V. M. Tissue Mechanics Promote IDH1-Dependent HIF1α-Tenascin C 
Feedback to Regulate Glioblastoma Aggression. Nat. Cell Biol. 2016, 18 (12), 1336–
1345. https://doi.org/10.1038/ncb3429. 
(258)  Kechagia, J. Z.; Ivaska, J.; Roca-Cusachs, P. Integrins as Biomechanical Sensors of the 
Microenvironment. Nat. Rev. Mol. Cell Biol. 2019, 20 (8), 457–473. 
https://doi.org/10.1038/s41580-019-0134-2. 
(259)  Atherton, P.; Stutchbury, B.; Wang, D.-Y.; Jethwa, D.; Tsang, R.; Meiler-Rodriguez, E.; 
Wang, P.; Bate, N.; Zent, R.; Barsukov, I. L.; Goult, B. T.; Critchley, D. R.; Ballestrem, C. 
Vinculin Controls Talin Engagement with the Actomyosin Machinery. Nat. Commun. 
2015, 6 (1), 1–12. https://doi.org/10.1038/ncomms10038. 
(260)  Cheng, B.; Wan, W.; Huang, G.; Li, Y.; Genin, G. M.; Mofrad, M. R. K.; Lu, T. J.; Xu, F.; 
Lin, M. Nanoscale Integrin Cluster Dynamics Controls Cellular Mechanosensing via 
FAKY397 Phosphorylation. Sci. Adv. 2020, 6 (10), eaax1909. 
https://doi.org/10.1126/sciadv.aax1909. 
(261)  Kanchanawong, P.; Shtengel, G.; Pasapera, A. M.; Ramko, E. B.; Davidson, M. W.; 
Hess, H. F.; Waterman, C. M. Nanoscale Architecture of Integrin-Based Cell Adhesions. 
Nature 2010, 468 (7323), 580–584. https://doi.org/10.1038/nature09621. 
(262)  Mason, D. E.; Collins, J. M.; Dawahare, J. H.; Nguyen, T. D.; Lin, Y.; Voytik-Harbin, S. L.; 
Zorlutuna, P.; Yoder, M. C.; Boerckel, J. D. YAP and TAZ Limit Cytoskeletal and Focal 
Adhesion Maturation to Enable Persistent Cell Motility. J. Cell Biol. 2019, 218 (4), 1369–
1389. https://doi.org/10.1083/jcb.201806065. 
(263)  Hou, J. C.; Shamsan, G. A.; Anderson, S. M.; McMahon, M. M.; Tyler, L. P.; Castle, B. 
T.; Heussner, R. K.; Provenzano, P. P.; Keefe, D. F.; Barocas, V. H.; Odde, D. J. 
Modeling Distributed Forces within Cell Adhesions of Varying Size on Continuous 
Substrates. Cytoskeleton 2019, 76 (11–12), 571–585. https://doi.org/10.1002/cm.21561. 
 
 193
(264)  Betz, T.; Koch, D.; Lu, Y.-B.; Franze, K.; Käs, J. A. Growth Cones as Soft and Weak 
Force Generators. Proc. Natl. Acad. Sci. 2011, 108 (33), 13420–13425. 
https://doi.org/10.1073/pnas.1106145108. 
(265)  Koch, D.; Rosoff, W. J.; Jiang, J.; Geller, H. M.; Urbach, J. S. Strength in the Periphery: 
Growth Cone Biomechanics and Substrate Rigidity Response in Peripheral and Central 
Nervous System Neurons. Biophys. J. 2012, 102 (3), 452–460. 
https://doi.org/10.1016/j.bpj.2011.12.025. 
(266)  Ghibaudo, M.; Saez, A.; Trichet, L.; Xayaphoummine, A.; Browaeys, J.; Silberzan, P.; 
Buguin, A.; Ladoux, B. Traction Forces and Rigidity Sensing Regulate Cell Functions. 
Soft Matter 2008, 4 (9), 1836–1843. https://doi.org/10.1039/B804103B. 
(267)  Kuipers, A. J.; Middelbeek, J.; Vrenken, K.; Pérez-González, C.; Poelmans, G.; 
Klarenbeek, J.; Jalink, K.; Trepat, X.; van Leeuwen, F. N. TRPM7 Controls Mesenchymal 
Features of Breast Cancer Cells by Tensional Regulation of SOX4. Biochim. Biophys. 
Acta Mol. Basis Dis. 2018, 1864 (7), 2409–2419. 
https://doi.org/10.1016/j.bbadis.2018.04.017. 
(268)  Fourriere, L.; Kasri, A.; Gareil, N.; Bardin, S.; Bousquet, H.; Pereira, D.; Perez, F.; Goud, 
B.; Boncompain, G.; Miserey-Lenkei, S. RAB6 and Microtubules Restrict Protein 
Secretion to Focal AdhesionsRAB6 and MTs Restrict Secretion to Focal Adhesions. J. 
Cell Biol. 2019, 218 (7), 2215–2231. https://doi.org/10.1083/jcb.201805002. 
(269)  Kobayashi, T.; Sokabe, M. Sensing Substrate Rigidity by Mechanosensitive Ion 
Channels with Stress Fibers and Focal Adhesions. Curr. Opin. Cell Biol. 2010, 22 (5), 
669–676. https://doi.org/10.1016/j.ceb.2010.08.023. 
(270)  Wang, Y. L.; Pelham, R. J. Preparation of a Flexible, Porous Polyacrylamide Substrate 
for Mechanical Studies of Cultured Cells. Methods Enzymol. 1998, 298, 489–496. 
https://doi.org/10.1016/s0076-6879(98)98041-7. 
(271)  Polio, S. R.; Smith, M. L. Patterned Hydrogels for Simplified Measurement of Cell 
Traction Forces. Methods Cell Biol. 2014, 121, 17–31. https://doi.org/10.1016/B978-0-12-
800281-0.00002-6. 
(272)  Théry, M.; Piel, M. Adhesive Micropatterns for Cells: A Microcontact Printing Protocol. 
Cold Spring Harb. Protoc. 2009. https://doi.org/10.1101/pdb.prot5255. 
(273)  Han, S. J.; Oak, Y.; Groisman, A.; Danuser, G. Traction Microscopy to Identify Force 
Modulation in Sub-Resolution Adhesions. Nat. Methods 2015, 12 (7), 653–656. 
https://doi.org/10.1038/nmeth.3430. 
(274)  Gillespie, D. T. Exact Stochastic Simulation of Coupled Chemical Reactions. J. Phys. 
Chem. 1977, 81 (25), 2340–2361. https://doi.org/10.1021/j100540a008. 
 
